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Abstract 
 The efficacy of three different wastewater treatment configurations, conventional 
activated sludge (CAS), nitrifying activated sludge (NAS) and biological nutrient 
removal (BNR) for removal of selected micropollutants from authentic wastewater was 
investigated. The processes were also characterized based on their proficiency to reduce 
the estrogenic activity of the influent wastewater using the in-vitro recombinant yeast 
assay. The selected micropollutants (MPs) covered a broad spectrum of therapeutic 
classes, i.e non-prescription analgesic (Ibuprofen (IBU)), anti-convulsant/epileptic 
(meprobamate (MEP) and carbamazepine (CBZ), lipid lowering drug (Gemfibrozil 
(GEM)), antibiotic (trimethoprim (TMP) and sulfamethoxazole (SMX)), steroid hormone 
(androstenedione (ADR)), estrogen (estrone (E1)) and estrogenic compounds (nonyl 
phenol (NP) and bisphenol A (BPA)). The removal efficiency of TMP improved with the 
complexity of the three treatment process configurations. IBU, ADR, SMX, NP, E1 and 
BPA had moderate to high removals (> 65%) while CBZ and MEP remained recalcitrant 
in the three treatment process configurations. The removal of GEM was better in the 
NAS than in BNR and CAS treatment configurations. The YES assay analyses showed 
an improvement in estrogenicity removal in the BNR and NAS treatment 
configurations as compared to the CAS treatment configuration. Comparing the 
estrogenic responses from the three treatment configurations, the removal efficiencies 
followed the order of BNR = NAS > CAS and all were greater than 81%. 
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The removal of estrogenicity in a University of Cape Town- biological nutrient 
removal (UCT-BNR) wastewater treatment processes was investigated using pilot and 
bench scale systems, batch experiments and mathematical modeling. In the pilot BNR 
process, 96 ± 5% of the estrogenicity exerted by the EDCs in the wastewater was 
removed by the treatment process. The degradation efficiencies in the anaerobic, anoxic 
and aerobic zones of the pilot BNR bioreactor were 11± 9%, 18 ± 2% and 93 ± 10% 
respectively. In order to further understand the performance of the BNR process in the 
removal of EDCs from wastewater, a bench scale BNR process was operated with 
synthetic wastewater dosed with E1 and E2. The removal of estrogenicity in the bench 
scale system (95 ± 5%) was comparable to the pilot BNR process and the degradation 
efficiencies were estimated to be 8± 0.8%, 38 ± 4% and 85 ± 22% in the anaerobic, anoxic 
and aerobic zones.  A biotransformation model developed to predict the fate of E1 and 
E2 in batch tests using the sludge from the BNR process was calibrated using the data 
from the experiments. The biotransformation rate constants for the transformation of E2 
to E1 were estimated as 71 ± 1.5, 31 ± 3.3 and 1 ± 0.9 L.gCOD-1d-1 for the aerobic, anoxic 
and anaerobic batch tests respectively while the corresponding biotransformation rate 
constants for the transformation of E1 were estimated to be 7.3 ± 1.0, 3 ± 2.0, and 0.85 ± 
0.6 L.gCOD-1d-1. A steady state mass balance model formulated to describe the 
interactions between E2 and E1 in BNR activated sludge reasonably described the fate 
of E1 and E2 in the BNR process.  
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A combination of pilot scale biological nutrient removal (BNR) process, batch 
experiments and modeling exercises were employed to investigate the removal and 
biotransformation of trimethoprim (TMP) in a BNR activated sludge. The 
concentrations of the active microbial groups- ammonia oxidizing bacteria (AOB), 
ordinary heterotrophic organism (OHO) and polyphosphate accumulating organism 
(PAO) in the BNR bioreactor were estimated to be 40, 780 and 2710 g COD/m3 
respectively. TMP was biotransformed in all the redox zones of the BNR bioreactor. The 
TMP biotransformation efficiencies in the anaerobic, anoxic and aerobic sections were 
13 ± 12%, 17 ± 10% and 24 ± 4% respectively. Batch tests with and without nitrification 
inhibition showed that AOB played a role in the biotransformation of TMP in BNR 
activated sludge.  A pseudo first order model that incorporated the contributions of 
PAO, OHO and AOB to the overall biodegradation of TMP was found to describe the 
biodegradation of TMP in batch tests with and without nitrification inhibition. The 
estimated biotransformation rate constant with respect to PAO, OHO and AOB were 
0.32 ± 0.06, 0.58 ± 0.06 and 13.7 ± 0.06 L/gCOD/d respectively. This model showed that 
PAOs, OHOs and AOBs contributed towards the biotransformation of TMP in BNR 
activated sludge with the trend AOBs = PAOs > OHOs. 
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Chapter 1 Introduction 
1.1  Background 
 Micropollutants (MPs) in wastewater have been reported as early as the 
1950’s (Stumm-Zollinger and Fair, 1965). However, recent interest of the presence 
of these compounds in the aquatic environment (Heberer, 2002; Kolpin et al., 
2002; Joss et al., 2005) was borne out of the advancement in analytical 
technologies available to detect trace levels of these compounds in different 
environmental matrices and the potential ecotoxicological effects of these 
compounds on aquatic organisms. This has led to the detection of MPs in 
wastewater treatment plants (WWTPs) effluents, surface waters, ground water, 
sediments and soil in Europe (Heberer, 2002; Carballa et al., 2004) North America 
(Kolpin et al., 2002) and Asia (Nakada et al., 2006).  These prior studies have 
recommended further investigation into the occurrence, fate, effect and 
attenuation of MPs in the environment. 
 Micropollutants such as human and veterinary pharmaceuticals and their 
metabolites, natural and synthetic endocrine disrupting compounds are usually 
excreted via urine and feces or inappropriately disposed in the septic system and 
can subsequently enter into the aquatic environment through municipal 
wastewater treatment plant effluents (Daughton and Ternes, 1999). Appendix A 
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presents a summary of the sources and distribution of pharmaceuticals in the 
environment. 
Wastewater treatment plant effluents have been identified as an important 
point of discharge for MPs into the aquatic environment (Koplin et al., 2002; Joss 
et al., 2004; Clara et al., 2005a) because WWTPs are not typically designed to 
remove MPs. The limited removals of MPs that have been reported from 
wastewater treatment processes are considered to be due to cometabolism 
because the concentrations at which the MPs exist in the WWTP influent are too 
low to sustain microbial growth or metabolic activities like conventional soluble 
organic substrates. The complex chemical structure of some MPs also enhances 
their persistence and recalcitrance during wastewater treatment.  
The concern about MPs has been accentuated by reports of gonad and 
reproductive abnormalities in various trophic levels of aquatic organisms at very 
low concentrations (Purdom et al., 1994; Gagne and Blaise, 1998; Fent et al., 2006). 
Thereafter, several questions have been raised concerning the chemical 
persistence, microbial resistance and synergistic effects of the cocktail of MPs 
present in the effluents of WWTP.   
Tertiary wastewater treatment technologies such as advanced oxidation 
process (using UV, hydrogen peroxide or ozone) and membrane technologies 
(using MBR, nano-filtration and reverse osmosis) have been reported to deliver 
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higher removal of MPs from wastewater (Ternes et al., 2003) as compared to 
conventional treatment methods.  However, there are concerns of producing 
more toxic oxidation by-products or metabolites during the use of advanced 
oxidation process to treat wastewater (Magdeburg et al., 2012; Maletz et al., 
2013). In addition, these tertiary treatment processes are energy intensive, 
resulting in increased operational cost to the plant owners. Therefore, the 
optimization of the operation of existing biological wastewater treatment 
processes to remove MPs is desirable. 
It is hypothesized that advanced biological wastewater treatment process 
such as BNR process could be optimized to deliver higher removal efficiencies of 
MPs as compared to conventional activated sludge treatment processes. The 
BNR processes develops a complex microbial consortia in unique reactor 
configurations to remove COD, nitrogen and phosphorus from wastewater. The 
important fundamental metabolic processes that occur in a typical BNR process 
include; nitrification, denitrification and biological phosphorus removal. These 
processes are mediated by diverse microorganisms that exists under different 
redox conditions and these organisms may cometabolically degrade MPs along 
with the utilization of macropollutants as growth substrates. Hence, the BNR 
process has the potential to degrade MPs in wastewater. 
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The microbial populations that exist in a BNR process vary, but based on 
the metabolic processes mediated by these organisms, three major groups can be 
identified, namely ammonia oxidizing bacteria (AOBs), ordinary heterotrophic 
organisms (OHOs) and phosphorus accumulating organism (PAOs). The AOBs 
mediates nitrification reaction while utilizing ammonia for growth and cellular 
maintenance, the OHOs mediate a wide range of processes including COD 
removal, hydrolysis, ammonification (conversion of organic nitrogen to 
ammonia), fermentation in anaerobic zones, and so on. The PAOs are responsible 
for the biological phosphorus removal from the process. Hence, the PAOs, OHOs 
and AOBs collectively co-exist in BNR activated sludge but function differently 
depending on the prevailing redox condition (Tchobanoglous et al., 2003).  
The role of the microbial communities in the biotransformation of MPs in 
activated sludge systems has been previously treated as a “black box”, where all 
the microbial communities are lumped together in one single term as mixed 
liquor suspended solid (MLSS) or mixed liquor volatile suspended solid 
(MLVSS) (Cowan et al., 1993-WWTreat; Monteith et al., 1995-ToxchemTM; Plotz et 
al., 2010-WEST®). This approach has been employed because of the difficulty in 
determining the active fractions of the various biomass groups, thus it is usually 
practiced in the modeling of the biotransformation of MPs in activated sludge 
system. The disadvantage of using MLSS or MLVSS for predicting the 
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biotransformation kinetics of MPs is that MLSS or MLVSS contains both active 
and inactive fractions of the biomass. While the inactive fraction does not 
contribute to the biotransformation of MPs, the active biomass is dependent on 
the process operating and design conditions (Layton et al., 2000). The dynamics 
of the microorganisms present in an activated sludge varies depending on the 
operating condition and configuration of the bioreactor and the ability of an 
activated sludge to degrade MPs strongly depends on the presence of 
appropriate microbial population (Tchobanoglous et al., 2003). Therefore, the use 
of the active biomass concentration rather than MLSS concentration should give 
a better description of the biotransformation kinetics of MPs in activated sludge 
systems. 
There are very few reports on the contribution of heterotrophic organisms 
to the biotransformation of MPs in activated sludge. Previous studies have 
identified some of the microorganisms responsible for MPs’ biotransformation in 
activated sludge systems (Shi et al., 2004; Gaulke et al., 2008; Khunjar et al., 2011), 
although this issue still remains debatable. These studies suggest that 
heterotrophic organisms co-contribute or predominantly contribute to the 
biotransformation of some MPs in activated sludge systems (Gaulke et al., 2008; 
Khunjar et al., 2011; Majewsky et al., 2011). However, no study has specifically 
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investigated the role of PAOs, OHOs and AOBs in the biotransformation of MPs 
in BNR activated sludge systems.  
The presence of different redox conditions is important to the operation of 
a BNR process because the alternating redox zones proliferate PAOs for 
biological phosphorus removal. Previous studies have shown that combined 
anaerobic/anoxic/aerobic processes may create favorable conditions for the 
removal of MPs in WWTPs (Li et al., 2010; Joss et al., 2004; Dytzak et al., 2008). 
Biodegradation of MPs like E1, E2 and EE2 has been found to depend on redox 
conditions, for example, a configuration of anaerobic/aerobic/anoxic yielded 18% 
overall removal of E2 while a sequence of anoxic/anoxic/aerobic and 
anaerobic/anoxic/aerobic yielded overall removal of 80% and 97.6% of E2 
respectively. These results suggest the possibility of a relationship between the 
redox zones in a BNR process and the removal of MPs as well as the importance 
of the zone sequencing in a BNR system because of the variability in the removal 
efficiencies in the different redox zones and with different redox zone 
arrangements in a multi-redox zone system. However, the data in literature on 
which this premise was based is limited. Therefore, further study is required to 
elucidate the contribution of redox conditions to the removal of MPs in BNR 
wastewater treatment processes. 
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Assessing the biological effects of MPs on the flora and fauna of the 
aquatic ecosystem is an indispensable tool for conducting detailed and 
appropriate risk assessment of MPs in the environment. Unlike chemical 
analyses that can provide a quantitative measure of the compounds present in a 
sample, biological analyses such as in vitro bioassays can provide a qualitative 
and quantitative measure of the estrogenic potential or estrogenicity of all the 
endocrine disrupting compounds (EDCs) that are present in an effluent (Leusch 
et al., 2010). Previous studies have investigated the removal of MPs in 
wastewater using different wastewater treatment technologies, but it has not 
been conclusively established whether an improved removal of MPs will 
translate into a reduction in the biological effects or estrogenicity. Hence, the 
investigation of the removal of MPs in a wastewater treatment process in relation 
to the degree of the estrogenic response in the effluents will provide a holistic 
approach in determining the performance of the treatment process. 
  A comprehensive review conducted by Pomies et al (2013) on modeling of 
MPs in biological wastewater treatment recommended the need for further 
research on the effects of oxidation-reduction conditions on biodegradation of 
MPs, the need for authors to clearly specify the operating conditions that guides 
the domain of validity of their models and the estimation of the active biomass 
fraction that mediates biodegradation or biotransformation of MPs.  Therefore, 
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there is the need to elucidate the role of PAO, OHO and AOB in the removal of 
MPs from wastewater, investigate the effects of redox conditions on the 
biotransformation of MPs in activated sludge systems and ultimately assess the 
treated effluent quality with respect to the removal of estrogenicity.  
1.2 Scope and Objectives 
  The overall scope of this study was to assess the impact of BNR process 
design and operating conditions on the removal of micropollutants from 
wastewater. The specific objectives of the research conducted over the course of 
this study were to: 
 Compare the performance of different activated sludge process 
configurations in terms of the removal of MPs and estrogenicity. 
 Assess the removal of endocrine disrupting compounds in BNR wastewater 
treatment process. 
 Elucidate the effects of redox conditions on the removal of MPs in a BNR 
process.  
 Evaluate the role of the active microbial groups in a BNR process 
bioreactor in the biodegradation of micropollutants.  
A portion of this research work was carried out at the Wastewater 
Technology Center (Science and Technology branch of Environment Canada), in 
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Burlington, Ontario. Existing pilot scale activated sludge treatment processes 
were employed in this research work while bench-scale BNR and batch tests 
were designed and operated in the University of Waterloo laboratory. The 
Wastewater Technology Center was suitable for this research study because the 
pilot plants had access to authentic wastewater from the Burlington Skyway 
WWTP and the center provided the logistics and technical support for the 
operation of the pilot plants. 
1.3 Thesis Outline    
  This thesis is divided into six chapters, references and seven appendices. 
Chapter one presents the introduction to the problem under investigation, the 
scope and objectives of the research work. Chapter two contains the literature 
review on micropollutants, BNR process, BNR process configurations, operating 
conditions necessary for biological phosphorus removal in BNR process, 
activated sludge microorganisms involved in MPs degradation, MPs removal 
mechanisms, MPs removal from wastewater and endocrine disrupting 
compounds in sewage treatment plant.  Chapters three, four and five are 
presented in paper format investigating the specified objectives. Chapter six 
contains the conclusions of the research, recommendations and suggestions for 
future research.  
 
  
10 
 
 
 
Chapter 2 Literature Review 
  This chapter reviews the important processes and the mediating 
organisms in a typical BNR system. The background information required to 
understand the operation of a typical BNR process was reviewed in this section. 
MP removal mechanisms and the role of the bacterial community in the removal 
of MPs were reviewed. Endocrine disrupting compounds in wastewater and the 
available biological analytical techniques were reviewed to determine the 
appropriate bioassay for qualitative and quantitative analysis. 
2.1 Micropollutants 
Micropollutants (MPs) can be broadly defined as any synthetic or 
naturally occurring chemical that is not commonly monitored in the environment 
but has the potential to enter the environment and cause known or suspected 
adverse ecological and or human health effects (USEPA, 2013) . These pollutants 
are usually organic compounds that persist in the environment because they do 
not biodegrade. The term MPs is believed to envelope a wide array of 
compounds which includes but not limited to human and veterinary MPs and 
their metabolites, personal care products - detergent, cosmetics, fragrance, 
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natural and synthetic hormones, fire retardants, surfactants, plasticizers, anti-
microbial compounds, endocrine disrupting compounds, ultraviolet absorbing 
compounds, domestic products and recently nanotechnology residuals. These 
compounds are typically detected at low concentrations, usually in the range of 
nanogram per liter or microgram per liter, hence the name “Micropollutants”. 
Other terms that are commonly used to refer to these compounds are “xenobiotic 
compounds” because most of these compounds are of anthropogenic origin; 
“emerging contaminants” because of the recent technological advancement in 
analytical methods that are sufficiently sensitive to detect the MPs at 
environmentally relevant trace concentrations ;“Trace organic compounds” 
because of their detectable low concentrations in different environmental 
matrices; “Persistent Organic Compounds” because of their non-biodegradable 
nature in the environment. 
2.2 Biological Nutrient Removal Processes in Wastewater 
Treatment 
  Biological nutrient removal (BNR) processes are advanced biological 
wastewater treatment processes for the removal of COD, nitrogen and 
phosphorus from wastewater. Despite the complexity of their design and 
operation, they have favor among researchers and operators as an economic and 
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effective method of treating municipal wastewater. Some of the benefits of BNR 
systems (Randall et al., 1992) are: 
 Reduction or elimination of chemical addition for phosphorus removal 
 Decrease in oxygen requirements as compared to nitrifying activated 
sludge 
 Decrease in sludge production as compared to conventional activated 
sludge 
 Recovery of alkalinity by the denitrification process (denitrification 
produces alkalinity) 
 Reduction in filamentous growth and improvement in sludge settleability. 
  A typical BNR system is an adaptation of a basic activated sludge system 
that involves: 1) a slurry of microorganisms, 2) suspended solid recycle, 3) 
quiescent sedimentation and 4) solid retention time (SRT) control. In addition, 
the bioreactor of a BNR is divided into different redox zones; anaerobic (AN), 
anoxic (AX) and aerobic (AO), and typically includes mixed liquor recirculation. 
These zones are defined in terms of the electron acceptor that is utilized. Oxygen 
is the electron acceptor in aerobic zone, nitrate-N is the electron acceptor in 
anoxic zone and neither oxygen nor nitrate-N is present in the anaerobic zone. 
The uniqueness of the BNR system is the presence of the alternating redox 
condition that enhances the cultivation of different microbial species. The 
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anaerobic zone is essential for phosphorus removal, the anoxic zone is necessary 
for nitrogen removal and the aerobic zone is a pivotal component of all BNR 
systems (Grady et al., 1999). 
The biological nutrient removal (BNR) process involves the utilization of 
three different biochemical processes for the removal of nutrients (N, P) in a 
wastewater treatment facility. These three key processes are nitrification, 
denitrification (both processes are termed biological nitrogen removal) and 
biological phosphorus removal.  
Nitrification is a two-step process that involves two obligate aerobic 
bacteria consortia namely, Ammonia Oxidizing Bacteria (AOB) and Nitrite 
Oxidizing Bacteria (NOB). Ammonia is initially oxidized to hydroxylamine, a 
reaction that is catalyzed by ammonia monooxidase (AMO). Hydroxylamine is 
then oxidized to nitrite, catalyzed by hydroxylamine oxidoreductase (HAO).  
This process is summarized in Equation 2-1.   
(2-1) 
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Nitrification converts nitrogen from a reduced form (ammonia) to an 
oxidized form (nitrate). It is not in itself a nitrogen removal mechanism, 
therefore; denitrification is employed after nitrification to achieve complete total 
nitrogen removal.  
  Denitrification involves the utilization of readily biodegradable organic 
matter (rbOM) by specific heterotrophic bacteria under anoxic conditions to 
reduce nitrate to nitrogen gas as shown in equation 2-3; 
 
𝑁𝑂2
− + 𝑟𝐵𝑂𝑀 → 𝑁2(𝑔) + 𝐶𝑂2 + 𝐻2𝑂 + 𝑂𝐻
− + 𝑁𝑒𝑤 𝑐𝑒𝑙𝑙𝑠      (2-3) 
 
  Biological phosphorus removal is achieved by cycling the mixed liquor 
between anaerobic and aerobic conditions to cultivate phosphorus accumulating 
organisms (PAOs) e.g Accumulibacter phosphatis (Gu et al., 2008), which are then 
removed through excess sludge removal. Figure 2-1 simplifies the events that 
occur in a typical BNR bioreactor with respect to poly-p organism (PAOs) and 
other non-poly-p accumulating organisms; ordinary heterotrophic organism 
(OHO) and ammonia oxidizing bacteria (AOB).  
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 In the anaerobic stage, PAOs do not grow because they cannot utilize 
or degrade the fermentative compounds in an anaerobic condition, but 
they convert short chain fatty acids (SCFAs) to intracellular energy rich 
carbon polymers, poly-β-hydroxybutyrate (PHB). The fatty acids 
(particularly acetate and propionate) are produced through the 
anaerobic activity of fermentative bacteria (anaerobic OHOs) or 
supplied externally by chemical addition. The polymerization of fatty 
acids requires an expenditure of cellular energy by the PAO. This 
energy is obtained from the breakdown of intracellular poly-
phosphates to release orthophosphates from the PAO into the bulk 
solution of the anaerobic tank. As a result of the release of 
orthophosphate from the poly-P bacteria, the anaerobic tank contains 
two pools of phosphorus; the phosphorus in the influent wastewater 
(feed phosphorus) and the released phosphorus by the poly-P bacteria. 
Magnesium and potassium ions are concurrently released to the 
anaerobic tank along with phosphate (WEF, 2005). Previous studies 
have shown that anaerobic phosphorus release is a precursor to 
effective aerobic phosphorus uptake by the PAOs (Barker and Dold, 
1996). 
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 Under anoxic condition, where nitrate (NO3) become available, it is 
believed that OHOs continues to mediate hydrolysis of particulate 
organic substrates while a fraction of the PAOs that is capable of 
utilizing nitrate as an electron acceptor (denitrification) oxidizes 
previously stored PHBs to obtain energy for growth and maintenance 
requirements (Barker and Dold 1996). However, the anoxic 
phosphorus uptake per intracellular PHB oxidized is less efficient 
when compared to aerobic phosphorus uptake and phosphorous 
uptake per unit PHB oxidized seems to occur simultaneously with 
phosphorus release per PHB storage when SCFAs are available under 
anoxic condition. 
 In the aerobic zone, where sufficient external electron acceptors (NO3 
and O2) become available, PAOs oxidize the previously stored PHBs to 
obtain energy for growth and maintenance requirements. PHB in 
PAOs serves two important functions. First, it helps the bacteria to 
grow and rebuild polyphosphates by taking up soluble phosphate. 
Second, PHB along with polyphosphates help aerobic poly-P bacteria 
to survive in an anaerobic condition. Concurrently, the poly-P bacteria 
restore intracellular energy reserves through absorption of 
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orthophosphate to form intracellular polyphosphates granules or 
volutins.  
  The energy obtained from the degraded PHB is high enough for the PAOs 
to absorb not only the released phosphorus but also a significant quantity of feed 
phosphorus. Phosphorus removal is achieved when the bacteria (sludge) are 
wasted from the secondary clarifier. Thus a low effluent phosphorus 
concentration is achieved from the BNR reactor (WEF, 2005). Sludge that is not 
wasted is returned to the anaerobic tank where the BNR process is repeated. By 
exposing the poly-P bacteria to alternating anaerobic and aerobic conditions, the 
poly-P bacteria are stressed and take up phosphorus in excess of normal cellular 
requirements. 
   Table 2-1 summarizes the processes occurring and the mediating 
organisms in the different zones of a typical BNR system.  From Table 2-1, it is 
quite clear that there are different processes that proceed in the different zones 
and the organisms responsible for these processes could either be heterotrophic 
or autotrophic. These organisms are present in all of the zones due to the internal 
recycles but growth and metabolic activity is however dependent on the redox 
conditions of the zones.  
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Figure 2-1. Events in a typical BNR process bioreactor (adapted from 
EnviroSim 2008). 
 
Table 2-1. BNR process reactions and mediating organisms 
Zone Process Mediating Organism 
Anaerobic Phosphorus release and PHB storage Heterotrophs (PAOs) 
Fermentation: Complex organics converted to 
VFAs. 
Heterotrophs (non-
PAOs) 
Pre-anoxic  Denitrification: Nitrate to nitrogen gas via the: 
-Use of influent substrate-BOD removal, and 
Heterotrophs (non-
PAOs) 
-Use of stored substrate (PHB) – phosphorus 
uptake 
Heterotrophs (DPAOs) 
Post Anoxic  
(if 
provided) 
Denitrification: Nitrate to nitrogen gas via the: 
-Use of cellular substrate (endogenous 
reactions), or 
-Use of methanol 
 
Heterotrophs (non-
PAOs) 
Aerobic BOD removal Heterotrophs (non-
PAOs) 
Ammonification: Organic nitrogen to 
ammonia nitrogen 
Heterotrophs (non-
PAOs) 
Nitrification: Ammonia nitrogen to nitrate 
nitrogen 
Autotrophs (AOB & 
NOB) 
PHB degradation and excess phosphorus 
uptake 
Heterotrophs (PAOs) 
Source: Jeyanayagam (2005). 
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2.2.1 Summary of BNR Processes in Wastewater Treatment 
Important fundamental processes that occur in a typical BNR system 
include 1) Nitrification, 2) denitrification and 3) biological phosphorus removal. 
Even though other processes like hydrolysis, fermentation and ammonification 
also occur in a typical BNR process, the former three directly relate to the 
existence of the different redox zones present in a BNR process. The 
microorganisms that mediate these processes are ammonia oxidizing organisms 
(Nitrosomonas and Nitrobacter), denitrifying bacteria and phosphorus 
accumulating organism all existing in the activated sludge but functioning 
differently depending upon the redox zones (anaerobic/anoxic/aerobic), 
assuming all other operating conditions are appropriate 
  BNR systems can be configured in various designs with differing zone 
sequence. The type of configuration employed may have an effect on the 
degradation or removal of micropollutants in wastewater treatment. The next 
section examines the various BNR basin configurations that have been explored 
for the treatment of wastewater.  
2.3  BNR Process Configurations 
  Various combinations and modifications of the BNR system have been 
developed to meet economic and regulatory demands that have been placed 
upon wastewater treatment.  BNR process configuration can be designed to 
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achieve either total nitrogen (TN) removal or both TN and total phosphorus (TP) 
based on the incorporation of either two of the three redox conditions 
(anoxic/aerobic) or a combination of the three (anaerobic/anoxic/aerobic) 
(Jeyanayagam, 2005).  There are a variety of configurations of BNR systems and 
the selection of a configuration depends on the influent characteristics, effluent 
limits and desired operating conditions (WEF, 2005). Although this list is not 
exhaustive, it presents common BNR system configurations, their process 
diagrams and brief descriptions. Detailed descriptions of the BNR process 
configurations have been reported by WEF (2005). 
1) Modified Ludzack-Ettinger (MLE) Process – continuous-flow suspended-
growth process with an initial anoxic stage followed by an aerobic stage, to 
enable denitrifying bacteria first access to the influent substrate. An 
increase in internal mixed liquor recycle (IMLR) rate increases the rate of 
denitrification, but a rate beyond 400% of influent, provides no added 
benefits (WEF, 2005). The absence of an anaerobic zone prevents MLE from 
being suitable phosphorus removal. Figure 2-2 presents the flow schematic 
of the MLE process. 
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Figure 2-2. Flow schematic of MLE process. 
 
2) Phoredox (A2O) Process – MLE process preceded by an initial anaerobic 
stage; used to  remove both TN and TP. Here the introduction of the 
anaerobic zone before the anoxic and aerobic zone enables the cyclic pattern 
required for proliferation of PAOs (phosphorus removal) and the IMLR from 
aerobic to anoxic zone enables nitrogen removal, although the system is 
sensitive to nitrate and dissolved oxygen recycle to the anaerobic zone. Figure 
2-3 presents the flow schematic of the A2O process. 
 
Figure 2-3. Flow schematic of A2O process. 
 
Influent Anoxic Aerobic Effluent
WAS
Anaerobic
Internal mixed liquor recycle 
Return Activated Sludge 
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3) Bardenpho Process (Four-Stage) – continuous-flow suspended-growth 
process with   alternating anoxic/aerobic/anoxic/aerobic stages. Excellent for 
total nitrogen removal but no capability for phosphorus removal due to the 
absence of an anaerobic zone, a selector for PAOs. Figure 2-4 presents the 
flow schematic of Bardenpho process. 
 
Figure 2-4. Flow schematic of Bardenpho process. 
 
4) Modified Bardenpho Process – Bardenpho process with addition of an 
initial anaerobic zone, a selector for PAOs enrichment in the sludge. It 
provides excellent nitrogen removal and good phosphorus removal. Figure 
2-5 shows the flow schematic of modified Bardenpho process. 
Influent Prim Anoxic Aerobic Effluent
WAS
Sec Anoxic Re-aer
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Figure 2-5. Flow schematic of modified Bardenpho process. 
 
5) Virginia Initiative Process (UCT-BNR) – A variation of the A2O 
configuration with the addition of an internal mixed liquor recycle from the 
anoxic zone to the anaerobic zone and the RAS returned to the anoxic zone 
rather than the anaerobic zone. This configuration minimizes the adverse 
effects of the nitrate return to the anaerobic zone. Here PAOs are given the 
selective advantage of full access to all available readily biodegradable 
organic matter or acetate. It is good for both total nitrogen and total 
phosphorus removal. Figure 2-6 shows the flow schematic of a UCT-BNR 
process. 
Influent Prim Anoxic Aerobic Effluent
WAS
Sec Anoxic Re-aerAnaerobic
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Figure 2-6. Flow schematic of UCT-BNR process. 
 
6) Modified University of Cape Town (UCT) Process – To further minimize 
the effects of the nitrate recycle to the anaerobic zone from the anoxic zone, 
a second anoxic stage is introduced, where the internal nitrate recycle is 
returned. The first anoxic zone provides the mixed liquor recycle to the 
anaerobic zone, and under appropriate design and operating conditions, no 
nitrates are returned to the anaerobic zone. It provides good nitrogen 
removal and excellent phosphorus removal.  Figure 2-7 shows the flow 
schematic of a modified UCT process. 
Influent Anoxic Aerobic Effluent
WAS
Anaerobic
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Figure 2-7. Flow schematic of modified UCT process. 
 
7) Step Feed Process – alternating anoxic and aerobic stages, influent flow is 
split to several feed locations and the recycle sludge stream is sent to the 
beginning of the process;  used to remove TN. Figure 2-8 shows the flow 
schematic diagram of step feed process. 
 
Figure 2-8. Schematic of Step Feed process. 
 
8) Sequencing Batch Reactor (SBR) Process – SBRs are fill‐and‐draw reactors 
that operate sequentially through the different redox conditions by 
adjusting the mixing and aeration. The anaerobic/anoxic/aerobic 
Influent Anaerobic Anoxic 1 Effluent
WAS
Anoxic 2 Aerobic
  
26 
 
progression is necessary for removal of phosphorus and total nitrogen. 
Because of the fill‐and‐draw nature of SBRs, it is necessary to remove the 
nitrates remaining from the previous aerobic cycle before anaerobic 
conditions can be established, thus the typical treatment progression 
becomes anoxic/anaerobic/aerobic as depicted in the Figure 2-9.  
 
Figure 2-9. Schematic of Sequencing Batch Reactor. 
 
9) Oxidation Ditch – continuous-flow process using looped channels to 
create time sequenced anoxic, aerobic, and anaerobic zones, cycling 
pattern essential for the proliferation of PAOs in the activated sludge. It 
provides both total nitrogen and total phosphorus removal. Figure 2-10 
shows flow schematic of the oxidation ditch process. 
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Figure 2-10. Schematic of Oxidation Ditch process. 
 
2.3.1 Summary on BNR Process Configurations 
Various configurations or basin arrangements of the BNR system have 
been developed to achieve efficient nutrient removal. The use of three zones, 
anaerobic/anoxic/aerobic is common in the configurations with exceptions that 
employ only two of the three. Two major features differentiate one configuration 
from the other; 1) zone sequencing and 2) recycle stream locations.  The 
proliferation and enrichment of PAOs in a BNR bioreactor requires the selection 
of an appropriate BNR configuration. This is essential so as to ensure a stable 
reactor performance in terms of meeting the effluent quality while 
simultaneously enriching the population of PAOs in the bioreactor. The UCT-
BNR process was selected for the research study because the process is amenable 
to changes in operating conditions and the configuration of the reactor supports 
proliferation of PAOs while maintaining good effluent quality.  
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  It has been proposed that subdivision of the reactor volume into a cascade 
of compartments, significantly improves the removal of biodegradable MPs 
compared to a single mixed reactor (Joss et al., 2006), suggesting that, different 
configurations of BNR systems may provide different MP removal. Therefore, 
the estimation of the biotransformation constants of MPs under different redox 
condition would provide a platform that could be extrapolated to other BNR 
configurations.  The next section examines the operating conditions for ensuring 
efficient biological phosphorus removal in a typical BNR process. 
2.4  Biological Phosphorus Removal in BNR Process 
  The previous section identified the importance of selecting a BNR 
configuration that includes sequencing of anaerobic, anoxic and aerobic zones, 
creating the appropriate conditions for the enrichment of PAOs. In addition to 
having proper zone sequencing, appropriate design and optimum operating 
conditions such as optimum recycle ratio, influent carbon to phosphorus ratio 
and solids retention time must be employed so as to sustain the redox conditions 
and ultimately establish a healthy biomass in the reactors (WEF, 2005). Therefore, 
an understanding of the factors that affect the performance and stability of the 
BNR process is needed to effectively design, maintain, control and optimize the 
performance of the process. This section summarizes the design and operating 
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conditions required for operating a BNR system for enhanced biological 
phosphorus removal. 
  PAOs are organisms capable of storing phosphate as intracellular 
polyphosphate, leading to phosphorus (P) removal from the bulk liquid phase 
via PAO cell removal in the waste activated sludge. Unlike most other 
microorganisms, PAOs can take up carbon sources such as volatile fatty acids 
(VFAs) under anaerobic conditions, and store them as intracellular carbon 
polymers, called poly-β-hydroxyalkanoates (PHAs). The energy for this anabolic 
build-up is generated by the cleavage of polyphosphate leading to the release of 
phosphate from the cell. Reducing power is also required for PHA formation, 
which is produced largely through the glycolysis of internally stored glycogen 
(Mino et al., 1998). Aerobically, PAOs use their stored PHA as the energy source 
for biomass growth, glycogen replenishment, P uptake and polyphosphate 
storage. Net P removal from the wastewater is achieved through the removal of 
waste activated sludge containing high polyphosphate content. While the 
majority of P removal from the BNR process is often achieved through 
anaerobic–aerobic cycling, anaerobic–anoxic operation also allows P removal to 
occur, due to the ability of some PAOs (i.e. denitrifying PAOs or DPAOs) to use 
nitrate or nitrite instead of oxygen as electron acceptors and, therefore, perform P 
uptake and denitrification simultaneously. Maximizing the fraction of P removal 
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in the anoxic zone can reduce process operational costs, due to savings in 
aeration as well as in the amount of carbon sources needed for denitrification. 
  The design of any BNR process configuration to optimize biological 
phosphorus removal requires that the microbial reaction proceed in favor of the 
PAO population (WEF, 2005). There are a number of operational conditions that 
affect PAO development and growth in a BNR activated sludge. These 
conditions include: 
 VFA potential of the influent stream (Jonsson et al., 1996; 
Mulkerrins et al., 2004) 
 SRT/HRT (Shao et al., 1992; Smoulder et al., 1995) 
 Temperature (Chang and Park, 2008; Whang and Park, 2001) 
 pH (Filipe et al., 2001; Mulkerrins et al., 2004) 
 Dissolved O2 (Jonsson et al., 1996) 
 Internal Mixed Liquor Recycle Rate (Jonsson et al., 1996) 
2.4.1 VFA Potential of the Influent Stream 
  The performance of biological phosphorus removal processes has been 
reported to depend on the composition of the readily biodegradable organic 
matter (acetates) in the influent (Comeau et al., 1986). These acids may be in the 
feed, produced through the fermentation of municipal wastewater or can be 
added as a commercial or waste product. As previously mentioned, PAOs 
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transforms short chain VFAs (acetate and propionic) into intracellular PHAs. 
Therefore, a high concentration of VFAs in the influent stream will result in their 
rapid phosphorus uptake by the PAOs (Copp, 1998). Jonsson et al. (1996) 
indicated that 14 mg of VFA-potential is required to remove 1 mg of phosphorus. 
VFA-potential was defined as the concentration of VFA in a fermented sample of 
wastewater. Abu-Ghararah and Randall (1991) reported similar VFA-potential 
values within the range of 10 to 20 mg VFA/Premoved.  
  Comeau et al. (1996) indicated that a critical factor essential for optimizing 
phosphorus removal in a BNR system is the amount of VFA in the influent 
stream. Barnard and Steichen (2006) reported that 7 – 9 mg of VFA was needed to 
remove 1 mg of phosphorus, while Oldham et al. (1994) used VFAs to achieve 
effluent phosphorus level as low as 0.2 – 0.3 mg/L. Typically, to achieve 
phosphorus removal to an effluent concentration less than 1.0mg/L, the COD: TP 
ratio should be 40 or more (U.S. EPA, 2009). 
  Another group of organisms, glycogen accumulating organisms (GAOs) 
e.g Competibacter and Defluviicoccus, also have the ability to take up acetate in the 
anaerobic zone, not by using energy in phosphate bonds but by using stored 
glycogen as the energy source (Kong et al., 2006). The VFA are stored as a 
complex carbohydrate containing polyhydroxyvalerate (PHV), instead of PHB 
formed with poly‐phosphorus as the energy source. Under certain conditions, 
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such as high temperatures over 28oC, high SRT, low pH in the aerobic zone or 
longer anaerobic HRT, GAOs may out‐compete PAOs for the VFAs, which 
would result in less or no release of phosphorus in the anaerobic zone. This in 
turn will result in fewer fractions of PAOs in the biomass and ultimately 
deterioration of the BNR system (Filipe et al., 2001; Saunders et al., 2003).  
  Oehmen et al. (2005) indicated that PAO can have a competitive 
advantage over GAO when the VFA consists of roughly equal proportions of 
acetic and propionic acid as substrate. This is because PAOs are able to switch to 
propionate much more quickly and effectively than GAOs. Therefore to 
stimulate optimal growth of PAOs, the strategy is to feed the BNR system with 
an equal amount of acetic acid and propionic acid (Oehmen et al., 2005; Bott et 
al., 2007).  
2.4.2 SRT/HRT 
The SRT represents the average length of time a particulate constituent 
stays in a bioreactor. HRT determines the contact time between the solution 
phase that contains the substrate and nutrients and the biomass, which is made 
up of the micro-organisms scavenging food materials for growth. Phosphorus 
release and uptake rates in anaerobic and aerobic zones must be considered in 
selecting the overall system and individual zone HRT values. The HRT value can 
be controlled by appropriate flow adjustments at constant volume.  
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  The effect of SRT on the BNR process has been widely investigated (Shao 
et al., 1992; Smoulder et al., 1995). An increase in SRT causes an increase in the 
concentration of ordinary heterotrophs that produce VFAs in the anaerobic zone 
and therefore proliferation of PAOs and subsequent P-removal may be enhanced 
in processes with low VFAs in the feed. However, the SRT increase could lead to 
reduction in P-removal due to reduced rate of sludge wastage.  
  BNR systems can operate at SRT values greater than 3 days. However, at 
SRT values greater than 4 days and at temperature greater than 15oC, nitrification 
will become active and nitrates should be denitrified. As the SRT is increased to a 
level where endogenous reactions become significant, secondary release of 
phosphorus may lead to decreased performance at constant feed VFA and COD 
values (WEF, 2005). Although the performance of other heterotrophic reactions 
rely more on the system sludge age, in BNR, performance cannot be defined 
solely based on the SRT and HRT. The feed COD: P ratio shapes the microbial 
composition of the BNR sludge and the effluent levels that can be attained (WEF, 
2005).  
  Previous studies have shown that the ratio of HRT in the anaerobic zone 
to the HRT in the aerobic zone is important for the optimal operation of a BNR 
system. Sufficient time should be allowed for the formation of VFAs and storage 
of intracellular PHAs in the anaerobic zone. If the time is too short, phosphorus 
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uptake in the aerobic zone will be lower than achievable because insufficient 
PHAs were stored in the anaerobic zone. Neethling et al. (2005) reported a ratio 
of between 3 and 4 for aerobic HRT to anaerobic HRT led to optimal 
performance of a BNR system. 
  Grady et al. (1999) suggested that at temperatures above 15oC, it may be 
very difficult to operate at an aerobic SRT sufficiently high to allow PAOs to 
grow without also populating nitrifying bacteria. Under such circumstances, the 
UCT-BNR process has distinct advantages. 
2.4.3 Temperature  
High temperature can have an adverse effect on phosphorus removal. 
Whang and Park (2006) and Lopez-Vazquez et al. (2007) reported that 
temperatures lower than 20oC could favor PAO over GAO, resulting in a stable 
BNR process, while the opposite could occur at temperature greater than 20oC. 
Bott et al. (2007) reported predominance of GAOs in a BNR operated at 
temperatures greater than 28oC.   
  Full and pilot scale studies have shown that BNR can be affected by low 
temperature. PAOs outcompete GAOs at temperatures as low as 5oC, the GAOs 
practically disappeared in the 5oC reactor (Erdal et al. (2002). However, 
fermentation in the collection system will decrease with decrease in temperature, 
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thus leading to insufficient VFA in the feed, thereby interfering with overall 
phosphorus removal. 
2.4.4 Effect of pH  
  Many studies have shown that a higher ambient pH in enriched PAO 
sludges has resulted in a higher anaerobic P release (Smolders et al., 1994; Liu et 
al., 1996; Bond et al., 1999; Filipe et al., 2001). Smolders et al. (1994) found that the 
ratio of anaerobic P release to acetate uptake varied linearly from 0.25 to 0.75 P-
mol/C-mol when pH rose from 5.5 to 8.5. The reason for this variation was 
explained as follows: under the assumption that the internal pH of the cell is kept 
constant, there is an increased pH gradient and a corresponding increase in 
electrical potential difference across the cell membrane at a high ambient pH. 
Therefore, more energy is needed for acetate transport through the membrane 
when external pH is high. This increased energy is generated through an 
increase in polyphosphate degradation.  
  However, the acetate uptake, glycogen degradation and PHA 
accumulation rates of PAOs have been shown in batch tests to be independent of 
pH over the range 6.5–8.0 (Filipe et al., 2001), indicating that the higher energy 
requirements to take up acetate does not negatively affect their ability to 
metabolize VFA. Aerobically, a series of batch tests has shown that P uptake, 
PHA utilization and biomass growth were all inhibited by a low pH (6.5), 
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suggesting that a higher aerobic pH (7–7.5) would be more beneficial for PAOs 
(Filipe et al., 2001). 
  It has been postulated that an anaerobic pH of 7.25 is a critical point, 
whereby GAOs are able to anaerobically take up VFA faster than PAOs at pH 
values below 7.25, and PAOs take up acetate faster above this pH value (Filipe et 
al., 2001). However, Liu et al. (1996) indicated an optimum pH of 6.8 ± 0.7 for 
anaerobic acetate metabolism (acetate uptake rate coupled with P-release rate). 
An improved level of P removal was observed when the anaerobic pH set point 
was increased from 6.8 to 7.25 (Filipe et al., 2001). Other studies have also shown 
higher P removal when the anaerobic and/or aerobic pH level was increased 
(from pH 7 to 7.5–8.5) (Bond et al., 1998; Serafim et al., 2002). The reason for the 
improved performance was hypothesized to be a shift in the microbial 
competition from GAOs to PAOs. 
2.4.5 Dissolved Oxygen (DO)  
A BNR process needs to satisfy different oxygen demands from the 
different bacterial populations present in the system. BNR systems designed for 
COD removal and nitrification typically require DO levels greater than 2 mg/L 
(Louzeiro et al., 2002). In a BNR system, the anaerobic zone must be kept devoid 
of oxygen (0 - 0.2 g/L O2) as the presence of oxidizing substances such as oxygen 
and nitrate interfere with the efficiency of the BPR process.   
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The presence of low levels of oxygen or other oxidizing agents affects the 
redox potential and thus negatively impacts on the rate of phosphate release. 
(Shehab et al., 1996). Maintaining an oxygen concentration of between 3.0 and 4.0 
mg/l in the aerobic zone has been recommended (Shehab et al., 1996). It has also 
been reported that, for successful BNR, a DO concentration 3.0 - 4.0 mg/l is 
essential. Brdjanovic et al. (1998) revealed that excess aeration can have a 
negative impact on the BPR process as cessation of P-uptake occurs due to 
depletion of poly-hydroxy-butyrate (PHB) in an over aerated process. 
  The presence of nitrate in the anaerobic zone has also been reported to 
affect the BPR process (Shehab et al., 1996). Residual nitrate in the anaerobic 
phase results in consumption of rbCOD by denitrifiers, thus decreasing the 
availability of organic matter for PAOs. 
2.4.6 Internal Mixed Liquor Recycle Flows (IMLR) 
Typical internal recycle flows employed in BNR processes include:  
 Recycle from aerobic zone to anoxic zone (nitrified mixed liquor 
recirculation-NR) 
 Recycle from anoxic zone to anaerobic zone (anoxic mixed liquor 
recirculation-AR), and 
  A low NR flow limits the amount of DO and nitrate available for the 
PAOs to uptake phosphorus and could lead to secondary release of phosphorus. 
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Increasing the NR recycle flow will reduce the retention time in the anoxic zone 
and increase the amount of nitrates and dissolved oxygen in the anoxic zone. 
This will stop secondary release of phosphorus thus reducing the mass of 
released phosphorus that must be taken up in the aeration basin. One of the 
major factors influencing the occurrence of DPAO and associated anoxic P 
uptake appears to be the nitrate load into the anoxic reactor, i.e, the nitrate load 
should be large enough or exceed the denitrification potential of ordinary 
heterotrophic organisms (OHO), i.e non-PAOs in the anoxic reactor to stimulate 
DPAO in the system (Hu et al., 2002).  If the nitrate load into the anoxic reactor is 
less than the denitrification potential of OHO, the OHO will outcompete PAO for 
the use of the limited nitrate, while if the nitrate load exceeds the denitrification 
potential of OHO, the PAO will utilize the “excess” nitrate and thus develop in 
the system (Hu et al., 2002). 
  The AR rate should be established such that oxygen and nitrates are not 
recycled to the anaerobic zone. The presence of oxygen and nitrate in the 
anaerobic zone inhibits fermentation of the soluble organics to acetate thereby 
starving the PAOs. Also, denitrifying bacteria and OHOs will compete with 
PAOs for rbCOD/VFA substrate, reducing the selective advantage for the PAOs 
in the zone. This inadvertently interferes with the efficiency of biological 
phosphorus removal.  
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  In the UCT process, an increase in the anoxic mixed liquor recycle (AR) 
provides for increased organic utilization in the anaerobic stage. In this 
configuration the AR contains soluble BOD but little or no nitrate, thereby 
providing optimal conditions for fermentation and VFA uptake in the anaerobic 
zone. Because the mixed liquor rather than the RAS is recycled to the anaerobic 
zone, the MLSS concentration in the zone is lower than the MLSS concentration 
in the remainder of the bioreactor. Therefore, a longer anaerobic zone HRT (1 to 2 
hrs) is needed to achieve the desired SRTs. The anoxic recycle (AR) and the 
nitrified mixed liquor recirculation rates (NR) are typically two times the process 
influent flow rates (Grady et al., 1999).  
  Phosphorus may also be released when there is a low nitrate 
concentration in the mixed liquor to the final clarifier. When a deep sludge 
blanket develops in the final clarifier, nitrates will be denitrified, clarifier 
becomes anaerobic and hence phosphorus can be released. This release may not 
affect the effluent phosphorus but may return a large portion of the released 
phosphorus back to the anoxic/aerobic zone, where there may not be enough 
VFA for uptake of this additional released phosphorus (WEF, 2005).    
  Typical operating parameters used in the design of various BNR systems 
are shown in Table 2-2.  The operating parameters vary depending on the BNR 
configuration. The BNR system selected for investigating MPs removal should be 
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able to accommodate the removal of conventional wastewater pollutants (COD, 
N, P) as well as the removal of MPs. As previously stated, the UCT-BNR design 
was selected for this study because it satisfies the requirements for the research 
work.  
Table 2-2. Typical design parameters for commonly used BNR processes 
Process/
Design 
Parame
ters 
SRT, d MLSS, 
mg/L 
Anaerobi
c HRT, h 
Anoxic 
HRT, h 
Aerobic 
HRT, h 
RAS, %  
of 
Influent 
IMLR, % of 
Influent 
UCT 
 
10-25 3000-4000 1-2 2-4 4-12 80-100 100-300 
(aero) 
200-
400(anoxic) 
A2O 5-25 3000-4000 0.5-1.5 0.5-1 4-6 25-100 100-400 
A/O 2-5 3000-4000 0.5-1.5 - 1-3 25-100  
PhoStrip 5-20 1000-3000 8-12  4-10 50-100 10-20 
SBR 20-40 3000-4000 1.5-3 1-3 2-4   
UCT-
BNR 
5-10 2000-4000 1-2 1-2 4-6 80-100 100-
200(anoxic) 
100-
300(aero) 
Modifie
d 
Bardenp
ho 
10-20 3000-4000 0.5-1.5 1-3 
(1st 
Stage)  
2-4 
(2ndStag
e) 
4-12 
(1stStage
) 
0.5-1 
(2ndStag
e) 
50-100 200-400 
 
 
 
General Design Considerations: Aerobic zone DO > 2 mg/L, pH > 6.5 
Adapted from Tchobanoglous et al., 2003. 
2.4.7 Summary of Biological Phosphorus Removal in BNR Process 
  One of the objectives of this research work was to investigation the role of 
PAOs in the removal of MPs in wastewater. PAO enrichment in a typical BNR 
system requires careful selection and operation of the system to achieve desired 
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objectives, given the fact that BNR operation is more onerous to maintain than 
conventional activated sludge system.  
  Factors that may affect the proliferation of PAOs in the anaerobic basin of 
a BNR include temperature, SRT, and pH. The selected experimental SRT was 
expected to favor PAOs over GAOs in the pilot plant because the operating SRT 
(18-20 days) was beyond the range that could affect the competition of PAOs and 
GAOs (3 to 5 days; Whang and Park, 2001). pH has been found to be one the key 
factors that affect the metabolic rates and competition between PAOs and GAOs 
(Filipe et al., 2001). Acetate uptake rate by both GAOs and PAOs has been shown 
to increase with pH up to 6.5, but while it starts to decrease at pH 7.5 for GAOs, 
it remains nearly constant from 7.0 to 8.5, and starts to decrease at pH 8.5 for 
PAOs (Filipe et al., 2001; Schuler and Jenkins, 2002). Therefore, the operating 
conditions of a BNR process should be carefully monitored and maintained in 
order to proliferate PAOs for enhanced biological phosphorus removal.  
2.5  Micropollutant Removal Mechanisms in Activated Sludge 
Systems 
  Sorption to solids (dependent on solid–water distribution coefficient), 
biodegradation (aerobic/anoxic/anaerobic), volatilization (influenced by Henry’s 
Law constants) and chemical transformation (hydrolysis, acid base, photolysis, 
and precipitation) are possible mechanisms of removal of MPs.   However, the 
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former two are typically considered as the most significant for many non-volatile 
MPs and personal care products (PPCP) (Ternes et al., 2004). In this section, the 
fundamental mechanisms (sorption and biodegradation) that impact MPs in 
activated sludge systems are reviewed. 
2.5.1 Sorption 
  The process by which chemicals become associated with the solid phase is 
generally referred to as sorption. The attachment of the molecule to a two-
dimensional surface is termed adsorption while molecular penetration into a 
three dimensional matrix is called absorption (Schwarzenbach et al., 2003).  In 
wastewater treatment, sorption onto reactor biomass can be an important 
removal mechanism depending on the propensity of MPs to partition to the 
sludge. The sorption potential of a given compound is largely dependent on the 
distribution coefficient, Kd. The distribution coefficient is the ratio between the 
concentration of a compound in the sorbed phase and the liquid phase. Under 
equilibrium conditions, the concentration sorbed onto sludge (X) is assumed to 
be proportional to the concentration in solution (S) (Ternes et al., 2004) :  
 
𝐾𝑑 =
𝑋𝑝𝑎𝑟𝑡
𝑆
=
𝑋
𝑋𝑠𝑠.𝑆
        (2-4) 
Where, 
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X= concentration sorbed onto sludge, per unit reactor volume [µg.L-1] 
Xpart= concentration sorbed onto sludge, per amount of sludge dry matter [µg.gSS-
1] 
Kd= solid-water distribution coefficient [L.gSS-1] 
Xss= suspended concentration in raw wastewater or production of suspended 
solids in primary and/or secondary treatment per L of wastewater [gSS.L-1] 
S= dissolved concentration [µg.L-1] 
The total concentration (C) of a compound in a solution is given as C=X+S and 
hence under equilibrium conditions,  
 
 C = S. (1+Xss.Kd)        (2-5) 
 
In a situation when Kd cannot be determined experimentally, Dobbs et al. (1989) 
presented an expression to estimate Kd of a substance from its Kow. This 
expression has been reported to be valid for determining the sorption of 
compounds in wastewater. 
 
 Log Kd = 1.14 + 0.58 Log Kow       (2-6) 
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The Kow (octanol-water partition coefficient) is defined as the ratio of the 
concentration of a chemical in octanol to the concentration of the chemical in 
water at equilibrium in a two phase water/octanol system at a specified 
temperature. 
  Table 2-3 shows solid-liquid partitioning coefficient, Kd values reported by 
different studies suggesting the existence of variability between secondary 
sludge which ultimately affects sorption. However, removal by sorption in 
municipal WWTP is typically considered to be negligible (<10%) for compounds 
with log Kd values ≤ 2.5 L.kgSS-1 (Joss et al., 2006; Ternes et al., 2004). Most 
hydrophilic MPs have log Kd values ≤ 2.5 L.kgSS-1. Therefore, removal efficiencies 
observed for most hydrophilic MPs in WWTP are attributed to biodegradation 
and not sorption (Ternes et al., 2004). Based on this premise, this study will be 
conducted with an assumption that sorption does not contribute significantly to 
the removal of the target MPs, since their log Kd values are ≤ 2.5 L.kgSS-1. 
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Table 2-3. Kd of selected Micropollutants in contact with secondary sludge 
Compound log Kd 
(Secondary sludge) 
L.kgSS-1 
pKa References 
Carbamazepine 1.4 
0.09 
1.8 
 
<1,13.9 
Jones et al., 2002 
Ternes et al., 2004 
Urase and Kikuta, 2005 
Trimethoprim 2.3 
0.28 
 Gobel et al., 2005 
Batt et al., 2006 
Estrone 3 
2.9 
 Joss et al., 2004 
Carballa et al., 2007 
17-β-Estradiol 2.8  Clara et al., 2004 
17-α-Ethinylestradiol 2.5  Ternes et al., 2004 
Gemfibrozil 1.9 4.8 Urase and Kikuta, 2005 
Ibuprofen 
 
2.7 
0.85 
1.9 
 
4.5-5.2 
Jones et al., 2002 
Ternes et al., 2004 
Urase and Kikuta, 2005 
Sulfamethoxazole 2.4 1.8/5.6 Gobel et al., 2005 
2.5.2 Biodegradation of Micropollutants 
  Biodegradation is considered the most important elimination process for 
MPs in activated sludge (Quintana et al. 2005). This process can occur through 
direct metabolism or cometabolism. Direct metabolism involves microbial use of 
MPs as primary or secondary carbon and energy sources while cometabolic 
transformation involves microbial energy gain from non-limiting biodegradable 
organic compounds (Volodymyr, 2011), while indirectly transforming MPs. 
Another facet of cometabolism, called ‘‘commensalism,’’ involves sequential 
transformation of a substance by a group of microbial species with some species 
of the community specialized in early and other in later stages of 
biotransformation (Volodymyr, 2011).  
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Various studies have examined MP removal by biodegradation in many 
different systems, including WWTPs, membrane bioreactors (MBRs), sequencing 
batch reactors (SBRs), and constructed wetlands. Some of these studies focus 
solely on biodegradation as a removal process (Layton et al., 2000; Quintana et 
al., 2005; Yu et al., 2006) , while others examined overall removal due to a 
combination of different processes including biodegradation (Andersen et al., 
2003; Carballa et al., 2005; Gobel et al., 2007). These studies have expanded the 
knowledge base regarding the fate of MPs in various treatment systems (Lab 
scale, pilot scale and WWTP). However, there exists a wide variation in removal 
efficiencies across therapeutic class, treatment processes, and even among 
separate studies for the same individual compounds (Onesios et al., 2009) as 
shown in Table 2-4. This variability prevents the generalization of compound 
behavior in engineered or natural systems thus making the characterization of 
the fate and risks associated with MPs in the environment challenging. However, 
these studies are useful as they provide insight into the potential for 
biodegradation or biotransformation of MPs in the environment. The results 
shown in Table 2-4 provide an overview of the removal efficiency of different 
processes where biodegradation or biotransformation has been assumed to be 
the predominant removal mechanism.  
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  The differences in removal of the compounds have been attributed to 
various factors (Xue et al., 2010; Onesios et al., 2009; Joss et al., 2006) including; 
the use of different definitions of removal by various studies investigating the 
removal of MPs, the physical and chemical properties of the MPs, the degree of 
biodegradation or biotransformation in different studies (operating condition of 
the system used), type of biological treatment employed, redox conditions of the 
reactors, initial MP concentrations, primary substrate concentrations, incubation 
times for batch experiments, and source or type and concentration of microbial 
inoculums. Therefore there is the need for more research to critically assess the 
effects of these factors on the removal of MPs and to investigate the optimization 
potential of these factors in improving the removal of MPs in treatment systems. 
  It is noted that the disappearance of the parent compound of MPs cannot 
be solely considered synonymous with complete biodegradation. The loss of the 
parent compound indicates biotransformation to an unknown degree, and not 
necessarily mineralization. Without monitoring of metabolites or mineralization 
end products, the extent or degree of biodegradation cannot be accurately 
determined. In order to determine the actual biodegradability of MPs, detailed 
biodegradation studies, such as mineralization experiments and biodegradation 
pathway studies, are employed (Onesios et al., 2009). Therefore, it is 
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recommended that proper nomenclature should be encouraged among 
researchers to avoid confusion or report variability. 
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Table 2-4. Micropollutant removal attributed to biodegradation/biotransformation 
Compound 
Removal 
efficiency 
System 
Studied Reference comments 
Anticonvulsant         
Carbamazepine 
0 (M), 0(T) 
Anaerobic 
digester, pilot 
scale 
Carballa et al. 
(2006) 
Anaerobic digester: Pilot scale, 
mesophilic (M) and thermophilic (T) 
conditions, 4–400 µg L-1 PPCP 
Hormone     
     
EE2 
<1 MBR, lab scale Cirja et al. (2007) 
MBR: Lab scale, % mineralization 
reported, 100 µg L-1 PPCP 
 85 ±  5 
(M),  
75 ±  15 
(T) 
Anaerobic 
digester, pilot 
scale 
Carballa et al. 
(2006) 
Anaerobic digester: Pilot scale, 
mesophilic (M) and thermophilic (T) 
conditions, 4–400 µg L-1 PPCP 
 
~ 100a, 
20.2 ±  11b Batch 
aVader et al. (2000); 
bLayton et al. 
(2000) 
Batch: Nitrifying activated sludge 
inoculum, 6 d incubation, 50 µg L-1 
PPCP; 72 µg L-1 PPCP, 24 h incubation, 
WWTP biosolids inoculum; % 
mineralization presented 
Lipid regulator 
and statin     
Gemfibrozil 
>99 Batch Yu et al. (2006) 
WWTP: 24 h composite influent and 
effluent samples 
 
   
Batch: Activated sludge inoculum, 50 d 
incubation, 1, 10, and 50 µg L-1 PPCP 
NSAID     
Ibuprofen 40 ±  
15(M),  
73 ±  9(T) 
Anaerobic 
digester, pilot 
scale 
Carballa et al. 
(2006) 
Anaerobic digester: Pilot scale, 
mesophilic (M) and thermophilic (T) 
conditions, 4–400 µg L-1 PPCP 
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Table 2.4 continued. Micropollutant removal attributed to biodegradation/biotransformation 
Compound 
Removal 
efficiency 
System 
Studied Reference comments 
 
64-701 Lab columns 
Zwiener and 
Frimmel (2003) 
WWTP: Pilot scale, activated sludge 
inoculum, 10 µg L-1 PPCP + 30 mg L-1 
acetone; 
 
17-212   
Lab column: Activated sludge 
inoculum, 10 µg L-1 + 35 mg L-1 
acetone, (1)oxic, (2)anoxic 
 
97- >99 Batch Buser et al.(1999) 
WWTP: 24 h flow proportional 
samples, influent to biological stage and 
treated effluent sampled; Batch: WWTP 
influent inoculum and activated sludge, 
incubated for 8 h 
 
ND1, 1002  
Quintana et al. 
(2005) 
WWTP: 24 h composite samples from 
WWTP MBR, mean removals reported; 
Batch: sludge inoculum, mean removals 
by transformation reported, 28 d 
incubation; (1)20 mg L-1, PPCP as sole 
carbon source, (2)5 mg L-1 PPCP and 50 
mg L-1 milk 
 
>99  Yu et al. (2006) 
WWTP: 24 h composite influent and 
effluent samples 
Batch: Activated sludge inoculum, 50 d 
incubation, 1, 10, and 50 µg L-1 PPCP 
Antibiotic     
Sulfamethoxazole 
99 ± 1(M), 
 99 ±  1(T) 
Anaerobic 
digester, pilot 
scale 
Carballa et al. 
(2006) 
Anaerobic digester: Pilot scale, 
mesophilic (M) and thermophilic (T) 
conditions, 4–400 µg L-1 PPCP 
Adapted from Onesois et al. (2009) 
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2.5.3 Micropollutant Biodegradation Models 
  Several models have been postulated to fit the biodegradation data for 
MPs in a biological reactor. Table 2-5 shows model equations that have been 
reported for modeling biodegradation of MPs. The table shows the common use 
of a pseudo-first order formulation which is dependent on the liquid phase 
concentration of the MPs and the mixed liquor biomass concentration, “X”. 
Different models have used different values for “X”. For example using the 
mixed liquor suspended solids (MLSS) concentration as the value of X in the 
model would lead to a linear increase in the removal rate from a system with a 
low value of MLSS to a system with a high value of MLSS without considering 
the sludge activity.  
  Some studies have used the volatile suspended solid (VSS) concentration 
for the value of “X” in their attempt to account for the active biomass 
concentration but there are concerns involved in the use of VSS as an estimate of 
the active bacterial population because it does not differentiate between active 
and inactive biomass. In fact, other protozoa and metazoan may contribute to the 
volatile content of the solid. It is not unreasonable to assume that not all the 
organic fraction of the biomass contributes to substrate degradation, only the 
active portion of the organic fraction does. Therefore the use of viable biomass 
concentration is more appropriate. 
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  Furthermore, it is also reasonable to assume that there are different groups 
of viable biomass that participate in the biodegradation of MPs in the activated 
sludge. For example, some studies have suggested that nitrifying bacteria and 
heterotrophic bacteria could be responsible for MP biotransformation or co-
metabolic transformation (Shi et al., 2004; Gaulke et al., 2008; Khunjar et al., 
2011). Therefore, the model developed for this study incorporates the 
concentration of specific groups of heterotrophs; poly-phosphate accumulating 
organisms (PAOs, XPAO) and ordinary heterotrophic organisms (OHOs, XOHO) 
rather than the concentration of the total organic fraction of the biomass, Xvss. 
Table 2-5. Biodegradation models for micropollutants removal 
Process Model Biodegradation rate equation References 
1a 1st order KmC Zhao et al., 2008 
1b 1st and pseudo order KmC(1+KdXv) Gang et al., 2007 
2 Two 1storder KmC + Km.Xv Cowan et al., 1993 
3a Pseudo-1st order KmXvC Schwarzenbach et al., 2003 
3b Pseudo-1st order KmXTC Joss et al., 2006 
3c Pseudo-1st order KmXHC Jacobsen et al., 1996 
3d Pseudo-1st order KmXcC Lee et al., 1998 
4 Monod Model KmC/(C+Ks) Marfil-Vega et al., 2010 
Source: adapted from Banihashemi and Drote (2011) 
Km-biodegradation rate coefficient; C-concentration of dissolved Micropollutants; Xv-
volatile suspended solid concentration (mg/L); XT-total concentration of solids (mg/L); 
XH-concentration of heterotrophy biomass (mg/L); Xc-concentration of specific 
Micropollutants degrader (mg/L); Ks-half velocity constant for soluble degradable 
substrate (ML-3) and K1-inhibition constant. 
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2.5.4 Summary of Micropollutant Removal Mechanisms in 
Activated Sludge System 
  Biodegradation has been suggested as the most important removal 
mechanism for MPs, especially for compounds with Log Kd ≤ 2.5 LkgSS-1. 
Micropollutants degradation by biomass in the activated sludge process is 
considered to be achieved through co-metabolic degradation due to the low 
concentrations at which the MPs exist in wastewater. A pseudo first order kinetic 
model is the most commonly used model to describe the degradation of MPs in 
wastewater. A modified form of this model was used in this research. 
2.6  Review of Microorganisms involved in Micropollutant 
Degradation 
  The source and type of the microbiological populations is an important 
factor in the removal of MPs, be it biotransformation, biodegradation or 
mineralization. This was demonstrated by Layton et al. (2000) when they 
reported that the removal efficiency of E2 in biosolids obtained from municipal 
plants was 80% greater than removal efficiency found in biosolids obtained from 
industrial plants. 
   Several previous studies investigating the removal mechanism of MPs in 
wastewater treatment have attributed their degradation to the presence of 
autotrophic ammonia oxidizing bacteria in nitrifying activated sludge (Clara et 
al., 2005b). Although an isolated culture of heterotrophic bacteria has been 
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grown under a high concentration of estrogens as primary substrate for carbon 
and energy (Shi et al., 2002; Haiyan et al., 2007), there has been very few reports 
on the role of heterotrophs in the removal of MPs at the concentrations typical of 
WWTPs. 
  A few recent studies (Table 2-6), have reported that heterotrophs play a 
role in the overall degradation of MPs. 
The important findings from these reports are; 
 Both autotrophic and heterotrophic organisms contribute to the removal 
of MPs from wastewater. 
 The relationships between autotrophic organisms and heterotrophic 
organisms in MP degradation in wastewater could lead to commensalism 
(Khunjar et al., 2011). Commensalism refers to the sequential 
transformation of a substance by a group of microbial species with some 
species of the community specialized in early and other in later stages of 
biotransformation. It is a relationship between biotic elements in which 
only one element benefits. (Volodymyr, 2011). 
 There are a variety of heterotrophic organisms that are involved in MP 
degradation but no report has investigated the role of PAOs. 
  
55 
 
 Co-metabolic enzymes produced by heterotrophic bacteria seem to cover 
broader range than ammonia oxidizing bacteria’s enzyme (Khunjar et al., 
2011). 
 There is insufficient information in the literature to conclusively link 
either autotrophic or heterotrophic organisms to MP degradation in 
wastewater treatment. 
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Table 2-6. Summary of reports on role of microorganisms in MP removal from wastewater 
Compound Degradation Environment 
Dominant Organisms/ 
Biomass involved in degradation  Comments Reference 
EE2,TMP 
Ammonia Oxidizing Bacteria 
(AOB) Culture 
AOB biotransformed EE2 but 
not TMP, AOB biotransformed 
EE2 
better than heterotrophs 
High degree of transformation 
(≤ 1mg/L) was observed for 
EE2 and TMP in the presence of 
heterotrophic dioxygenase 
enzyme. AOB and heterotrophs 
may cooperatively enhance the 
efficiency of EE2 removal. 
Khunjar et al., 
2011 
Heterotrophic culture devoid of 
nitrifiers 
Heterotrophs mineralized EE2, 
biotransforms TMP and 
mineralized EE2-derived 
metabolites generated by AOBs 
     
EE2 
Batch test with enriched 
Autotrophic Ammonia Oxidizer 
AOB 
Strong relationship between 
nitrification and co metabolic 
EE2 degradation. Suggested 
heterotrophic organisms might 
play a role but not investigated. 
Yi and Harper 
(2007) 
EE2 Batch test with AOB 
N. europaea & Nitrospira 
multiformis 
Results suggested EE2 removal 
at concentrations found in 
WWTP is not due to co 
metabolic degradation by AOB 
or abiotic nitration, but most 
likely due to heterotrophic 
bacteria. 
Gaulke et al., 
2008 
EE2 Batch Test at low and High SRT Autotrophs and Heterotrophs 
Suggested Heterotrophs are 
capable of PhAc degradation at 
low and high SRT 
Gaulke et al., 
2009 
     
E1, E2, EE2 Batch Test with a culture of AOB N. europaea 
Suggested there are other 
organisms involved in Estrogen 
degradation apart from AOB 
Shi et al., 2004 
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Table 2-6 (continued). Summary of reports on role of microorganisms in MP removal from wastewater. 
Compound Degradation Environment 
Dominant Organisms/ 
Biomass involved in degradation  Comments Reference 
CAF,CBZ, 
DCF,SMX, 
PCT 
Batch Test with heterotrophs Heterotrophs 
Reported faster degradation of 
PhAc in the presence of  high 
concentration of heterotrophs 
and low SRT 
Majewsky et al., 
2011 
     
4-NP, TCS, 
BPA 
Batch experiment using sludge 
from 3, 10 and 20 d SRT 
Autotrophic and Heterotrophic Org. 
High removal rate (>90% were 
reported for the compounds at 
the 3 SRTs, suggesting 
heterotrophs also play  a 
significant role in 
Micropollutants degradation 
Stasinakis et al., 
2010 
     
Various EDCs 
and PhAcs 
Pilot scale experiment with NAS, 
CAS, BNR 
Autotrophic and Heterotrophic Org. 
BNR achieved better removal of 
EDC and PhA/cs than other 
methods suggesting the 
involvement of other 
heterotrophs in the removal of 
Micropollutants. 
Ogunlaja et al., 
(2013) 
E1, E2, E3, 
EE2 
Batch test with isolated 
Heterotrophic bacteria 
Rhodococcus erythropolis 
 
Reported rapid degradation of 
estrogen 
Yoshimoto et al., 
2004 
Sphingobacterium sp. 
The microorganism grew on 
EE2 (30mgL-1) as the sole 
carbon and energy source (87% 
metabolized) within 10 days and 
30oC 
Haiyan et al., 
2007 
CAF-caffeine, CBZ-carbamazepine, DCF-Diclofenac, SMX-Sulfamethoxazole, BPA-Bisphenol A, 4-NP-4 Nonyl phenol,TCS-Triclosan, 
PhAc-pharmaceutically active compounds, TMP-Trimethroprim, E1- Estrone, E2- Estradiol, EE2- Ethinylestradiol, PCT- Paraceutamol.
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 Research into novel methods of isolating and culturing MP degrading 
inocula found in WWTP and introducing them in bulk concentration into the 
biological reactors of wastewater treatment plants could potentially reduce the 
concentrations and estrogenic activities of MP released into the environment. 
However, isolation of the microbial species in the activated sludge of a BNR 
process is not a trivial task. 
Currently, investigation of the microbial ecology in BNR systems has 
relied on molecular based techniques such as fluorescence in situ hybridization 
(FISH) or PCR-based methods (Seviour et al., 2003; Oehmen et al., 2010).  BNR 
performance, kinetics and metabolic characterization has typically been based on 
measurements of the substrates and products using enrichment mixed cultures 
due to the unsuccessful attempts to obtain any PAO isolates. As a result, BNR 
population characterization has been limited to the species whose phylogenetic 
information has been obtained.  
However, it is recognized that the phylogenetic diversity of PAOs in full-
scale BNR systems are likely larger than those known (Gu et al., 2008; Seviour et 
al., 2003). On the other hand, phylogenetic identification and quantification do 
not necessarily reflect cell metabolic state and their activities and so, linking the 
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BNR performance activities with the relative population composition/structure 
has been quite difficult.  
Advanced techniques such as FISH combined with microautoradiography 
are useful to identify and understand the in vivo physiology, diversity and 
activity of functional microbial groups in biological processes (Nielsen et al., 
1999), but again, this method can reveal organic substrate assimilation and 
phosphate uptake by only those bacteria that can be targeted by available probes 
(Kong et al., 2004). Recently, flow cytometry was used as a novel fluorescent 
staining technique that allows reliable quantification of PAOs and 
polyphosphate accumulation dynamics revealing growth activities of not-yet 
cultivable bacteria in BNR (Gunther et al., 2009). However, these methods are 
very laborious, time consuming and require specialized technical knowhow. 
Therefore, quantification of active biomass species would not be carried out 
during this study but their abundance will be monitored through their metabolic 
activities in the BNR process. 
2.6.1 Summary of Microorganisms involved in Micropollutant 
Degradation 
  Microorganisms that co metabolize or commensalize MP in wastewater 
treatment plants are diverse but can be grouped as either autotrophic or 
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heterotrophic organisms. Previous attention has been given to autotrophic 
organisms as the dominant contributors to MP degradation with little insight 
into the likely contribution of heterotrophic organisms. Currently, there is no 
consensus on the type of active organism responsible for the biotransformation 
of MPs in activated sludge systems. Hence, further study is required to elucidate 
the active microorganisms involved in the biotransformation of the MPs in 
wastewater. It is believed that the current study is the first to investigate the role 
of PAOs, OHOs, and AOB in the removal of MPs in a BNR activated sludge 
treatment configuration. 
2.7 Influence of Redox Conditions on Micropollutant Removal  
The removal mechanisms for conventional contaminants under different 
redox conditions are well understood and have been efficiently employed in 
most full-scale WWTPs. The impact of redox conditions on the removal of MPs in 
WWTPs is however still unclear.  
  The relatively few studies that have investigated the influence of redox 
condition on MP removal from wastewater are summarized in Table 2-7. Many 
of the studies were conducted using synthetic wastewater in batch experiments 
and the sludge samples were either taken from an existing full scale wastewater 
treatment plant or a lab scale continuous system. Typically the MPs were spiked 
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into the reactor and the degradation rate in each redox zone or the overall 
removal from the system was monitored. Some of the findings from the literature 
review summarized in Table 2-7 are itemized below; 
 There has been more research on estrogen (E1, E2, and EE2) removal 
under different redox condition than other MPs.  Apart from estrogens, 
few studies have been conducted to investigate the removal of MPs under 
anaerobic conditions. 
 Due to the scarce research data describing removal of MPs under different 
redox condition, it is difficult to make broad comparisons or 
generalizations. 
 With the exception of a few studies, most reports that describe the effect of 
different redox condition on MP removal, have reported only the overall 
removal without considering the contribution of each zone. 
 MP removal seems to be affected by the different redox conditions, some 
positively, with better removal along the reactor like Ibuprofen, 
Roxithromycin, Estrone, E1+E2, Estradiol (E2) and Ethinylestradiol (EE2), 
some negatively, with worse removal along the reactor like 
Carbamazepine, Citalopram, Triclosan and Sulfametazine and some in 
between like Sulfamethoxazole and Sulfadiazine. 
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 Different redox conditions do not seem to have an effect on the adsorption 
of MPs to activated sludge biomass (log Kd). 
 Except for E1 and E2, there is no consistency in the reported values from 
the various studies of the removal of compounds under different redox 
conditions. 
 Aerobic and anoxic zones seem to be the dominant zones that contribute 
to the removal of MPs from wastewater.  Except for SDZ, SMR and SMX, 
the greatest removals of MPs were observed under aerobic conditions. 
  Since most of the literature reviewed investigated the removal of 
estrogens under different redox conditions, listed below are some important 
findings in relation to estrogen degradation; 
 E1 could be degraded under all redox condition but at different rates. 
 E2 could be degraded under all redox condition but at different rates. 
 E1, E2, E3 and EE2 could be significantly degraded under anaerobic 
digestion. 
 Overall removal of E1 and E2 does not seem to depend on the redox zone 
sequence but similar conclusions cannot be drawn for EE2. 
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Table 2-7. Summary of influence of redox condition on Micropollutant removal 
      
Removal % due to Transformation 
during batch experiment   
 
Compound 
Redox 
Comb. Log Kd (L kgss-1) Ao Ax An 
Overall 
removal Reference 
    (An/Ax/Ao)           
                
4-NP An/Ax/Ao 4.6/4.9/5.1       75.6 Xue et al. (2010) 
                
4-Op An/Ax/Ao 4.9/4.5/4.2       79.3 Xue et al. (2010) 
                
AHTN Ao/Ax   99.9 82.9     Levine et al. (2006) 
                
BPA An/Ax/Ao 4.6/5.1/5.4       >90 Xue et al. (2010) 
                
Bromoform Ao/Ax   93 96     Levine et al. (2006) 
                
Caffeine An/Ax/Ao 2.5/2.8/2.9       >90 Xue et al. (2010) 
Caffeine Ao/Ax   90 -68.2     Levine et al. (2006) 
CBZ Ao/Ax   68.6 21.4     Levine et al. (2006) 
        
CBZ Ao/Ax 0.1 6±12 1±10     Suarez et al (2010) 
CBZ An/Ax/Ao 3.6/3.8/3.0       <20 Xue et al. (2010) 
                
CTL Ao/Ax 2 60±17 44±9     Suarez et al (2010) 
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Removal % due to Transformation 
during batch experiment     
Compound 
Redox 
Comb. Log Kd (L kgss-1) Ao Ax An 
Overall 
removal Reference 
    (An/Ax/Ao)           
                
DZP Ao/Ax 1.3 17±11 16±17     Suarez et al (2010) 
                
E1 An/Ax/Ao 3±2       96±1 Joss et al. (2004) 
E1 An/Ao/Ax   99 0 70 99 Pholchan et al. (2008) 
E1 An/Ao   90   75 100 Pholchan et al. (2008) 
E1 An/Ax/Ao 4.3/4.5/4.7       >90 Xue et al. (2010) 
E1 Ao/Ax   83.8 9.6     Levine et al. (2006) 
        
                
E1 + E2 Ao/Ax   99±0 72±2     Suarez et al (2010) 
E1 + E2 Ax/Ax/Ao   96.5 -96.6/85.4   97.8 Anderson et al.(2003) 
                
E2 An/Ax/Ao 2.8±1.3/2.7±1.1 97±0.1 37±1 10±0.5 99.99± 0.0002 Li et al (2010) 
E2 Ax/Ao   94 85     Dytzak et al (2008) 
E2 An/Ax/Ao 2.4±2.2       >97 Joss et al. (2004) 
E2 An/Ax/Ao 4.4/4.5/4.7       >90 Xue et al. (2010) 
E2 An/Ao   100   70 100 Pholchan et al. (2008) 
E2 An/Ao/Ax   99 0 90 100 Pholchan et al. (2008) 
17α-E2 An/Ax/Ao 4.8/4.6/5.3       >90 Xue et al. (2010) 
        
                
E3 An/Ax/Ao 2/1/1.5       >90 Xue et al. (2010) 
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Removal % due to Transformation 
during batch experiment 
    
Compound 
Redox 
Comb. Log Kd (L kgss-1) Ao Ax An 
Overall 
removal Reference 
    (An/Ax/Ao)           
EE2 Ax/Ax/Ao   71.4 -14.3/-42.9   80 Andersen et al.(2003) 
EE2 An/Ax/Ao 4.1/5.3/5.2       97.6 Xue et al. (2010) 
EE2 Ao/Ax 2.5 87±11 20±10     Suarez et al (2010) 
EE2 An/Ax/Ao 
2.8±0.95/2.8±0.85
/2.8±0.5 27±2 10±0.9 n.r 79.13±0.77 Li et al (2010) 
EE2 Ax/Ao   22 5     Dytzak et al (2008) 
EE2 An/Ax/Ao 2.5±1.6       94±2 Joss et al. (2004) 
EE2 An/Ao   -58   0 0 Pholchan et al. (2008) 
EE2 An digester       89.6 41.9 Esperanze et al. (2006) 
EE2 An/Ao/Ax   45 30 -98 18 Pholchan et al. (2008) 
        
ERY Ao/Ax 2.2 89±2 20±10     Suarez et al (2010) 
                
Fluoxetin Ao/Ax 0.7 92±3 88±15     Suarez et al (2010) 
                
HHCB An/Ax/Ao 3.8/3.5/3.6       59 Xue et al. (2010) 
                
Ibuprofen Ao/Ax 0.9 95±4 37±26     Suarez et al (2010) 
                
METOP An/Ax/Ao 1.3/1/1         Xue et al. (2010) 
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Removal % due to Transformation 
during batch experiment 
      
Compound 
Redox 
Comb. Log Kd (L kgss-1) Ao Ax An 
Overall 
removal Reference 
    (An/Ax/Ao)           
ROX Ao/Ax 2.2 91±0 15±17     Suarez et al (2010) 
                
SDZ Ax/An/Ao   41 49 -27   Hong et al. (2008) 
                
SMR Ax/An/Ao   0 73 47   Hong et al. (2008) 
                
SMX Ao/Ax 2.4 22±5 n.a     Suarez et al (2010) 
SMX Ax/An/Ao   40 43 -89   Hong et al. (2008) 
                
SPD Ax/An/Ao   33 24 -91   Hong et al. (2008) 
                
TMP Ao/Ax 2.3 14±10 n.a     Suarez et al (2010) 
                
Triclosan Ao/Ax   11.8 -17.7     Levine et al. (2006) 
SMX; Sulfamethoxazole, CBZ;Carbamazepine, TMP;Trimethroprim, DZP;Diazepam, NPX; Naproxen, TCS; Triclosan, ERY;Erythromycin, 
CRL; Citalopram, ROX; Roxithromycin, 4-NP; 4Nonyl phenol, 4-OP; 4 Octyl phenol, BPA; Bisphenol A, E1; Estrone, E2; Estradiol, EE2; 
Ethinylestradiol, DCF; Diclofenac, METP; Metoprolol, CAF; Caffeine, SDZ;  Sulfadiazine,  SPD; Sulfapyridine, SMR; Sulfamerazine, 
IBU;Ibuprofen, BRMF;Bromoform, 
n.d-non detect; n.a- not analysed; n.r- not recorded. An-Anaerobic; Ax-Anoxic; Ao- Aerobic.
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 Oxidation of E2 to E1 was observed under aerobic and anoxic conditions 
(Dytczak et al., 2008). 
 Reduction of E1 to E2 could occur under anaerobic condition (Joss et al., 
2004). 
 EE2 seems to be significantly degraded under aerobic conditions. 
 EE2 is more resistant to degradation than E1 and E2. 
 Slight EE2 degradation could occur under anoxic condition (Dytczak et al., 
2008; Li et al., 2011 and Suarez et al., 2010). 
Based on these findings it is clear that there is need for more information on the 
effects of redox conditions on the removal of MPs from wastewater. 
  For contaminant fate modeling, estimation of the values of biodegradation 
rate constants of the MPs is essential in order to assess the kinetics of the MPs in 
the environment.  Suarez et al. (2010) reported faster degradation under aerobic 
condition for over 90% of the investigated MPs compared to the anoxic 
condition. Table 2-8 shows the reported biodegradation rate constants under 
different redox conditions and treatment conditions for the target MPs. It is 
obvious from Table 2-8 that the different redox zones contributed to the overall 
degradation of the MPs with the aerobic zone contributing the largest 
percentage. It also shows that few reports exist that present the biodegradation 
rate coefficients of MPs with respect to varying redox condition. Therefore it is 
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recommended that a comprehensive data base be generated to present the 
biodegradation rate coefficient of various MPs of environmental concern with 
respect to varying redox conditions since these chemicals has the tendency of 
existing under different redox conditions in the natural environment.  
Table 2-8. Pseudo first order biodegradation rate coefficient (kb) (Lgss-1d-1) of 
selected micropollutants during biological  wastewater treatement 
MP log Kow AO AX AN CAS MBR Reference 
CBZ  2.45 <0.06 <0.03    Suarez et al., 2010 
        
E1 3.13 162 ± 25 30 ± 10 10 ± 1   Joss et al., 2004 
  32/77     Lust and Stensel, 2011 
  32/66    Lust and Stensel, 2011 
        
GEM 4.77    6.4-9.6 0.5-1.8 Joss et al., 2006 
     2.26 ± 1.35  Urase and Kikuta, 2005 
        
IBU 3.97 20 1.5    Suarez et al., 2010 
     21-35 9.0-22 Joss et al., 2006 
     1.33  Abegglen et al., 2009 
     10.75 ± 13.08  Suarez et al., 2010 
     3.04 ± 1.59  Urase and Kikuta, 2005 
     15.38 ± 14.95  Clara et al., 2005a 
        
SMX 0.89 0.3 n.a    Suarez et al., 2010 
     5.9-7.6 3.2-5.0 Joss et al., 2006 
     0.2  ± 0.01  Abegglen et al., 2009 
        
TMP 0.91    0.15  Suarez et al., 2010 
     0.22  Abegglen et al., 2009 
          0.56 ± 0.46   Xue et al., 2010 
AO-Aerobic; AX-Anoxic, AN- Anaerobic 
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2.7.1 Summary of Influence of Redox Condition on Micropollutant 
Removal 
  Previous studies have investigated the effects of redox condition on the 
removal of MPs from wastewater. Most of these studies have focused on 
estrogens, with very few investigations of other MPs. The degradation of E1, E2 
and EE2 has been found to depend on redox condition but the overall removal of 
E1 and E2, yielded consistent results (> 96%) regardless of the sequence of the 
redox condition while EE2 removal seems to be affected by the redox zone 
sequencing, for example, a configuration of anaerobic/aerobic/anoxic yielded 
18% overall removal while a sequence of anoxic/anoxic/aerobic and 
anaerobic/anoxic/aerobic yielded overall removal of 80% and 97.6% respectively.   
  Many researchers have also indicated that the aerobic zone contributed 
the largest removal of the three redox zones investigated for MP removal. 
Although the transformation of MPs has been reported to occur under anoxic 
and anaerobic conditions, the studies are few and there is considerable 
variability between studies. The proposed work will seek to address this 
knowledge gap and hence one of the objectives of this study is to investigate the 
effects of redox condition on the removal of MPs from wastewater.  Investigating 
the effects of redox conditions on the removal and biodegradation of MPs will 
give vital information required to optimize the efficiency of the treatment 
method employed. 
  
70 
 
2.8 Endocrine Disrupting Compounds in Wastewater Treatment 
Plant Effluents 
    Endocrine disrupting compounds (EDCs) are defined by their ability to 
mimic or interfere with the mechanisms that govern the biosynthesis, transport 
or availability, and metabolism of hormones (Lister et al., 2001). The Canadian 
Environmental Protection Act of 1999, article 3, subsection 43 defined “hormone 
disrupting substance” also known as EDC as “a substance that has the ability to 
disrupt the synthesis, secretion, transport, binding action or elimination of 
hormones in an organism, or its progeny, that are responsible for the 
maintenance of homeostasis, reproduction, development or behavior of an 
organism”.  
  Steroid sex hormones and related synthetic compounds such as those 
used in contraceptive pills, have been shown to be present in the aquatic 
environment, mainly as a result of inefficient removal in sewage treatment 
plants. The concentrations of these compounds, although very low, at ng/L, are 
sufficient to induce estrogenic responses and alter the normal reproduction and 
development of wildlife and human endocrine system.  
  A number of previous studies have investigated the concentrations of 
EDCs in treated wastewater effluents (Ternes, 1998; Jones et al., 2002; Kolpin et 
al., 2002) and some studies have investigated the ecotoxicological effects of EDCs 
in treated wastewater (Cleuvers, 2003; Koh et al., 2009).  In these studies, the 
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acute toxicity in the environment was found to be very rare except during spills. 
However, there are concerns that chronic or synergistic effects may exist due to 
their persistence in the environment (Fent et al., 2006). 
  Although various studies have been conducted to investigate the 
ecotoxicological effects of wastewater effluents on the environment, it is still not 
clear whether the cost that would be required to upgrade existing WWTPs to 
accommodate EDCs removal along with conventional pollutants removal would 
eventually reduce the intrinsic effects of the EDCs on the environment. The 
investigation of the relationship between the removal of EDCs from wastewater 
and the reduction of effects when discharged into the environment is challenging 
because there are various mechanism by which these chemicals may exert effects 
on organisms (e.g., interference with various receptors which affect enzymatic 
processes and antagonistic effects of mixture of EDCs). In addition, it is difficult 
to link EDC concentrations and biological effects in the environment because of 
the weak correlation between intrinsic gene expression and physiological effects 
on organisms after exposure. One of the objectives of this study is to compare  
treated effluents that are generated under different treatment configurations with 
respect to MPs  and estrogenicity removal.  
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2.8.1 Bioassays for Detection of EDCs  
One of the methods used to detect EDCs in the environment is the use of 
biologically based assays (Chang et al., 2009). They usually provide either 
qualitative or quantitative responses especially in the presence of multiple EDCs. 
The use of mass-based analytical methods to quantify EDCs has provided 
accurate and precise measurements. However, these methods are limited in their 
ability to describe overall estrogenic effects, such as the synergistic or anti-
estrogenic influences in the presence of multiple EDCs (Liu et al., 2010). 
Therefore, biological assays are useful methods in studying the overall effects of 
EDCs as well as the identification of other xenobiotic compounds that exhibit 
endocrine disrupting behaviors similar to EDCs. 
Several mechanisms have been employed in biological assays that are 
used to measure EDCs and these include; cell proliferation, luciferase induction, 
ligand binding, vitellogenin induction, or antigen–antibody interactions.  
 Cell proliferation utilizes the estimation of cell growth and 
reproduction in different samples, while ligand binding quantifies 
the number of specific estrogen binding sites (Soto et al., 2004; 
Hamers et al., 2008).  
 Luciferase induction measures the amount of luciferase induced 
from estrogen receptors and response elements with luminescence 
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after cell lysing and the addition of luciferin (Legler et al., 2002; 
Michallet-Ferrier et al., 2004).  
 Vitellogenin induction quantifies the amount of vitellogenin in the 
plasma of female fish liver after extraction, which is secreted as a 
response to estrogens. In addition, the production of vitellogenin in 
male fish can be seen as an indication of endocrine disruption 
(Jimenez, 1997; Saaristo et al., 2009).  
 Antigen–antibody interactions use the principle of immunoassays 
based upon the non-covalent binding of antigen to antibodies 
(Gascón et al., 1997; Alyea and Watson, 2009). 
Biological assays could either be “in vivo” or “in vitro”. “In vivo” assays 
utilize the endocrine disruption process in amphibians, fishes, birds, and insects 
in order to monitor the EDCs in aquatic environments. The responses in the 
organisms are determined by deformities, reproductive deficiencies, egg and 
offspring development, and serum protein production, such as vitellogenin 
(Chang et al., 2009).  Many “In vivo” assays have been used to investigate the 
effects of EDCs on fishes, some of the species used include rainbow trout 
(Oncorhynchus mykiss), fathead minnow (Pimephales promelas), sheephead 
minnow (Cyprinodon variegates), and zebrafish (Brachydanio rerio) to mention but a 
few (Fenner-Crisp et al., 2000; Folmar et al., 2000; Legler et al., 2002; Micael et al., 
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2007; Warner and Jenkins, 2007; Soares et al., 2008). In addition, the populations 
of wild leopard frogs (Rana pipiens) have been known to be particularly sensitive 
to the exposure of EDCs, based on a study of their gonadal abnormalities (Hayes 
et al., 2002; Opitz et al., 2006). 
An advantage of using “In vivo” assays in the detection of EDCs is the 
ability to quantify the actual effects of EDCs on a target species as well as the 
usage of the species as a representative biological indicator in their natural 
habitats. In addition, the method may provide a cumulative estrogenic effect 
caused by exposure to a mixture of EDCs in a given environment. The major 
disadvantage of this method is associated with the deficiency of a specific 
organism response to certain EDCs (Chang et al., 2009). 
  The “in vitro” assays can be categorized into three types (Kinnberg, 2003):  
 1)  Estrogen receptor (ER) competitive ligand binding assays: measure the 
binding affinity of a chemical to ERs 
 2) Cell proliferation assays: measure the increase in the number of target 
cells during the exponential phase of proliferation (i.e. E-screen assay) and 
 3) Reporter gene assays: measure ER binding-dependent transcriptional and 
translational activity (i.e. ER-CALUX assay, MVLN cell assay, Yeast 
estrogen screen (YES) assay). 
  
75 
 
The aforementioned in-vitro assays use a protein expression system, 
representing the estrogen response formed or stimulated by a dimer that is 
produced from the binding between the estrogen and the estrogen receptors. 
Luciferase, quantified with a luminometer after cell lysis and β-galactosidase, 
measured with a spectrophotometer, using a back-calculation from the amount 
of colored products after the enzyme-catalyzed reaction process has been 
completed, are some examples of these types of response proteins (Chang et al., 
2009). Out of all the methods available for measuring the estrogenic activity of 
water samples, the yeast assay has been reported to be fast, sensitive and reliable. 
Therefore, the YES assay method was used to estimate the estrogenicity of the 
pilot plant effluents in relation to the different operating conditions. 
2.9 Summary of Literature Review 
  A detailed understanding of the active microbial groups involved in the 
removal of MPs from BNR wastewater treatment process will enhance the ability 
to design treatment methods which would lead to a reduced load and ultimately 
reduced effects of MPs on the environment.  Presently, there is no general 
consensus among researchers on the role of various active microbial groups in 
activated sludge with respect to the removal of MPs from wastewater. Some 
studies have suggested that nitrifying organisms contributed significantly to 
biodegradation while other studies suggested that heterotrophs played a 
  
76 
 
dominant role in the biotransformation of MPs in wastewater.  Other studies 
have suggested that nitrifying and heterotrophic organisms work together as co-
contributors to biotransform MPs. These inconsistencies impede the 
development of a robust model for the removal of MPs in activated sludge 
wastewater treatment processes. Hence, further study is required to elucidate the 
role of active microbial groups in the biotransformation on MPs.  
  Previous studies have shown that high removals of some MPs can be 
achieved through biological wastewater treatment processes operated under 
different redox conditions. However, these studies are few and the variability 
between studies prevents the generalization of conclusions. Therefore, the 
investigation of the removal of MPs under different redox conditions will 
contribute to the general data base of knowledge while presenting the 
opportunity for optimization of existing biological wastewater treatment 
processes. 
  The YES assay is a useful biological tool for detecting EDCs present in 
different matrices in the environment. This method is appropriate for estimating 
qualitative or quantitative estrogenic responses of environmental samples. It is 
unique in its mode of operation because it quantifies the overall estrogenic effects 
(synergistic or anti-estrogenic) induced by the WWTP effluents. However, the 
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YES assay has limitations in that it can produce false negative results due to the 
presence of antagonistic compounds or toxicants in the extracted samples. 
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Chapter 3 Impact of Activated Sludge Process Configuration on 
Removal of Micropollutants and Estrogenicity 
A version of this chapter was published as the paper: Ogunlaja, O. O.; Parker, J. W.; Metcalfe, C.; 
Seto, P. (2013) “Impact of activated sludge process configuration on removal of Micropollutants 
and estrogenicity” Proceedings of the 86th Annual Water Environment Federation 
Technical Exposition and Conference (CD-ROM), Illinois, Chicago, Oct. 5-9. Water 
Environment Federation: Alexandria, Virginia. 
Other collaborative publications involving the study in this chapter are; 
1) Pileggi V., M. Ogunlaja, X. Chen, J. W. Parker, P. Yang, S. Kleywegt, N. 
Feisthauer, S. Tabe, J. Schroeder, T. Fletcher and  P. Seto (2013). Comparison 
of effluent conventional and microcontaminant chemistry in three pilot 
wastewater treatment processes during winter and summer simulated 
conditions, Proceedings of the 86th Water Environment Federation Technical 
Exposition and Conference, Chicago, IL. 
2) Wojnarowicz, P., O. Ogunlaja, C. Xia, W. Parker, C. Helbing. (2013). Impact of 
Wastewater Treatment Configuration and Seasonal Conditions on Thyroid 
Hormone Disruption and Stress Effects in Rana catesebeiana Tailfin. Enviro. Sci. 
Technol., 47(23), 13840-13847. 
3) Parker W.J., V. Pileggi, P. Seto, X. Chen, M. Ogunlaja, G. Van Der Kraak, J. 
Parrott. (2014). Impact of Activated Sludge Configuration and Operating 
Conditions on In Vitro and In Vivo Responses and Trace Organic Compound 
Removal. Sci. of Total Environ., 490,360-369. 
Summary of contributions to aforementioned publications; 
 Conducted daily checks and measurements to maintain the smooth 
operations of the pilot plants.  
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 Collected and prepared samples before other chemical quantifications. 
 Conducted YES assay analysis on collected samples.  
 Prepared samples before sending to laboratories for chemical analysis 
 Collated conventional pollutants and chemical analysis results for ease of 
comparison between treatment trains. 
 Participated in writing a portion of article #2. 
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3.1 Introduction 
  Wastewater treatment plant (WWTP) effluents have been identified as the 
primary route of entry for micropollutants (MPs) into the aquatic environment 
(Joss et al., 2004). The concern with respect to MPs in the environment results 
from the potential deleterious effects of these chemicals on the aquatic 
ecosystem. These chemicals have been shown to cause developmental and 
reproductive abnormalities in various trophic levels of organisms when present 
at very low concentrations (Purdom et al., 1994; Fent et al., 2006; Parrott and 
Blunt, 2005, Parrott et al., 2009) and their occurrence has been measured in both 
effluent and surface water in North America (Kolpin et al., 2002, Metcalfe et al., 
2003; Lishman et al., 2006).   
  Wastewater treatment plants are generally designed to remove 
conventional pollutants such as nitrogen, phosphorus, BOD and TSS and the 
limited removal of MPs from WWTPs is generally fortuitous. A multi-level 
approach with layers of different removal mechanisms (sorption, 
biodegradation, size exclusion, oxidation, etc.) has been suggested for 
improvement in the removal of MPs from wastewater (Koh et al., 2009; Qian et 
al., 2011). However, there is still uncertainty as to whether upgrading wastewater 
treatment for enhanced conventional pollutant removal (i.e. nitrification, 
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denitrification, enhanced biological phosphorous removal) will yield improved 
removal of MPs. 
  Assessing the biological effects of MPs on the flora and fauna of the 
aquatic ecosystem is an indispensable tool required to conduct detailed and 
appropriate risk assessment of MPs in the environment. Unlike chemical 
analyses that can provide a quantitative measure of the compounds present in a 
sample, biological analyses such as in vitro bioassays can provide a qualitative 
and quantitative measure of the net endocrine-disrupting potential of all the 
endocrine-active substances that are present in an effluent (Leusch et al., 2010). 
Studies that have compared the removal of micropollutants and the potential for 
endocrine disruption in the effluents between different wastewater treatment 
technologies are few.  Specifically, it has not been established whether improved 
removal of MPs will translate into a reduction in the biological effects on an 
aquatic ecosystem.  
  In this study, the removal of 10 MPs classified according to EU directive 
93/67/EEC as either toxic (gemfibrozil, ibuprofen, trimethoprim), harmful 
(carbamazepine), non-toxic (sulfamethoxazole, trimethoprim), estrogenic 
(estrone, bisphenol-A and nonyl-phenol) or androgenic (androstendione) in three 
different wastewater treatment technologies (conventional activated sludge 
(CAS), nitrifying activated sludge (NAS) and biological nutrient removal (BNR)) 
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was investigated.  The assessment was conducted at steady state in pilot scale 
processes treating authentic municipal wastewater as an influent. In addition, the 
potential biological effects of the effluents were assessed using a recombinant 
yeast estrogen screen (YES) assay to quantify their net estrogenicity. The 
reduction of estrogenic activity was estimated by calculating E2-Equivalent 
concentration (E2-Eq) in the effluents of the treatment trains. It was hypothesized 
that as the sophistication of the treatment methods increased from CAS to BNR, 
there would be an improvement in MP removal and reduction in estrogenic 
activity in the effluents.  
3.2 Methodology 
3.2.1 Process Description 
  Three pilot wastewater treatment plants located at the Environment 
Canada Wastewater Technology Centre (WTC) in Burlington, Ontario were 
employed for this study. The WTC receives raw municipal wastewater from 
Burlington Skyway Wastewater treatment plant. Schematics of the pilot plants 
are shown in Figures 3-1 and 3-2. The conventional activated sludge (CAS), 
nitrifying activated sludge (NAS) and biological nutrient removal (BNR) pilots 
were fed from a common primary clarifier that received the raw wastewater. The 
activated sludge reactors were segmented into six cells (60 L each) to simulate 
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pseudo-plug flow. Coarse bubble aerators were used for aeration and mixing (in 
a cyclic pattern; high air flow at 40 Lpm and low air flow at 10 Lpm) in the CAS, 
NAS and the aerated zones of the BNR.  The operating and design conditions are 
presented in Table 3-1. An insulated water jacket with automatic temperature 
controller was installed around the bioreactors to control the temperature of the 
bioreactors. Di-potassium phosphate (K2HPO4) (11 g/L at the rate of 14.4 L/d) and 
sodium bicarbonate (NaHCO3) (22 g/L at the rate of 14.4 L/d) were added to the 
primary effluent before entering into the reactors. This was done to ensure the 
system was not phosphorus limited and to provide a pH buffer for the system.  
  The CAS pilot was a single sludge aerobic system operated at sludge 
retention time (SRT) of 3 days to facilitate BOD removal without nitrification. 
The NAS was a single sludge aerobic system operated at SRT of 10 days to 
facilitate BOD removal and nitrification. The longer SRT enabled the 
proliferation of autotrophic nitrifying bacteria which mediates nitrification 
reactions. The BNR process consisted of anaerobic, anoxic and aerobic zones and 
was operated at a SRT of 20 days.  This mode of operation was designed to 
achieve nitrification, denitrification and enhanced biological phosphorous 
removal. To achieve an appropriate range of COD/P ratio that would support a 
healthy BNR activated sludge, the clarified influent wastewater stream to the 
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BNR bioreactor was augmented with an exogenous source of readily 
biodegradable organic substrate (150 mg/L of acetate).  
  The pilot plants were operated for over 365 days with monitoring for over 
180 days to ascertain stable operation in terms of biomass and effluent 
characteristics so as to enable a comparison among the three treatment trains. 
Plant performance was ascertained by monitoring SRT, temperature, COD, NH3-
N, TP, soluble PO4-P, NO3-N, TSS, VSS and pH. 
 
Figure 3-1. Flow diagram of the pilot-scale BNR treatment process. 
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Figure 3-2. Flow diagram of the pilot-scale CAS and NAS treatment process. 1. 
Primary clarifier; 2. Aerobic bioreactor; 3. Final clarifier. 
 
Table 3-1. BNR, NAS and CAS operating and design information 
 Size/description Unit 
Flow rate (Q) 1282 L/d 
Primary settler Area = 0.46 m2 
 Depth = 1.56 m 
Activated sludge Pass volume = 6 X 60 L 
 Depth = 1.28 m 
Dissolved Oxygen CAS-DO  = 2-2.5 
NAS-DO  = 4-4.5 
BNR 
DO(aerobic) = 4-5 
DO(anoxic) = 1-2.5 
DO(anaerobic) = 0-0.2 
mg/L 
Final settling tank Area = 0.204 m2 
 Depth = 1.4 m 
 Underflow = 962 L/d 
Waste flow CAS = 107 
NAS = 34 
BNR = 18 
L/d 
CAS-BNR 
Internal recirc. split factor 
Aerobic = 2Q 
Anoxic = Q 
L/d 
SRT CAS = 3 
NAS = 10 
BNR = 20 
days 
HRT Average nominal = 7 h 
Temperature 18 ± 2 oC 
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3.2.2 Sample Collection and Extraction 
A total of 5 sampling campaigns were conducted over three months 
during the steady state plant operation (July 2011 – Sept. 2011).  The influent 
samples were collected after it had passed through primary clarification while 
the effluent from each train was collected at the outlet of the secondary clarifier. 
Eight hour composite grab samples were also collected from the anaerobic, 
anoxic and aerobic zones of the bioreactor during the same time as when the 24 h 
composite samples were collected. To reduce the influence of diurnal changes, 24 
h composite samples of the influent and effluent were collected in 10 L stainless 
steel canisters using flow proportional (150 mL / 30mins) refrigerated auto 
samplers (HACH Company, Loveland USA).  
Immediately after sample collection, the samples were centrifuged at 4000 
rpm for 5 minutes and the supernatant filtered through 1.5 µm glass microfiber 
filters (Whatman, Toronto, Ontario, Canada). The filtered samples were split into 
two sub-samples each with a volume of 120 mL.  The sub-samples were acidified 
to pH 3 and stored in amber glass bottles at 4oC until they were extracted and 
analyzed. One set of sub-samples was extracted using the subsequently 
described multi-residue solid phase extraction technique (SPE) before shipping 
to Trent University for chemical quantification using LC/MS-MS. The second set 
of samples was extracted using the same procedure as the first set but without 
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spiking with deuterated compounds and processed for the yeast estrogen screen 
(YES) assay.  
The samples were also analyzed for conventional wastewater parameters 
(as per Standard Methods for the Examination of Water and Wastewater (Eaton, 
2005)) including, chemical oxygen demand (COD), biochemical oxygen demand 
(BOD), total Kjeldahl nitrogen (TKN), ammonia, nitrate, total suspended solids 
(TSS), alkalinity and pH. 
3.2.3 Solid Phase Extraction 
A multi-residue extraction procedure was used for extraction of the 
compounds from the water samples (Li et al., 2010) prior to the MP analysis and 
the YES assays.  The samples extracted for MP analysis were initially spiked with 
surrogate standard solution (100 µL of 0.5 ppm) of the selected compounds 
prepared in methanol before the extraction.  The samples extracted for 
characterization by the YES assay did not include the spiked standards. The SPE 
process is summarized in Figure 3-3. 
In the extractions, Visiprep solid-phase extraction (SPE) vacuum 
manifolds coupled with Oasis® MAX SPE 6 mL (500 mg) SPE cartridges were 
used to concentrate the filtered samples (sample pH  was initially adjusted to  8 
by adding 0.1M NaOH). The HLB tubes were conditioned with 6 mL of 
methanol, 6 mL 0.1M NaOH in Milli-Q water, and 6 mL of Milli-Q water, taking 
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care not to let the cartridge go dry. The filtered wastewater sample was loaded 
onto the cartridge at a flow rate of approximately 5 mL/min to ensure good 
recovery and the sample bottles were rinsed with 10 mL of pH 8 distilled water. 
After loading, the cartridges were rinsed with 2 mL of pH 8 water and dried 
under vacuum for 10-20 minutes. The compounds were then eluted from the 
cartridges with 2 mL of MeOH at a flow rate of about 1 mL/min and rinsed thrice 
with 3 mL of 2 % formic acid in methanol at a flow rate of 1 mL/min, waiting six 
minutes between each elution. After elution, the cartridge was aspirated to 
dryness for about 10 min under vacuum. The eluted fractions were collected in 
amber glass tubes and dried under a gentle stream of nitrogen gas (N2). The 
dried residue was dissolved in 0.4 mL of methanol and stored at 4oC before using 
it for YES assay or LC-MS-MS analysis. 
Figure 3-3. Summary of multi-residue extraction procedure. 
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3.2.4 Biological Testing 
The estrogenic activity of the extracted samples was evaluated using the 
recombinant yeast screen for estrogenicity bioassay (YES) according to the 
methods developed by Routledge and Sumpter (1996) with adjustments 
described by Citulski and Farahbakhsh, (2010). A recombinant yeast strain 
(Saccharomyces cerevisiase) containing the human estrogen receptor was used for 
the assay. The strain contains an expression plasmid carrying the lac-Z reporter 
gene. When the cells are incubated for 3 days at 32oC in the presence of 
estrogenic compounds, the lac-Z product, β-galactosidase, is secreted into the 
medium and causes the chromogenic substrate, chlorophenol red-β-D-
galactopyranoside (CPRG), to turn from yellow to red.  
In the YES assay, the samples were initially evaporated to dryness under 
N2, after which the evaporated residue was re-dissolved in 400 µL of ethanol. 
The sample was then transferred to a vial which was stored at 4°C. A 100 µL 
aliquot of each E2 sample was transferred to a 96 well micro titer plate (the 
dilution plate) and a dilution series was produced (using 100 µL of absolute 
ethanol).  Standard curves for each test were prepared from positive-control 
rows of 17-β-estradiol (E2) in ethanol, diluted from 10 nM to 5x10-3 nM nominal 
concentration. The dilution factor in each titre plate was 2 times with ethanol 
across the 12 wells to produce a final dilution of 1/2048 (i.e 211 times dilution).   
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A 10 µL aliquot of each dilution was transferred to a new micro titer plate 
(the assay plate) in a laminar air flow bench. The assay plate contained one row 
of standard solutions (17β-estradiol as positive control), one row of blank 
samples (absolute ethanol as negative control) and three rows of serially diluted 
environmental samples (80 µL of sample extract diluted with 80 µL of ethanol). 
The assay plates were allowed to dry in the laminar air flow bench after which 
200 µL of combined growth medium/CPRG/yeast mixture were added. 
Subsequently, the assay plates were incubated at 32°C with the shaker tray set to 
150 rpm for 72 hours to promote suspension of the yeast cells and constant 
mixing with the assay medium. 
The absorbance (AB) at 540 nm and 620 nm was determined using a micro 
titer plate reader (Sunrise Basic TECAN). In order to adjust the absorbance of 
chlorophenol red at 540 nm for the extent of yeast growth (turbidity), the 
absorbance measurements for E2 standards and environmental samples were 
transformed as per equation 3-1 (Fent et al., 2006): 
 
Adj. Absorbance = AB540nm (sample) – [AB 620nm (sample) – AB 620nm (blank, average)] 3-1 
 
The dose response curve for the standards and environmental samples 
were calculated using GraphPad Prism 6 (v. 6.02) that employed a four-
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parameter sigmoidal Hill equation to calculate the EC-50. To obtain the 
estrogenicity values for the extracted sample, the logarithm of the extraction 
dilution that yield a 50% response was computed from the fitted curve. The E2-
Eq was calculated as the ratio between the amount of E2 in the incubation well at 
EC50 in the standard curve and the equivalent volume at EC50 as per equation 3-
2. 
 
E2 − 𝐸𝑞 (
𝑛𝑔
𝐿
) =  (
𝐸2 𝐸𝐶50( 𝑛𝑔 𝐿)⁄
𝐸𝐶50 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟∗0.4
)     3-2 
 
The value 0.4 accounted for the air dried 80 µL sample extract applied to the titer 
well and reconstituted with  200 µL of the  growth medium containing yeast cells 
(80/200 = 0.4). The method detection limit based on E2 standard was determined 
as 1 ng/L. 
3.2.5 Target MPs 
The micropollutants investigated in this study are presented along with 
their physicochemical characteristics in Table 3-2. The target compounds 
included a broad range of substances including acidic, basic and neutral drugs 
and estrogenic compounds and were selected on the basis of their detection 
frequency in WWTP effluents (Metcalfe et al., 2003; Lishman et al., 2006) and the 
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ability to detect low concentrations (ng/L) using LC-MS/MS (Miao and Metcalfe, 
2002) 
3.2.6 Statistical Analysis  
The conventional and chemical data were analyzed for outliers using the 
Grubb’s test. The regressions used to construct the YES assay response curves for 
the samples were compared to the response curves of estradiol (E2) standard 
using the F-test. To check the yeast growth absorbance (AB620 nm) for the 
presence of toxic effects resulting from the wastewater extracts,  the yeast growth 
was compared to the average turbidity (± 3 standard deviations) of 12 ethanol 
only negative-control wells that were incubated in the same plate as the samples. 
Samples that had yeast growth with turbidity values below the average minus 3 
standard deviations of the negative control were removed from the dose-
response curve analysis. The final conditioned data were employed to generate 
the dose-response curve for the estimation of the EC50. A paired-t-test was 
employed to compare the MPs’ concentrations and the E2-Eq concentrations in 
the influent and pilots’ effluent streams at the 95% confidence level using 
Microsoft excel 2013.
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Table 3-2. Physicochemical properties of selected micropollutants 
Micropollutants 
Molecular 
mass  
(g/mol) 
Water solubility @ 
25oC (mg/L) - 
Dissolving 
Henry’s law 
constant @ 
25oC(atm m3 /mol)- 
Evaporation 
(Log Kow)-
Bioconcentration 
(Kd)*  
L/KgSS 
Biological or Clinical effects 
Ibuprofen 206.29 21 (moderate) 1.5E-07 (moderate) 3.97 (moderate) <30 Non-prescription analgesic 
Meprobamate 218.25 4700 (high) 1.8E-10 (high) 0.7 (low) <30-190 Anti-convulsant 
Nonyl phenol 220.35 7 (low) 3.4E-05 (low) 5.76 (high) 7k-13kc Estrogenic 
Bisphenol A 228.29 120 (moderate) 1E-11 (high) 3.32 (moderate) 314-502 Estrogenic 
Carbamazepine 236.27 17.7 (moderate) 1.08E-10 (high) 2.45 (low) 36-65 Anti-epileptic 
Gemfibrozil 250.33 10.9 (moderate) 1.19E-08 (high) 4.77 (high) 30-45 Cholesterol lowering Drug 
Sulfamethoxazole 253.28 
610 @ 37oC 
(moderate) 
6.42E-13 (high) 0.89 (low) 200-400 Antibiotic 
Estrone 270.37 30 (moderate) 3.8E-10 (high) 3.13 (moderate) 607-645 Estrogen 
Androstenedione 286.41 57.8 (moderate) 3.68E-08 (high) 2.75 (moderate) 134-174 Steroid hormone 
Trimethoprim 290.32 400 (moderate) 2.39E-14 (high) 0.91 (low) 119-251 Antibiotic 
 
Physprop Database. http://www.syrres.com/esc/physdemo.htm *Stevens-Garmon et al., 2011; c  Xue et al.,2010
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3.3 Results and Discussions 
3.3.1 Conventional Parameters 
The pilot plants were monitored with respect to the removal of 
conventional wastewater pollutants such as biochemical oxygen demand (BOD) 
and nitrogen species.  This data was employed to establish whether the treatment 
plants were operating within normally established ranges and to provide insight 
into the types of microbial metabolisms (i.e. aerobic heterotrophic growth, anoxic 
heterotrophic growth, aerobic autotrophic growth) that were active in the 
bioreactors.  The measured responses are presented in Table 3-3. 
Considering the inherent variability of processes treating raw municipal 
wastewater, the effluents from the pilot plants as indicated in Table 3-3, were 
relatively consistent with time. Carbonaceous BOD5 was consistently removed in 
all pilot plants and most final concentrations were less than 10 mg/L.  This was 
considered indicative of good removal of biodegradable organic matter.  The 
BNR and NAS processes produced the lowest effluent BOD concentrations while 
the effluent concentrations from the CAS process were slightly elevated (average 
of 13.3 mg/L). 
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Based upon the operating conditions that were employed in this study it 
was expected that the effluents from the CAS pilot would have higher 
concentrations of TKN and TAN and low concentrations of NO3-N and NO2-N as 
compared to NAS and BNR pilot effluents.  From Table 3-3 it can be observed 
that the CAS pilot effluent NO3-N concentrations were consistently low and the 
effluent TKN and TAN concentrations remained elevated. The NAS pilot was 
expected to have low concentrations of TKN and TAN and elevated 
concentrations of NO3-N in the effluent.  From Table 3-3 it can be seen that these 
patterns were consistently observed.  Hence, it was concluded that the CAS pilot 
was not nitrifying while the NAS pilot was nitrifying effectively.  The BNR pilot 
was expected to have low effluent concentrations of PO4-P, TKN, TAN, NO3-N 
and NO2-N.  A review of Table 3-3 indicated that these patterns were consistently 
observed.  Hence, it was concluded that the BNR process was effectively 
nitrifying, denitrifying and biologically removing phosphorus.  Collectively, it 
was concluded that the pilots were achieving levels of treatment that are typical 
of their respective operations at technical scale (Tchobanoglous et al., 2003). 
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Table 3-3. Influent and effluent concentrations of conventional responses 
(mg/L) (Mean (S.D)) 
  TAN  NO3-N NO2-N TKN cBOD5 PO4-P 
Influent 20.9(6.6) 0.62(0.9) 0.16(0.23) 27.1(10.4) 79.8(56.4) 5.15(1.6) 
CAS 21.1(6.4) 1.7(4) 0.4(0.6) 21.4(5.7) 13.3(10.1) 5.38(1.4) 
NAS 0.076(0.039) 22(2.6) 0.013(0.018) 1.2(0.3) 3.5(1.7) 5.24(1.4) 
BNR 1.3(2.1) 5.4(2.2) 0.3(0.4) 2.4(2.3) 6.4(6) 0.19(0.4) 
 
3.3.2 Micropollutant Removal during Treatment 
All 10 compounds were detected in the influent wastewater. The observed 
average influent concentrations were generally lower than previously reported 
studies (Lishman et al., 2006, Lajeunesse et al., 2012). The influent data was 
conditioned by using Grubb’s test to determine any outliers which were 
removed before conducting other statistical analysis. There were some overall 
variability associated with the influent concentrations of the selected compounds 
with a median relative standard deviation (RSD) of 25% across all influent 
samples for the five sampling campaigns. The variability was primarily 
attributed to temporal changes in the influent concentrations.  
The effluents from the three pilots were compared to examine whether 
any of the pilot out performed each other by examining the responses of 10 
representative MPs. The effluent data was conditioned by using Grubb’s test to 
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determine any outliers which were removed before conducting other statistical 
analysis. A paired-t-test was employed to compare the mean concentrations of 
the MPs in the influent to the mean concentrations of the MPs in the effluent 
streams from CAS, NAS and BNR treatment configurations. A paired-t-test was 
also used to compare the mean concentrations of the MPs in the BNR to the mean 
concentrations of the MPs in the effluent from NAS and CAS treatment 
configuration. This analysis was conducted in order to determine the statistical 
significance of the differences in the mean concentrations between the influent 
and the effluent streams from the treatment configurations. Hence, Table 3-4 
summarizes the results from the statistical analysis.  
Table 3-4 shows the p-values of the paired t-tests that compared the mean 
concentrations in the streams from the pilot plants.  The results of the paired-t-
test showed a statistically significant difference between the mean concentrations 
in the influent and CAS, NAS and BNR effluents for IBU, CBZ, GEM, ADR, E1, 
NP and BPA. There was no statistically significant difference between the mean 
concentrations in the influent and CAS, NAS and BNR for MEP. The result 
showed that the mean concentrations in the influent and the NAS effluent for 
GEM were statistically significant. The mean of the difference in the 
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concentrations of TMP in the influent and in the BNR effluents were also 
statistically significant. In addition, there were no statistical difference between 
CAS and BNR effluents or NAS and BNR effluents at the 95% confidence level 
for all the investigated compounds except for TMP. These results show that 
majority of the responses of the MPs in the influent and the effluent from the 
CAS, NAS and BNR treatment configurations were significant. Hence, the data 
were employed for further technical comparisons among the three treatment 
configurations. 
Table 3-4. Statistical significant (p ≤ 0.05) testing results – P values 
Comparison IBU MEP GEM CBZ TMP SMZ ADR E1 NP BPA 
IN-CAS 0.002 0.252 0.425 0.025 0.219 0.020 0.006 0.038 0.042 0.004 
IN-NAS 0.002 0.429 0.001 0.006 0.201 0.003 0.005 0.017 0.035 0.01 
IN-BNR 0.002 0.402 0.091 0.043 0.008 0.067 0.005 0.018 0.036 0.004 
           
BNR-CAS 0.07 0.64 0.23 0.62 0.03 0.62 0.13 0.06 0.24 0.08 
BNR-NAS 0.09 0.99 0.08 0.41 0.03 0.15 0.35 0.72 0.19 0.19 
IN-influent 
Box plots and averages of the concentrations of the compounds in the 
influent and effluents from CAS, NAS and BNR are presented in Figures 3-4, 3-5, 
and 3-6. These plots show that 5 MPs (IBU, ADR, E1, NP and BPA) had 
comparable effluent concentrations for CAS, NAS and BNR. Two MPs (CBZ, 
MEP) had effluent concentrations equal or higher than the influent 
concentrations for all the treatment processes. TMP, GEM and SMX effluent 
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concentrations followed the trend of BNR < NAS < CAS, NAS < BNR < CAS and 
NAS < CAS = BNR respectively.  
The removal efficiencies of each compound across the treatment processes 
were calculated as the percent difference in concentration from influent to 
effluent. The term removal used in this study described the loss of the target 
compound and did not necessarily imply mineralization. The removal of the 
target compound could have proceeded via different mechanisms including 
chemical and physical transformation, biodegradation or biotransformation and 
sorption. The MPs removal efficiencies across the three treatment processes are 
presented in Figure 3-7.  It is apparent from Figure 3-7 that 6 MPs (IBU, ADR, 
SMX, E1, NP and BPA) were consistently removed with removal efficiency 
greater than 65% across the three treatment processes while no removal was 
observed for 2 MPs (CBZ and MEP) regardless of the treatment process utilized.  
The moderate to high removal efficiencies for the IBU, ADR, SMX, E1, NP 
and BPA were consistent with the removal efficiencies previously reported in the 
literature (USEPA 2010). Treatment processes with SRTs ranging from 2 – 68 
days in a lab scale and 22- 82 days in WWTP pilot scale were reported to have 
IBU removals ranging from 80% to 100% (Onesios et al., 2009). The average 
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reported removal efficiency for BPA in a variety of treatment processes and SRTs 
was reported to be 83% (Melcer and Klecka, 2011). Clara et al. (2005) reported 
BPA and IBU average removals of 82 to 98% at SRTs as low as 2 days in an 
activated sludge system. Reported values for ADR, NP and E1 removal efficiency 
in various aerobic activated sludge systems and SRTs have ranged from 98 to 
100% with an average of 99%. These results suggest that the removals of IBU, 
ADR, SMX, E1, NP and BPA in the CAS, NAS and BNR were independent of the 
process configuration or system’s SRT.  
The apparent negative removals for CBZ and MEP (Figure 3-7) reflected 
the increased effluent concentrations of CBZ and MEP from the treatment 
processes as compared to the influent concentrations (Figures 3-4D and 3-5E). 
This suggests that CBZ and MEP were not removed by any of the treatment 
processes. This may have resulted from de-conjugation of conjugated versions of 
the parent compounds by the action of the microorganisms during the treatment 
process (Lindqvist et al., 2005). Gobel et al. (2007) suggested that the increase in 
effluent concentration of some MPs as compared to their influent concentration 
could be due to the encasing of the influent MPs in fecal particles leading to an 
apparent increase in concentration during treatment as the fecal particles are 
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degraded. Previous studies have shown that recalcitrant compounds like CBZ 
rarely sorb or degrade in a variety of wastewater treatment processes (Ternes et 
al. 2004; Clara et al. 2005a). The recalcitrant behavior of CBZ and MEP could be a 
useful characteristic in applications where they might be employed as an 
anthropogenic tracer.  
Figure 3-7 shows an increase in the removal of TMP as the treatment 
process complexity progressed from a simple non-nitrifying CAS to a complex 
BNR configuration.  Longer solids retention times (SRTs) accommodate slower 
growing bacteria like nitrifiers and can also support the proliferation of a wider 
range of bacteria species. The presence of a broad array of bacteria likely allows 
for a wider range for biotransformation of TMP thereby leading to improved 
removal at longer SRTs (CAS-3 days, NAS-10 days and BNR- 20 days). 
Correlations between treatment efficiency and SRT have previously been 
established (Clara et al., 2005a) and an SRT longer than 10 days has been 
suggested as being more effective in removing micropollutants such as estrogens 
(Carballa et al., 2007). Gobel et al., 2007 investigated the removal of MPs by 
activated sludge and showed an increase in the removal of TMP from 50% to 
90% when SRTs were increased from 16 ± 2 to 60 days. Therefore, the increased 
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removal efficiency of TMP in the BNR could be due to microbial diversity and 
SRT of the process as compared to the CAS and NAS treatment configurations.
 
Figure 3-4. Box plot and average of influent and effluents concentrations from 
CAS, NAS and BNR treatment A- Ibuprofen, B- Gemfibrozil, C- 
Trimethoprim, D- Carbamazepine. 
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Figure 3-5. Box plot and average of influent and effluents concentrations from 
CAS, NAS and BNR treatment. E- Meprobomate, F- Sulfamethoxazole, G- 
Androstedione, H-Estrone. 
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Figure 3-6. Box plot and average of influent and effluents concentrations from 
CAS, NAS and BNR treatment. I- Nonyl-phenol, J- Bisphenol-A. 
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Figure 3-7. Micropollutant removal efficiencies in pilots. 
 
3.3.3 Micropollutant Removal in BNR Treatment Configuration 
 The bioreactors of the CAS and NAS pilots were operated as single 
aerobic reactors but the BNR bioreactor was divided into three different zones 
operated at different redox conditions. Therefore, it was expected that the 
different zones would contribute differently to the biotransformation of the MPs 
in the BNR treatment configuration. This expectation was based on the fact that 
the amount of energy that is captured by the microorganisms in aerobic 
conditions is usually higher than the energy captured in anoxic and anaerobic 
conditions (Tchobanoglous et al., 2003). This bioenergy could be instrumental to 
the biotransformation of the MPs in the BNR bioreactor. Hence, the contribution 
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of the redox conditions to the removal of the MPs that were removed in the BNR 
treatment configuration was assessed.  
 The MPs concentrations in the influent and the intermediate stages of the 
BNR bioreactor are presented in Figures 3-8 and 3-9. It is apparent from Figures 
3-8 and 3-9 that the concentrations of the MPs decreased through each stage of 
the bioreactor, which suggested that each of the zones contributed to the overall 
MPs’ removal. However, during the operation of the pilot BNR process, mixed 
liquors were recycled from the aerobic zone to the anoxic zone and from the 
anoxic zone to the anaerobic zone. The returned activated sludge was also 
recycled from the final clarifier to the anoxic zone of the bioreactor. These recycle 
flows can have dilution effects on the pilot plant influent at different points of the 
treatment system. Therefore, a set of mass balances were employed to 
characterize the fate of the MPs that were removed in the pilot BNR treatment 
configuration.    
 In the mass balances, the biotransformation efficiencies of the MPs in each 
zone were calculated as the difference between the mass flow entering and 
leaving the zone, divided by the mass flow entering the zone. The difference 
between the mass inflow and outflow in the aqueous phase across each zone of 
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the bioreactor was assumed to be due to microbial biotransformation within the 
zone of the bioreactor. Figure 3-10 shows a representative schematic of the mass 
flows employed for the MPs that were removed in the BNR treatment 
configuration. The biotransformation efficiencies of the MPs in the anaerobic, 
anoxic and aerobic sections of the BNR bioreactor are presented in Table 3-5. 
Table 3-5 shows that the biotransformation efficiencies in the bioreactor of the 
BNR process increased from the anaerobic to the anoxic and aerobic zone for IBU 
and TMP while only the aerobic zone degraded SMX, ADR, E1 and GEM.  
Hence, it was concluded that out of the 6 MPs that were removed in the BNR 
treatment configuration, only IBU and TMP were biotransformed in all the redox 
zones of the BNR bioreactor at different percentages while the other 4 MPs were 
biotransformed only in the aerobic zone. 
 The energy that is captured by the microorganisms in aerobic conditions is 
higher than the energy captured in anoxic and anaerobic conditions 
(Tchobanoglous et al, 2003). This difference in energy could explain why the 
aerobic zone had the highest and in some cases only biodegradation efficiency 
among the three stages for the pilot BNR treatment configuration. The high 
biotransformation efficiencies in the aerobic zones as compared to the anoxic and 
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aerobic zones suggests the potential for significant removal of MPs in aerobic 
environments. It was concluded that the aerobic environment is an important 
condition for significant biotransformation and removal of MPs in wastewater 
treatment. However, further study is recommended to investigate ways of 
improving the removal of MPs in anoxic and anaerobic environments.   
 
Figure 3-8. Ibuprofen concentrations in the influent and stages of BNR process 
 (deviation bar represents standard deviation of measurements (n = 5)). 
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Figure 3-9. Micropollutant concentrations in the influent and stages of BNR 
process (deviation bar represents standard deviation of measurements (n = 5)). 
 
 
 
Figure 3-10. Mass balances of Ibuprofen in BNR pilot plant. (mass flow rate in 
µg/d). 
 
 
 
 
Table 3-5. Biotransformation efficiency of MPs in BNR bioreactor 
  Biodegradation efficiency (%) 
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Micropollutant Anaerobic Anoxic Aerobic 
Ibuprofen 15 ± 1 45 ± 1 83 ± 5 
Trimethoprim 13 ± 12 17 ± 10 24 ± 4 
Sulfamethoxazole n.d n.d 48 ± 11 
Androstendione n.d n.d 100 ± 14 
Estrone n.d n.d 95 ± 0.2 
Gemfibrozil n.d n.d 67 ± 23 
n.d – not degraded. 
 
3.3.4 Biological Activity 
Due to constraints on chemical analysis, it is unlikely that the suite of 
chemicals selected for characterization will account for the entire range of 
endocrine disrupting compounds (EDCs) present in the effluent. Hence, chemical 
quantification may not present a holistic picture of the potential for endocrine-
disrupting activity of the effluents.   In fact, differences in endocrine-active 
potency amongst different chemical species, or possible antagonism or 
synergism of chemical mixtures cannot be accounted for by chemical analysis. 
Therefore, the application of in-vitro bioassays to determine the estrogenicity of 
environmental samples (Leusch et al., 2006; Fernandez et al., 2009) has been 
developed and were examined in this study. 
The YES assay was employed to assess the performance of the treatment 
processes in terms of estrogenicity removal. The YES assay E2-Eq values from the 
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treatment processes are summarized in Figure 3-11. The influent estrogenic 
equivalence (E2-Eq) ranged from 32 to 44 ng/L with an average concentration of 
37.6 ± 5 ng/L and relative standard deviation (RSD) of 14% across all influent 
samples. The effluent E2-Eq values ranged from 4.2 - 8.5 ng/L for the CAS, 0.6 - 
8.6 ng/L for the NAS and 0.2 - 2.1 ng/L for the BNR. The average effluent 
concentrations for the three processes were 6.3, 4.7 and 0.84 ng/L for the CAS, 
NAS and BNR processes respectively.   
A paired-t-test was used to compare the E2-Eq in influent to the E2-Eq in 
the three effluent streams from CAS, NAS and BNR treatment configuration. The 
results of the paired-t-test showed a statistical difference between the influent 
and CAS, NAS and BNR effluents (p < 0.05).  The BNR effluent values were 
significantly lower than the CAS (p = 0.006) but not significantly lower than the 
NAS effluent values.  Further statistical analysis could not be employed to 
discriminate between the means of the data set because of the relatively limited 
number of available data. The removal efficiencies calculated as the percent 
difference between the influent and effluent E2-Eq concentrations across each 
treatment process were 84 ± 3 %, 89 ± 10 % and 98 ± 2 % for CAS, NAS and BNR 
respectively. The results show that the BNR and the NAS performed better than 
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the CAS in terms of estrogenicity removal. In general, the trend in the removal of 
estrogenicity by the process configurations were consistent with the removal of 
E1, NP and BPA that were previously presented. 
 
Figure 3-11. Box plot comparing the E2-Eq responses of influent and effluents 
from CAS, NAS and BNR (n = 4-5). 
 
Conclusions 
A comparative study of the performance of 3 different wastewater 
treatment processes was conducted. The concentrations of 10 MPs including 
acidic, basic and neutral compounds were determined in the influent and the 
effluent of CAS, NAS and BNR treatment configurations. The estrogenic activity 
of the influent and effluent from each of the treatment configuration was also 
analyzed using the YES assay. The removal efficiency of TMP improved with the 
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complexity of the three treatment processes configurations and SRTs. IBU, ADR, 
SMX, NP, E1 and BPA had moderate to high removals (> 65%) while CBZ and 
MEP remained recalcitrant in the three treatment process configurations. The 
removal of GEM was better in the NAS than in the BNR and CAS treatment 
configurations. The fact that only TMP showed an increase in removal as the 
complexity of the treatment configuration increased from CAS to NAS and to 
BNR suggests further study to assess the behavior of TMP in BNR systems. The 
YES assay analyses showed an improvement in estrogenicity removal in the BNR 
and NAS treatment configurations as compared to the CAS treatment 
configuration. In general, similar trend was observed among the treatment 
processes in terms of the removal of MPs and estrogenicity. However, it is 
important to note that the similarity in the trends in MP and estrogenicity 
removals does not imply that the reduction in estrogenicity across the treatment 
trains was as a result of the MPs removed.  
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Chapter 4 Assessment of the Removal of Estrogenicity in Biological 
Nutrient Removal Wastewater Treatment Processes 
An abridged version of this chapter was submitted for publication in the journal of Science of the 
Total Environment on Dec. 14, 2014; resubmitted with revisions on Jan. 15, 2015 and accepted 
for publication January 28, 2015.   
 
Ogunlaja O. O., Parker W. J., Assessment of the removal of estrogenicity in 
biological nutrient removal wastewater treatment processes, Sci. Total Environ 
(2015), doi/10.1016/j.scitotenv.2015.01.100. 
4.1 Introduction 
 Effluents from wastewater treatment plants (WWTPs) have been shown to 
contain a mix of various endocrine disrupting compounds (EDCs) that could 
induce physiological effects either individually or synergistically on aquatic 
organisms (Desbrow et al., 1998; Sumpter, 1998; Nakada et al., 2004; Vajda et al., 
2011; Wojnarowicz, et al., 2013; Parker et al., 2014). The USEPA has defined EDCs 
as exogenous agents that interfere with the synthesis, secretion, transport, 
binding action, or elimination of natural hormones in the body that are 
responsible for the maintenance of homeostasis, reproduction, development, and 
/or behavior. Some of the effects of EDCs on aquatic organisms include reduced 
reproductive capacity and vitellogenin production (precursor of egg yolk 
protein) in male fish, decreased female fish fertility and survival of juveniles, 
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reduced fish egg fertilization and thyroid hormone disruption in tadpoles 
(Purdom et al., 1994; Jobling and Sumpter, 1993, Jobling et al., 1998; Andersen et 
al., 2003; Vajda et al., 2011; Wojnarowicz, et al., 2013; Parker et al., 2014).   
 Synthetic and natural EDCs enter sewer systems through human and 
animal excretions (Combalbert and Hernandez-Raquet, 2010). Stringent policies 
could be formulated by regulatory agencies to attenuate the risks associated with 
EDCs in the environment. However, the anthropogenic release of these 
substances into the environment is difficult to control because some of these 
compounds are naturally produced in the human or animal body. For example, 
the natural estrogens, E1 and E2 excreted by pregnant women could be as high 
as 600–940 and 170–330 μg/day/person respectively (Johnson et al., 2000). Hence, 
the removal of EDCs in wastewater treatment processes will be required for 
attenuating their release into the aquatic environment. 
 Biological nutrient removal (BNR) wastewater treatment processes are 
advanced configurations that provide carbon, nitrogen and phosphorus removal. 
The removal and biodegradation of macropollutants in BNR processes is well 
documented but the fate of EDCs that are prevalent in wastewater in these 
processes is less well understood. Previous studies that have investigated the 
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removal of EDCs in BNR wastewater treatment processes have reported greater 
than 90% removal efficiencies of the compounds (Koh et al., 2009; Li et al., 2011). 
However, it is still unclear whether the high removal of EDCs in BNR treatment 
processes can be translated into a high reduction in estrogenic responses from 
the systems. A recent study that compared the removal of estrogenicity in 
conventional activated sludge (CAS), nitrifying activated sludge (NAS) and 
biological nutrient removal (BNR) processes showed greater than 80% 
estrogenicity removal in all processes with the highest removal in the BNR 
treatment process (Ogunlaja et al. 2013). However, the impact of the different 
stages of treatment on estrogenicity reduction was not examined in detail.  
 The quantification of the estrogenic potency of EDCs in WWTPs is not 
trivial because EDCs exist as a cocktail in WWTPs influents and effluents. The 
potential for synergistic action of the mixture of EDCs in wastewater has 
challenged previous attempts to relate calculated EDC concentrations with 
measured estrogenicity in WWTPs (Petrovic et al., 2004). Therefore, in order to 
give a holistic assessment of the estrogenicity of a WWTP effluent, previous 
studies have employed in vitro bioassays to augment chemical measurements 
(Servos et al., 2005; Wu et al., 2011; Parker et al., 2014). 
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 In general, there have been few studies that have employed bioassays to 
investigate estrogen biodegradation in BNR activated sludge.  Previous studies 
that have investigated the biodegradation of EDCs in activated sludge systems 
have monitored the disappearance of the compounds using chemical techniques 
without an understanding of the estrogenicity associated with the disappearance 
of the compounds (Joss et al., 2004; Dytczak et al., 2008). However, it has been 
demonstrated in other process configurations that the disappearance of 
estrogenic compounds does not necessarily eliminate estrogenicity. For example, 
the transformation of 17β-estradiol (E2) in activated sludge processes was 
reported to involve E2 oxidation to estrone (E1), another estrogenic compound 
(Ternes et al., 1999; Shi et al., 2004; Dytczak et al., 2008). There is the potential for 
differing conversions between estrogenic compounds in different redox 
conditions (Joss et al., 2004; Czajka and Londry, 2006; Dytczak et al., 2008). 
Hence, bioassay could be an important tool for characterizing the impact of 
redox on estrogenicity.  
   This study employed the YES assay technique to investigate the removal 
and biotransformation of EDCs in BNR activated sludge. In the current study, E1 
and E2 were evaluated as target EDCs because several studies have shown that 
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E1 and E2 constitute a substantial fraction of the dominant estrogens found in the 
effluents of WWTPs (Nakada et al., 2004; Aerni et al., 2004; Fernandez et al., 2007; 
Muller et al., 2008). Specifically, this study employed the recombinant yeast 
screen to 1) investigate the removal of estrogenicity in BNR processes operated 
with both authentic and synthetic wastewater, 2) estimate the biotransformation 
rate constants for E1 and E2 in aerobic, anoxic and anaerobic batch reactors, and 
3) investigate the transformation kinetics between E2 and E1 under anaerobic, 
anoxic and aerobic conditions.  
4.2 Approach 
A combination of pilot and bench scale tests, batch experiments and 
mathematical modeling was employed to assess the removal and 
biotransformation of EDCs in BNR activated sludge processes. The experimental 
approach employed a pilot scale BNR process fed with authentic municipal 
wastewater and a bench scale BNR process fed with synthetic wastewater that 
was dosed with EDCs. The objective of operating the pilot scale BNR was to 
investigate the removal and biotransformation of EDCs in each treatment zone of 
a BNR treatment process. The goal of operating the bench scale BNR system was 
to investigate the removal kinetics of the natural estrogens, E1 and E2 and their 
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associated estrogenicity under controlled conditions. In addition, a series of 
batch experiments were conducted to investigate the transformation between E1 
and E2 under aerobic, anoxic and anaerobic conditions in order to provide 
further insight into the removal and biodegradation of the compounds in BNR 
processes.  
4.2.1 Pilot Scale BNR Wastewater Treatment Process 
A detailed description of the UCT-BNR pilot plant was described 
elsewhere (Ogunlaja et al, 2013). The operating and design conditions are 
summarized in Table 4-1. The pilot UCT-BNR was operated on authentic 
municipal wastewater that was augmented with sodium bicarbonate (22 g/L at 
the rate of 14.4L/d) to provide alkalinity, di-potassium phosphate (11 g/L at the 
rate of 14.4 L/d) as phosphorus source and sodium acetate (34.36 g/L at the rate 
of 14.4 L/d) to enhance the proliferation of PAOs.  The resultant influent 
concentration of COD, alkalinity and total phosphorus were 367 ± 48 mg/L, 268 ± 
21 mg/L and 11 ± 7 mg/L respectively. The pH range of the authentic wastewater 
entering the bioreactor was 7.5 – 8.2. The bioreactor was partitioned into six 60L 
cells to simulate pseudo plug flow (Figure 4-1). The first cell was operated as an 
anaerobic zone, the next two cells were operated as anoxic zones and the last 
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three cells were operated as aerobic zones. Coarse bubble aerators were used for 
aeration and mixing in the aerobic section of the bioreactor while mechanical 
mixers were used in the non-aerated zones. The solids residence time (SRT) was 
maintained by wasting mixed liquor from the last aerobic section of the 
bioreactor. The temperature was controlled by an insulated water jacket that was 
wrapped around the bioreactor, primary and final clarifier. 
Table 4-1. Pilot BNR operating and design conditions 
Unit Size/description Unit 
Flow rate  1.3 m3/d 
Primary clarifier Area = 0.46 m2 
 Depth = 1.56 m 
Bioreactor Volume = 0.36 m3 
 Depth = 1.28 m 
 DO(aerobic) = 4-5 
DO(anoxic) = 1-2.5 
DO(anaerobic) = 0-0.2 
g/m3 
g/m3 
g/m3 
Final clarifier Area = 0.204 m2 
 Depth = 1.4 m 
Recycle rate Aerobic = 2.6 
Anoxic = 1.3 
m3/d 
m3/d 
SRT 
Aerobic SRT 
RAS flow rate 
Waste rate 
20 
10 
0.9 
0.018 
d 
d 
m3/d 
m3/d 
HRT 7 h 
Temperature 18 ± 2 oC 
RAS-return activated sludge,SRT-solid residence time,HRT-hydraulic retension time 
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Figure 4-1. Flow schematic of pilot BNR activated sludge treatment system. 
 
4.2.2 Bench Scale BNR Wastewater Treatment Process 
The bench scale UCT-BNR process consisted of 3 - 10 L coupled reactors 
made of acrylic plastic and a 25 L final clarifier for solid –liquid separation 
(Figure 4-2). The aerobic reactor was mixed and aerated with fine bubble aerators 
while the anaerobic and anoxic reactors were mechanically mixed. The influent 
flow to the system was maintained at 0.086 ± 0.01 m3/ day and the HRT was 5 
hours.  The return activated sludge was operated at 75% of the influent flow rate 
and the internal recycle ratios were 200% and 100% of the influent flow rate for 
the aerobic and anoxic recycles respectively. Approximately 0.9 ± 0.1 L/d of 
sludge was wasted from the aerobic zone of the bioreactor to maintain a total 
SRT of 20 days. The DO in the aerobic zone was maintained at 5-7 mg/L and the 
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temperature of the system was maintained at 20 ± 2oC. The operational 
parameters of the bench scale BNR process were consistent with typical 
operational parameters of commonly used BNR processes (WEF, 2005). 
The bioreactors were inoculated with mixed liquor collected from the 
return activated sludge stream of a full scale BNR WWTP in southern Ontario. 
The system was fed with a synthetic wastewater containing carbon source, 
nitrogen source, phosphate buffer and micronutrients. The constituents of the 
synthetic wastewater and their target concentrations are presented in Table 4-2. 
The system was initially maintained without addition of E1 and E2 into the 
influent stream for one SRT to allow acclimatization of the biomass to the 
synthetic feed. Subsequently, a volume of E2 and E1 dissolved in water was 
dosed into the synthetic wastewater with the objective of achieving a target 
concentration of 100 ng/L for E1 and E2 to acclimatize the biomass to the 
estrogenic compounds. These dosed concentrations were higher than those 
typically observed in Canadian wastewater (Servos et al., 2005). However, this 
concentration enabled measurement of the estrogenicity in the samples, 
considering the sample matrix. After two months of operation, steady state was 
achieved and the aerobic bioreactor mixed liquor with an MLVSS concentration 
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of 3817 ± 150 g MLVSS/ m3 was employed for the batch tests. 
 
Figure 4-2. Flow schematic of the bench scale BNR system. 
 
Table 4-2. Composition of influent synthetic wastewater 
Function Name 
Molecular 
Formula 
Target feed 
concentration Unit 
Carbon source Sodium acetate  NaCH3 CO2 475 g COD/ m3  
Nitrogen source Ammonium chloride NH4 Cl 15 g N/ m3  
Phosphorus 
source 
Monopotassium 
phosphate KH2PO4 10 g P/ m3  
Alkalinity Sodium bicarbonate NaHCO3 167 g/ m3  
Micronutrients 
Calcium chloride CaCl2·2H2O 250 g/ m3  
Magnesium sulfate MnSO4·H2O 180 mg/ m3 
Copper sulfate CuSO4·5H2O 35 mg/ m3 
Zinc sulfate ZnSO4 ·7H2O 130 mg/ m3 
Iron (II) sulfate FeSO4·7H2O 390 mg/ m3 
Cobalt chloride CoCl3 ·6H2O 34 mg/ m3 
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4.2.3 Monitoring and Sampling–Pilot and Bench Scale BNR 
System 
  The pilot plant was operated for over 12 months with consistent 
monitoring of the conventional and operational parameters for over 6 months. 
The bench scale setup was operated for 3 months with consistent monitoring for 
one month. Performance was assessed by  monitoring chemical oxygen demand 
(COD), Total Kjeldahl Nitrogen (TKN), ammonia (NH3), nitrite (NO2), nitrate 
(NO3), phosphate (PO4), total suspended solid (TSS) and volatile suspended solid 
(VSS).  
  Twenty four hour composite samples of the pilot plant influent and 
effluent were collected in pre washed stainless steel containers, three times a 
week for two weeks using a refrigerated autosampler for estrogenicity analysis. 
Eight hour composite grab samples (sampled every 2 hours for eight hours and 
mixed together) were also collected thrice a week for two weeks from the 
anaerobic, anoxic and aerobic zones of the bioreactor. Five hour composite 
samples were collected from the bench scale influent and effluent streams in 
prewashed amber glass bottles thrice a week for 2 weeks for estrogenicity 
analysis. In addition, grab samples with a volume of 40 mL were collected thrice 
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a week for two weeks from the mixed liquors in the anaerobic, anoxic and 
aerobic reactors. The samples were centrifuged at 4000 rpm for 5 minutes and the 
supernatant filtered through 1.5 µm glass microfiber filters (Whatman, Toronto, 
Ontario, Canada). The filtered samples for the pilot plant were adjusted to pH 8 
with 0.1M NaOH and stored in amber bottles in preparation for solid phase 
extraction while the bench scale samples were extracted immediately. 
4.2.4 Batch Experiments  
The mixed liquor from the aeration zone of the bench scale UCT-BNR was 
employed as the innoculum in a series of batch tests that were conducted to 
investigate the biotransformation of E2 and E1 under anaerobic, anoxic and 
aerobic conditions using the YES assay method. The batch experiments were 
conducted as described by Shi et al., 2004. The batch experiments were 
performed using a 1L Erlenmeyer flask placed on a magnetic stirrer and 
wrapped with aluminium foil to prevent photodegradation of the EDCs. In the 
aerobic experiment, the mixed liquor was mechanically stirred and air was 
supplied through air pumps to maintain a dissolved oxygen (DO) concentration 
of approximately 2 – 7 mg/L. The mixed liquor was mechanically stirred in the 
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anaerobic and anoxic experiments without aeration. The reactors were 
maintained at a temperature of 20 ± 2oC and pH range of 7.2 - 8.5.  
 A solution of either E2 or E1 in ethanol solution was added to the 
sterilized erlenmeyer flask to achieve a target concentration of 0.1g/m3. After 
evaporation of the solvent,  approximately 125 mL of mixed liquor from the BNR 
process was diluted with an appropriate volume of synthetic wastewater to 
achieve a mixed liqour volatile suspended solid (MLVSS) concentration of 255 
gMLVSS/m3.  The batch experiments were conducted once and duplicate samples 
collected at every time interval The concentrations of the chemicals added into 
the batch reactors to facilitate biomass growth throughout the duration of the 
biotransformation tests are presented in Table 4-3.  
Table 4-3. Feed composition for batch tests 
Function Molecular Formula Anaerobic Anoxic Aerobic Unit 
Carbon source NaCH3 CO2 305 330 375 gCOD/m3 
Phosphorus source KH2PO4 20 15 20 g P/m3 
Nitrogen source NH4 Cl n/a n/a 14 g N/m3 
Nitrate source KNO3 n/a 72 n/a g N/m3 
n/a-not added 
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4.2.5 Batch Experiment Monitoring and Sampling 
The concentrations of E2, E1 (as indicated by the YES test) and 
conventional parameters in the mixed liquor in the batch reactors were analyzed 
to assess the removal of estrogenicity and conventional pollutants. From each 
batch reactor, 40 mL of mixed liquor samples were collected in prewashed amber 
bottles before the addition of E1 and E2 to the reactors in order to quantify 
background concentrations. Samples of the reactors’ mixed liquor were then 
collected 15 minutes after dosing and subsequently every four hours for three 
days. The collected samples were centrifuged at 4000 rpm for 5 minutes and the 
supernatant liquids were filtered using 1.5 µm glass fiber filters (Whatman 
934/AH). A volume of 10 mL was analyzed for conventional pollutants after 
filtering and the remaining 30 mL was immediately analyzed using SPE analysis. 
All parameters were analyzed in duplicates.  
4.2.6 Sample Extraction  
 Solid phase extraction (SPE) is the most common extraction method used 
to concentrate EDCs in environmental samples and hence the method of Li et al., 
(2010) was employed to extract the EDCs from the wastewater samples in this 
study.  
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4.2.6.1 Solid Phase Extraction  
100 ml of the filtered samples were passed through 6cc/500 mg OASIS 
HLB cartridges (Waters, USA) using Visiprep solid-phase extraction (SPE) 
vacuum manifolds and a vacuum pump. The cartridges were initially 
conditioned sequentially with 5 mL of methanol and 5 mL of Milli-Q water 
before loading the samples onto the cartridge. After extraction, the cartridges 
were rinsed with 5mL of water and 5 mL of hexane before being dried under 
vacuum for 5 minutes. Two 5-mL aliquots of ethyl acetate at an approximate 
flow rate of 1mL/min were subsequently used to elute the samples into 10 mL 
borosilicate collection tubes. The eluate was dried under a gentle stream of 
nitrogen gas and vortex-mixed with 500 µL of methanol. The final samples were 
transferred into amber bottles and stored at 4oC until the YES assay procedure 
was conducted. 
4.2.6.2 Extraction Recovery 
 A volume of 100 mL of mixed liquor from the anaerobic, anoxic and 
aerobic sections of the WWTP that was the source of the inoculum for the bench 
scale BNR was dosed with 30 µg/L of E2 to determine the sample extraction 
recovery. 100 mL of milli-Q water was also dosed with the same concentration of 
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E2 to investigate the possible effect of sample matrix on the extraction procedure. 
The wastewater samples were centrifuged at 5000 rpm for 5 minutes and the 
supernatant liquid were filtered using 1.5 µm glass fiber filter before solid phase 
extraction and YES assays were conducted.  
4.2.7 Chemical Analysis 
  Conventional wastewater parameters including chemical oxygen demand 
(COD), total suspended solids (TSS), total Kjeldahl nitrogen (TKN), total 
phosphorus, ammonia-nitrogen, nitrate-nitrogen, total suspended solid (TSS) 
and volatile suspended solid (VSS) were analyzed according to Standard Methods 
(Eaton., 2005). 
4.2.8 YES Assay 
 One of the widely used in vitro bioassays for the determination of 
estrogenicity in environmental samples is the recombinant yeast estrogen screen 
(YES) (Fent et al., 2006; Leusch et al., 2010; Citulski and Farahbakhsh, 2012).  The 
recombinant yeast strain contains yeast cells that has been integrated with the 
DNA of human estrogen receptors (hER). The YES assay provides a qualitative 
and quantitative measure of the endocrine-disrupting potential of all EDCs 
present in WWTP effluent (Leusch et al., 2010). Hence, this method has proved to 
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be a useful tool in determining the combined estrogenic effects of the mixture of 
EDCs in complex environmental matrices such as WWTPs effluents.  
 A sample of concentrated human estrogen-receptor (hER) transfected 
recombinant yeast stock was provided by Prof. C. Metcalfe, (Trent University, 
Peterborough, ON). The YES assays were conducted as described by Routledge 
and Sumpter (1996) with modifications as reported by Citulski and Farahbakhsh, 
(2010).  The bioassays were conducted in a sterilized laminar air flow cabinet to 
minimize aerosol formation and contamination. Each 96 well optically flat-
bottom microtiter plate contained one row of 100 µL of serially diluted positive 
control of E2 (10 nM to 5 x 10-3 nM) in triplicates, one row of ethanol as negative 
control and three rows of serially diluted 80 µL extracted wastewater samples. A 
volume of 200 µL of combined growth medium/CPRG/yeast mixture was added 
to the dried wells of the plates. The plates were sealed with parafilm to prevent 
drying of the well solution in the incubator and shaken at 150 rpm and 32oC for 
72 hours. The yeast growth in the plates was measured using a micro titer plate 
reader (Sunrise Basic TECAN) at an absorbance of 620 nm to measure turbidity 
and 540 nm to detect color change of the assay medium. 
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4.2.8.1 Data Processing 
  The absorbance measurements for E2 standards and wastewater samples 
were adjusted as per Fent et al (2006) (Equation 4-1) in order to adjust the 
absorbance of chlorophenol red at 620 nm for the extent of yeast growth 
(turbidity). 
Adjusted Absorbance = AB540nm (sample) – [AB 620nm (sample) – AB 620nm 
(blank, average)]         4-1 
Where, 
AB540nm (sample) = sample absorbance at 540 nm 
AB 620nm (sample) = sample absorbance at 620 nm 
AB 620nm (blank, average) = average of blank absorbance at 620 nm. 
  The dose response curve for the standards and environmental samples 
were input to GraphPad Prism 6 (v. 6.02) that employs a four-parameter 
sigmoidal Hill equation to calculate the EC-50. To obtain the estrogenicity values 
for the extracted sample, the logarithm of the extraction dilution that yielded a 
50% response was computed from the fitted standard curve.  The estrogenicity of 
the samples were expressed as 17β-estradiol equivalents (E2-Eq), or the 
equivalent concentration of E2 that would have to be present in the wastewater 
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sample to achieve a response of the same magnitude. The E2-Eq was calculated 
as the ratio between the amount of E2 in the incubation well at EC50 in the 
standard curve and the equivalent volume at EC50 as follows: 
𝐸2 − 𝐸𝑞 (
𝑛𝑔
𝐿
) =  (
𝐸2 𝐸𝐶50( 𝑛𝑔 𝐿)⁄
𝐸𝐶50 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟∗0.4
)      4-2 
The value of 0.4 employed in equation 2 accounted for dilution when the air 
dried 80µL wastewater sample extract applied to the titer well was reconstituted 
with  200µL of the  growth medium containing yeast cells (80/200 = 0.4). The 
method detection limit for the assay was determined to be 1 ng/L.  
4.2.8.2 Determination of Relative Potency between E1 and E2-
Eq (𝐲) 
 In order to determine the relative estrogenic response of E1 as E2-Eq, E1 
stock solution was added to a volume of 100 mL of the mixed liquor used for the 
batch tests to achieve concentrations in the range of 100-2000 ng/L. The dosed 
mixed liquor samples were centrifuged at 5000 rpm for 5 minutes and the 
supernatant liquids were filtered using 1.5 µm glass fiber filter before SPE and 
YES assays were conducted.  
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4.2.9 Statistical Analysis 
  Outliers in replicate measurements were detected using Grubb’s test. The 
regressions used to construct the YES assay response curves for the samples were 
compared to the response curves of estradiol (E2) standard using the F-test. To 
check the yeast growth absorbance (AB620nm) for the presence of toxic effects 
resulting from the wastewater extracts,  the yeast growth was compared to the 
average turbidity (±3 standard deviations) of 12 ethanol only negative-control 
wells that were incubated in the same plate as the samples. Samples that had 
yeast growth with turbidity values below the average minus 3 standard 
deviations of the negative control were removed from the dose-response curve 
analysis. The final conditioned data were employed to generate the dose-
response curve for the estimation of the EC50. 
4.3 Results and Discussions 
As previously described, this study integrated results from pilot and 
bench scale BNR processes and batch tests to obtain an improved understanding 
of the fate of EDCs in BNR processes. The UCT-BNR pilot and bench scale 
systems were monitored with respect to the removal of conventional wastewater 
pollutants and estrogenicity to establish the performance of the treatment 
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processes. Samples collected from the batch reactors were analyzed for 
conventional pollutants to monitor the progress of typical metabolic processes 
and to estimate the biodegradation and biotransformation kinetics of E1 and E2 
in BNR activated sludge. The biotransformation and biodegradation rate 
constants for E1 and E2 were estimated using pseudo first order kinetic 
expressions.  
4.3.1 Performance of Pilot and Bench Scale BNR System – 
Conventional Pollutants 
The conventional pollutants of the pilot and bench scale BNR processes 
were analyzed to determine whether the processes were functioning within 
typical operating ranges of a BNR process. The influent and effluent 
concentrations of the conventional contaminants from the pilot and bench scale 
BNR processes are presented in Table 4-4. As expected, low effluent 
concentrations were observed for COD, TKN, NH4, NO3, and TP. The results 
indicate that the treatment systems were effectively nitrifying, denitrifying and 
biologically removing phosphorus during the sampling period. The performance 
of both BNR systems was consistent with typical operation of BNR systems 
(Jeyanayagam, 2005). Hence, it was assumed that the biomass contained 
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representative quantities of active ordinary heterotrophic organisms (OHOs), 
nitrifiers and polyphosphate accumulating organisms (PAOs). 
Table 4-4. Conventional pollutants responses in BNR processes (Mean ± SD.) 
 
 
 
 
 
 
 
4.3.2 Evaluation of Extraction Recovery 
The extraction recoveries of the EDCs in the wastewater samples were 
analyzed to assess the performance of the solid phase extraction procedure 
employed in extracting the EDCs in the treated wastewater. The results of the 
tests with known concentrations of E2 are presented in Table 4-5. The Table 
shows that the extraction procedure gave a high recovery of E2 from the 
wastewater samples and milli-Q water. As expected, the milli-Q water had the 
highest recovery. The comparable recoveries observed in the mixed liquor 
 Pilot Scale (mg/L) Bench Scale (mg/L) 
Parameter Influent Effluent Influent Effluent  
COD 367 ± 48 33 ± 12 447 ± 150 23 ±13  
TKN 25 ± 12 2.3 ± 0.2 20 ± 10 3.2 ± 0.1  
NH4-N 19 ± 8 0.04 ± 0.03 15 ± 4 0.03 ± 0.01  
NO3-N 0.54 ± 0.2 3 ± 2 0.61 ± 0.24 4 ± 2  
TP 11 ± 7 3 ± 2 10 ± 2 1± 0.3  
MLSS (gCOD/L) 6.8 ± 0.9 7.2 ± 0.3  
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samples and the milli-Q sample were deemed to indicate that the mixed liquor 
suspended solids did not adsorb the dosed E2 and the solid phase extraction 
method extracted most of the dosed E2. Hence, the solid phase extraction 
procedure used in this study was deemed appropriate to quantify the 
estrogenicity in the treated wastewater samples. 
Table 4-5. Solid phase extraction recovery of E2 
Sample Recovery % 
Anaerobic mixed liquor 90 ± 20 
Anoxic mixed liquor 87.5 ± 11 
Aerobic mixed liquor 86.4 ± 6 
Milli Q water 98.8 ± 13 
 
4.3.3 Estrogenicity Removal in Pilot and Bench Scale BNR 
The estrogenicity was assessed at different points during the operation of 
the pilot and bench scale BNR process in order to analyze and compare the 
performance of the processes in terms of estrogenicity removal. The responses 
reported as E2-Equivalent (E2-Eq) concentrations in the influent, effluent, and 
the interstages of both systems are presented in Figure 4-3.The deviation bars in 
the figure represent the standard deviation of the measurements (n = 6). It is 
apparent from the figure that the estrogenicity concentration decreased through 
each successive stage of both BNR processes. The overall estrogenicity removal 
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efficiency was calculated as the difference between the E2-Eq concentrations in 
the influent stream into the bioreactor and that of the effluent exiting the 
bioreactor, divided by the E2-Eq concentration in the influent stream into the 
bioreactor. Thus, the overall estrogenicity removal efficiencies for the pilot and 
bench scale BNR processes were 96 ± 5% and 95 ± 5% respectively. Hence, 
significant estrogenicity removal was observed in the pilot and the bench scale 
BNR processes. This observation was consistent with previous studies that 
reported removal of estrogens in BNR wastewater treatment systems (Joss et al., 
2004; Wu et al., 2011, Li et al., 2011). The consistency of the high estrogenicity 
removal in this study with the results of previous studies that have reported high 
removal of EDCs based on chemical measurements suggests that a high removal 
of EDCs in BNR process could be interpreted as a high removal of estrogenicity. 
It was concluded that both pilot and bench scale BNR processes were performing 
equivalently with respect to overall estrogenicity removal.  
Mass balances were conducted to account for the effects of the recycle 
streams on the observed estrogenicity removal efficiencies. The mass balances 
around the bioreactors for both pilot and bench scale BNR are presented in 
Figures 4-4 and 4-5 respectively. The degradation efficiency of EDCs in each zone 
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was calculated as the difference between mass flow entering and leaving the 
zone, divided by the total mass flow entering the zone. The difference between 
the mass inflow and outflow for each redox zone was assumed to be due to 
biodegradation within the zone of the bioreactor. Previous studies have shown 
that sorption typically accounts for less than 10% of the estrogen removal from 
wastewater (Andersen et al., 2003; Joss et al., 2004; Ternes et al., 1999). Hence, the 
degradation efficiencies in the anaerobic, anoxic and aerobic reactors were 
calculated as 11± 9%, 18 ± 2%, 93 ± 10% and 8± 0.8%, 38 ± 4%, 85 ± 22% in the pilot 
and bench scale reactors respectively. Generally, these results show that similar 
degradation efficiencies were observed in corresponding redox zones of the pilot 
and bench scale processes. Therefore, it was concluded that comparable 
degradation of estrogenic compounds occurred in the individual zones of both 
BNR processes, albeit at different percentages. 
Similar estrogenicity degradation efficiencies were observed along the 
bioreactors for both systems despite the fact that the pilot plant BNR was fed 
with authentic wastewater with presumably a mix of estrogens and the bench 
scale BNR was operated with synthetic wastewater with only two estrogens. 
Previous studies have shown that approximately 95% of the estrogenic activity in 
  
139 
 
treated effluents was due to the presence of the natural estrogens while other 
estrogenic compounds such as alkyl-phenol contributed less than 5% of the 
estrogenicity in WWTPs effluents (Matsui et al., 2000; Aerni et al., 2004; Muller et 
al., 2008). The results suggest that the majority of the estrogenic activity in the 
authentic wastewater was contributed by estrogens similar to the ones added to 
the synthetic wastewater. 
4.3.4 Interstage Comparison of Estrogenicity Removal in Pilot and 
Bench Scale BNR 
The analysis of the mass balance in the BNR processes enabled an 
assessment of the importance of the redox conditions towards the estrogenicity 
removal. It also enabled a comparison between each redox zone in order to 
assess which zone could be optimized to improve overall process performance. 
The ratio of the degradation efficiencies in the aerobic, anoxic and anaerobic 
zones for both pilot and bench scale BNR process were 8:2:1 and 11:5:1 
respectively. The observed high degradation efficiencies in the aerobic zones of 
the pilot and the bench scale BNR process was consistent with previous studies 
that reported high degradation of EDCs as monitored by chemical concentrations 
(Joss et al., 2004; Dytczak et al., 2008 ). Under aerobic conditions, heterotrophic 
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organisms have the capability to produce oxygenase enzymes that catalyze the 
direct incorporation of oxygen molecule into the molecule of the organic 
compounds. This oxygenase reaction weakens the ring structure in the synthetic 
compounds which makes it accessible for subsequent oxidation steps and more 
water soluble (Rittman and McCarty, 2001). Thus, the high reductions of 
estrogenicity in the aerobic zone could be due to the combination of the redox 
condition and the bacteria activity on the estrogenic compounds.  
The performance of the anoxic zones was compared to that of the 
respective aerobic zones of the BNR processes. The degradation efficiencies of 
EDCs in the anoxic zones of the pilot and bench scale BNR processes were lower 
than that of the aerobic zones. This result was consistent with previous studies 
that reported biodegradation of EDCs or removal of estrogenic activities in the 
anoxic zones of BNR processes (Jurgens et al., 2002 and Lee and Liu, 2002; Joss et 
al., 2004; Wu et al., 2011). The lower biodegradation efficiency in the anoxic zones 
as compared with the aerobic zones could be as a result of the lower energy 
available to the biomass in the zones due to the utilization of nitrate as electron 
acceptor instead of oxygen (Tchobanoglous et al., 2003). Hence, it was concluded 
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that estrogenicity removal can occur in anoxic zone of a BNR process, but at a 
lower efficiency when compared to the estrogenicity removal in the aerobic zone. 
The performance of the anaerobic zones were compared with the 
respective aerobic and anoxic zones of the BNR processes. The degradation 
efficiencies of EDCs in the anaerobic zones of the pilot and bench scale BNR 
processes were the lowest out of the three zones. The lowest biodegradation 
efficiency in the anaerobic zones as compared with the anoxic and aerobic zones 
could be as a result of the low energy available to the biomass in the anaerobic 
zones (Tchobanoglous et al., 2003). The comparable and low biodegradation 
efficiencies in the anaerobic zones of both the pilot and bench scale BNR 
processes suggest that only modest removals of estrogenicity occur in the 
anaerobic zones of BNR processes.  
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Figure 4-3. E2-Equivalent profiles along pilot and bench scale BNR bioreactors. 
AN-Anaerobic, AX-Anoxic, AO-Aerobic. 
 
 
 
Figure 4-4. Mass balances (µg/d) of estrogenicity around pilot BNR bioreactor. 
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Figure 4-5. Mass balances (µg/d) of estrogenicity around bench scale BNR 
bioreactor. 
 
4.3.5 Biotransformation of E2 and E1 in Batch Tests 
  A series of batch tests were conducted under similar redox conditions as 
the stages of the BNR process in order to further understand the 
biotransformation kinetics of E1 and E2 under the different redox conditions. The 
profiles of E2 equivalents in each batch test dosed with either E1 or E2 are 
presented in Figure 4-6. It is apparent from the Figure that the estrogenicity in all 
the reactors decreased with time, although at different rates.  
  The E2-Eq in reactors dosed with either E1 or E2 decreased at the fastest 
rate under aerobic conditions, followed by anoxic conditions and the slowest rate 
was observed under anaerobic conditions. These results were consistent with the 
previously described degradation efficiencies of the EDCs in the stages of the 
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pilot and bench scale BNR processes where the highest degradation occurred in 
the aerobic zones, followed by the anoxic zones and lastly the anaerobic zones. 
Therefore, it was concluded that biotransformation of E1 and E2 in the aerobic, 
anoxic and anaerobic batch reactors leads to a reduction in estrogenic responses 
in the reactors, albeit at different rates in the order of aerobic > anoxic> anaerobic. 
   Figure 4-6 shows that the E2 equivalence of the aerobic and anoxic 
reactors dosed with E2 decreased quickly during the first 4.25 hours of the tests. 
Previous studies have shown that the transformation or oxidation of E2 to E1 can 
occur under both aerobic and anoxic conditions (Ternes et al., 1999; Shi et al., 
2004; Dytczak et al., 2008). This transformation reaction has also been previously 
reported to be rapid and usually occur early in batch experiments (Onda et al., 
2002). It was not possible to separately monitor the biotransformation of E2 to E1 
using the YES assay technique because the method measures the total estrogenic 
response elicited by both E1 and E2 at every point interval. However, since the 
relative estrogenic potency of E2 is significantly higher than that of E1 (Svenson 
et al., 2003; Tanaka et al., 2001), a significant reduction in E2 in the reactors 
would lead to a significant reduction in the total estrogenic response. Hence, the 
observed sharp decline in estrogenicity within the first approximately 4.25 hours 
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of the tests suggested the transformation of E2 to E1 in the aerobic and anoxic 
reactors.  
  From Figure 4-6 it can be seen that the E2-Eq of both E1 and E2 dosed 
reactors declined at the same rate in the anoxic and aerobic reactors after 
approximately 16 hours of reaction and this trend remained the same throughout 
the duration of the experiment. The E2-Eq in the E2 dosed reactors were the 
combined estrogenicity elicited by the residual E2 and the formed metabolite, E1 
while the E2-Eq in the E1 dosed reactors only measured the estrogenicity due to 
residual E1 during the experiment. Hence the results support the previous 
observation that transformation of E2 to E1 occurred in the early stages of the 
experiments with E2 dosed reactors and that after approximately 16 hours, the 
majority of the estrogenicity was contributed by E1. Hence, these results suggest 
an accumulation of E1 in the E2 dosed reactors before further degradation as the 
experiment proceeded. 
  Previous studies have reported that biotransformation of E2 proceeded 
through initial formation of E1 and subsequent formation of metabolites or 
mineralization in anoxic and aerobic conditions (Ternes et al., 1999; Onda et al., 
2003; Shi et al., 2004; Dytczak et al., 2008). However, similar conclusions were not 
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reported for biotransformation of E1 and E2 under anaerobic conditions.  The 
reduction of E1 to E2 has been reported in anaerobic batch tests that were 
conducted with activated sludge taken from an anaerobic/anoxic/aerobic MBR 
pilot plant (Joss et al., 2004), an oxidation ditch (Mes et al., 2008) and a lab scale 
anaerobic/aerobic SBR (Lust and Stensel, 2011). On the contrary, other studies 
have reported oxidation of E2 to E1 under various anaerobic conditions ((Jürgens 
et al., 2002; Lee and Liu, 2002; Czajka and Londry, 2006). Hence, this study used 
bioassays to assess the biotransformation kinetics between E1 and E2 under 
anaerobic conditions.  
  Based on the bioassay method employed in this study, it was initially 
expected that the E2-Eq in the anaerobic reactor dosed with E2 would decrease to 
confirm the oxidation of E2 to E1 and increase in the E1 dosed anaerobic reactor 
to confirm the conversion of E1 to E2. This expectation was based on the fact that 
the estrogenic potency ratio of E2 to E2-Eq was 1:1 and E1 to E2-Eq was 1: 0.56. 
The results showed that the E2-Eq decreased in the anaerobic reactors dosed 
with either E1 or E2. The decline in the E2-Eq in the E1 dosed anaerobic reactor 
was faster than that of the E2 dosed reactor (Figure 4-6). This result implied that 
E2 was converted to E1 in the E2 dosed reactor and that degradation of E1 
  
147 
 
produced other metabolites than E2 in the E1 dosed reactor. This result was 
consistent with the previously observed reduction in estrogenicity in the 
anaerobic zones of the bench scale BNR, which was the source of the mixed 
liquor for the batch tests. Hence, it was concluded that the conversion of E1 and 
E2 to less estrogenic metabolites occurred in the anaerobic batch tests, with E1 
degrading at a faster rate than E2. 
 
 
Figure 4-6. E2 equivalent profiles for batch tests dosed with E1 or E2. O2-
aerobic, AX- anoxic, AN-anaerobic. 
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4.3.6 Modeling of Biotransformation of E1 and E2 in Batch Tests  
  Mathematical modeling was employed to further understand the 
biotransformation kinetics of E2 and E1 in terms of their estrogenicity response 
under anaerobic, anoxic and aerobic conditions. The models commonly used to 
predict biodegradation kinetics of EDCs in wastewater treatment typically 
employ either first order (Zhao et al., 2008) or pseudo first order expressions 
(Schwarzenbach et al., 2003; Joss et al., 2006).  Therefore, a pseudo first order 
expression was employed to characterize the biotransformation kinetics of E2 
and E1 in the aerobic, anoxic and anaerobic batch tests (Equation 4-3).  
𝑟𝑖 = −𝑘𝑏𝑋𝑆𝑖         4-3 
Where, 
𝑟𝑖 = rate of biotransformation of compound i in batch reactor [µg L-1hr-1] 
𝑘𝑏 = biotransformation rate constant [L gCOD-1hr-1] 
𝑋= MLVSS concentration [gCOD L-1] 
𝑆𝑖= E2Eq due to E1 [µg L-1] 
  The use of the YES assay technique to describe the behavior of E1 and E2 
in batch tests was novel to this study. However, to employ the results of this 
study for modeling the biotransformation of E2 in the batch tests it was necessary 
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to address the degradation of E2 to E1, which is also an estrogenic compound, 
and the subsequent degradation of E1 (Ternes et al., 1999; Shi et al., 2004; 
Dytczak et al., 2008; Hashimoto and Murakami, 2009) (Equation 4-4). The 
measured E2-Eq values in the E2 dosed batch tests were recognized as the total 
estrogenic response elicited by E1 and E2 (Equation 4-5). 
𝐸2 
𝑘𝑏,1
→ 𝐸1
𝑘𝑏,2
→ 𝑢𝑛𝑘𝑛𝑜𝑤𝑛        4-4 
Where, 
𝑘𝑏,1 = biotransformation rate constant for the conversion of E2 to E1 [L gCOD-1hr-
1] 
𝑘𝑏,2 = biotransformation rate constant for the degradation of E1 [L gCOD-1hr-1] 
 
𝑆′𝐸2,𝑡 = 𝑆𝐸2,𝑡 + 𝑦𝑆𝐸1,𝑡  @ t = 0, 𝑆𝐸1,𝑡 = 0    4-5 
Where, 
S′E2,t = total E2-Eq at time t [µg.L-1] 
SE2,t = E2 concentration at time t [µg.L-1] 
SE1,t = E1 concentration at time t [µg.L-1] 
y = relative potency between E1 and E2-Eq   
 
Equation 4-5 describes the E2-Eq concentrations in terms of summative 
effects of E1 and E2 in the E2 dosed reactors. The relative potency (y) was 
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employed to convert the E1 concentration to E2-Eq.  This conversion was not 
required for E2 as the relative potency of E2 to E2-Eq is 1:1 (Svenson et al., 2003; 
Rutishauser et al., 2004). The measured E2-Eq in the E2 dosed batch tests was 
employed directly in the modelling of E2 in the reactors. 
The mass balance on E1 in the E2 dosed batch reactors is presented in 
Equation 4-6, and includes the production of E1 from E2 and the subsequent 
biotransformation of E1     
𝑑𝑆𝐸1
𝑑𝑡
= 𝜇𝑘𝑏,1𝑋𝑆𝐸2 − 𝑘𝑏,2𝑋𝑆𝐸1       4-6 
 
Where, 
μ = stoichiometric conversion between E2 and E1 
𝑋= MLVSS concentration [g COD L-1] 
𝑆𝐸1=soluble concentration of E1 [µg.L-1] 
𝑆𝐸2=soluble concentration of E2 [µg.L-1] 
𝑘b,1 = biotransformation rate constant for the conversion of E2 to E1 [L gCOD-1hr-
1] 
𝑘b,2 = biotransformation rate constant for the conversion of E1 to metabolites [L 
gCOD-1hr-1] 
 
Assuming a 1:1 mole ratio between E2 and E1, solving for E1 in equation 4-6 and 
substituting into equation 4-5 yields equation 4-7. 
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𝑆′𝐸2,𝑡 = 𝑆𝐸2,𝑡 + 𝑦( 𝑆𝐸2,𝑡𝑘1 (
𝑒−𝑘1𝑋𝑡
𝑘2−𝑘1
+
𝑒−𝑘2𝑋𝑡
𝑘1−𝑘2
))    4-7 
The biotransformation rate constants  k2 and k1 were estimated by solving 
equations 4-3 and 4-7 for each redox condition using an integral least square 
method that minimized the sum of squares of the residuals between the 
predicted and measured E2-Eq in the E1 and E2 dosed batch tests respectively.  
4.3.7 Relative Potency between E1 and E2-Eq (𝐲) 
The estrogenic potency of E1 relative to E2 was determined based on the 
tests at known concentrations of E1 and measured E2 Eq. Figure 4-7 shows the 
relationship between E1 concentrations and measured E2 Eq. It is apparent from 
the plot that there was a linear relationship between the measured E2-Eq and the 
E1 concentrations as indicated by the r2 value and residuals. The estrogenic 
potency of E1 was obtained from the slope of the linear fit and was estimated to 
be 0.56 ngE2/ngE1. This value was consistent with previously reported relative 
potencies between E2-Eq and E1 as measured by YES assays (Rutishauser et al., 
2004; Muller et al, 2008). These previous studies reported relative potencies 
between E1 and E2-Eq in the range of 0.35 - 0.7. Hence, the estimated value of 
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0.56 was assumed to be reasonable and was employed as the relative potency 
between E1 and E2-Eq in this study. 
 
Figure 4-7. Correlation between E1 concentrations and E2 Equivalents as 
measured by YES assay. 
    
4.3.8 Modeling Results  
  The integral least squares method was employed to estimate the 
biotransformation rate constants (kb) for E1 and E2 in the aerobic, anoxic and 
anaerobic batch tests. Figure 4-8 presents the results of the model fitting for the 
measured E2-Eq in each of the reactors dosed with E1 and E2 while Table 4-6 
presents the estimated parameter values and model performance evaluators. The 
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model performance evaluators, r2 and NSE were deemed to be within a 
satisfactory performance rating range and hence it was concluded that there was 
a good fit between the predicted and measured E2-Eq in each of the reactors. 
From Table 4-6, it can be seen that the kb values for both E2 and E1, decreased 
from the aerobic, to anoxic and anaerobic reactors. The trend in the kb values 
among the three redox conditions was consistent with the previously described 
observations on the biodegradation efficiencies and removals from the different 
redox zones in the BNR processes and batch reactors. Hence, it was concluded 
that the biotransformation of E1 and E2 followed pseudo first order kinetics in 
the anaerobic, anoxic and aerobic batch tests. 
  The confidence intervals of the estimated parameter values were 
calculated in order to assess the uncertainty in the parameter values. The 
estimated kb values along with their 95% confidence intervals are presented in 
Table 4-6. The confidence intervals of the estimated parameter values were less 
than 14%, 67% and 90% of the estimated values in the aerobic, anoxic and 
anaerobic zones respectively. Considering the uncertainty associated with 
analyzing estrogens in wastewater, this degree of uncertainty in the model 
parameter values was deemed to be acceptable. 
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  The biotransformation of E2 through the intermediate metabolite, E1 was 
assumed to proceed as depicted in equation 4-4. Table 4-6 shows that the 𝑘1 
values in the aerobic and anoxic reactors were approximately an order of 
magnitude higher than the 𝑘2 values in the corresponding test conditions. By 
contrast, the 𝑘1 and 𝑘2values in the anaerobic reactor were not statistically 
different. Thus, these results suggests that the biotransformation of E1 was the 
slower step in the two step reaction occurring in the aerobic and anoxic batch 
tests while under anaerobic conditions the rates of biotransformation of E2 to E1 
and the biodegradation of E1 were similar. 
 
Table 4-6. Model Performance and biotransformation rate constants with 95% 
confidence intervals 
   Aerobic     Anoxic     Anaerobic     
kb 
L.gCOD-
1d-1 
r2 NSE 
L.gCOD-
1d-1 
r2 NSE 
L.gCOD-
1d-1 
r2 NSE 
k1 71 ± 1.5 0.901 0.998 31 ± 3.3 0.972 0.998 1 ± 0.9 0.998 0.998 
k2 7.3 ± 1.0 0.959 0.998 3 ± 2.0 0.967 0.998 0.85 ± 0.6 0.998 0.998 
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Figure 4-8. Measured and predicted E2-Eq in E1 and E2 dosed batch tests 
(aerobic (AO), anoxic (AX) and anaerobic (AN)). 
 
4.3.9 Biotransformation Dynamics between E2 and E1 With 
Respect to E2-Eq  
  The calibrated model was employed to simulate the behaviors of E1 and 
E2 in the E2 dosed batch tests. This exercise was undertaken so as to elucidate 
the dynamics of the transformation between E2 and E1 in each of the batch 
reactors. Figures 4-9, 4-10 and 4-11 depict the results of the simulations of 
aerobic, anoxic and anaerobic batch reactors respectively and include the 
measured E2-Eq concentrations. It is apparent from the Figures that the 
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measured E2-Eq concentrations in all the reactors were described well by the 
simulated E2 + yE1 curves. The simulated E1 values were greater than the E2 + 
yE1 and E2-Eq responses in the aerobic and anoxic tests, but lower in the 
anaerobic tests. However, the predicted E2 concentrations were consistently 
lower than E2 + yE1 and E2-Eq in all three reactors. In the aerobic and anoxic 
tests (Figure 4-9 and 4-10), there was a rapid decline in E2 which led to an 
accumulation of E1 followed by subsequent degradation of E1. However, this 
pattern was different in the anaerobic test due to the much slower rates of 
transformation of E2 and degradation of E1 (Figure 4-11).  The simulations 
provided useful insight into the dynamic responses of E2 and E1 in the batch 
tests that could not be directly elucidated from the YES responses. 
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Figure 4-9. Simulated and observed estrogen concentration vs time in E2 dosed 
aerobic batch tests. 
 
  
Figure 4-10. Simulated and measured estrogen concentrations vs time curve in 
E2 dosed anoxic batch tests. 
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Figure 4-11. Simulated and measured estrogen concentrations vs time in E2 
dosed anaerobic batch tests. 
4.3.10 Model Verification 
The biotransformation rate constants estimated from the bench scale 
testing were employed in a mass balance model to assess the behavior of E1 and 
E2, measured as E2-Eq along the stages of the bench scale BNR bioreactor. The 
model verification was conducted using the configuration and operating data 
that were employed in the bench scale BNR process, which was the source of the 
mixed liquor for the batch tests. Figure 4-12 shows the flows and concentrations 
employed to develop the mass balance models of the bench scale BNR process.  
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Figure 4-12. Flow and mass balance schematic for prediction of E2-Eq in BNR 
bioreactor. 
 
The steady state mass balances for E2 and E1 in the anaerobic, anoxic and 
aerobic reactors are presented in equations 4-10-4-15.  
 
Anaerobic 
𝑄𝑆𝐸2,0 − (𝑄 + 𝛼2𝑄)𝑆𝐸2,1 + 𝛼2𝑄𝑆𝐸2,2 − 𝑘1,𝑎𝑛𝑆𝐸2,1𝑋1𝑉1 = 0    4-10 
 
𝑄𝑆𝐸1,0 − (𝑄 + 𝛼2𝑄)𝑆𝐸1,1 + 𝛼2𝑄𝑆𝐸1,2 + 𝑘1,𝑎𝑛𝑆𝐸2,1𝑋1𝑉1 − 𝑘2,𝑎𝑛𝑆𝐸1,1𝑋1𝑉1 = 0  4-11 
 
Anoxic 
(𝑄 + ∝2 𝑄)𝑆𝐸2,1 − (𝑄 +∝3 𝑄 + 𝑄𝑅)𝑆𝐸2,2 − ∝2 𝑄𝑆𝐸2,2 + ∝3 𝑄𝑆𝐸2,3 +𝑄𝑅𝑆𝐸2,3 − 
𝑘1,𝑎𝑥𝑆𝐸2,2𝑋2𝑉2 = 0         4-12 
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(𝑄 + ∝2 𝑄)𝑆𝐸1,1 − (𝑄 +∝3 𝑄 + 𝑄𝑅)𝑆𝐸1,2 − ∝2 𝑄𝑆𝐸1,2 + ∝3 𝑄𝑆𝐸1,3 +𝑄𝑅𝑆𝐸1,3 +
𝑘1,𝑎𝑥𝑆𝐸2,2𝑋2𝑉2 − 𝑘2,𝑎𝑥𝑆𝐸1,2𝑋2𝑉2 = 0        4-13 
     
 
Aerobic 
(𝑄 + ∝3 𝑄 + 𝑄𝑅)𝑆𝐸2,2 − (𝑄 + 𝑄𝑅−𝑄𝑤)𝑆𝐸2,3 −∝3 𝑄𝑆𝐸2,3 − 𝑄𝑤𝑆𝐸2,3 −  
𝑘1,𝑜2𝑆𝐸2,3𝑋3𝑉3 = 0         4-14 
 
(𝑄 + ∝3 𝑄 + 𝑄𝑅)𝑆𝐸1,2 − (𝑄 + 𝑄𝑅−𝑄𝑤)𝑆𝐸1,3 −∝3 𝑄𝑆𝐸1,3 − 𝑄𝑤𝑆𝐸1,3 + 𝑘1,𝑜2𝑆𝐸2,3𝑋3𝑉3 −
 𝑘2,𝑜2𝑆𝐸1,3𝑋3𝑉3 = 0         4-15 
 
Where, 
𝑄 = influent flow rate 
𝑆𝐸1,0 = influent E1 concentration 
𝑆𝐸2,0 = influent E2 concentration 
∝2=  anoxic recycle ratio with respect to influent flow rate 
∝3=  nitrified recycle ratio with respect to influent flow rate 
𝑘1,an = anaerobic zone biotransformation rate constant for E2 to E1 
𝑘1,ax = anoxic zone biotransformation rate constant for E2 to E1 
𝑘1,o2 = aerobic zone biotransformation rate constant for E2 to E1  
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𝑘2,an = anaerobic zone biodegradation rate constant for E1 
𝑘2,ax = anoxic zone biodegradation rate constant for E1 
𝑘2,o2 = aerobic zone biodegradation rate constant for E1 
𝑄𝑤 = wasted activated sludge flow rate 
𝑄𝑅 = returned activated sludge flow rate 
𝑉1 = anaerobic zone volume 
𝑉2 = anoxic zone volume 
𝑉3 = aerobic zone volume 
𝑋1 = anaerobic zone MLVSS concentration 
𝑋2 = anoxic zone MLVSS concentration 
𝑋3 = aerobic zone MLVSS concentration 
𝑦 = relative potency of E1 with respect to E2-Eq, 
The equations incorporated the inflow and outflow of both E1 and E2 and 
described the degradation of E2 through the intermediate metabolite E1 in each 
of the redox zones. The six equations were solved simultaneously, using the 
‘Inverse’ and ‘MMult’ matrices functions in Excel, to determine the 𝑆𝐸1and 𝑆𝐸2 in 
each of the redox zones. The relative potency of E1 that was previously estimated 
as 0.56 was then employed to convert the predicted E1 concentrations to E2-Eq, 
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to determine the E2-Eq in each of the redox zones (𝑆′𝐸2,1, 𝑆′𝐸2,2 and 𝑆′𝐸2,3). Thus, 
the predicted E2-Eq along with the measured E2-Eq are presented in Figure 4-13. 
Figure 4-13 shows the plot of predicted E2, yE1, E2 +yE1 and the 
measured E2-Eq in the BNR bench scale process. It is apparent from the plot that 
the predicted E2 +yE1 values reasonably described the measured E2-Eq in the 
BNR processes with slight deviation in the anoxic and aerobic zones. Figure 4-13 
also shows that both the measured E2-Eq and the predicted E2 +yE1 
concentrations decreased along the treatment zones of the BNR bioreactor. The 
plot shows that majority of the predicted E2 degraded along the bioreactor 
reaching a complete removal by the time the mixed liquor reached the aerobic 
zone. In contrast, the E1 remained in the system with a slight decrease in the 
anaerobic zone. The simulated behavior of E2 and yE1 in the bench scale BNR 
process was consistent with the simulated behavior of E2 and yE1 in the batch 
tests.  In all, there was a good agreement between the measured E2-Eq and the 
predicted E2 + yE1 concentrations along the stages of the bench scale BNR 
process. The results were deemed to verify the model formulation describing the 
interactions between E2 and E1 and the estimated biotransformation rate 
constants reasonably estimated from the batch tests. 
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Figure 4-13. Measured E2-Eq and predicted E2, yE1 and E2 + yE1 in the influent 
and along the bioreactor in bench scale BNR process. 
 
Conclusions 
The estrogenicity in two BNR wastewater treatment processes was 
measured using a recombinant yeast screen assay. The removal and 
biodegradation of EDCs in a pilot BNR process fed with authentic wastewater 
was investigated and 96 ± 5% of the estrogenicity exerted by the EDCs in the 
wastewater was removed by the treatment process. The degradation efficiencies 
in the anaerobic, anoxic and aerobic zones of the bioreactor were calculated as 
11± 9%, 18 ± 2% and 93 ± 10% respectively. In order to further understand the 
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performance of the BNR process in the removal of EDCs from wastewater, a 
bench scale BNR process was operated with synthetic wastewater dosed with E1 
and E2. The removal of estrogenicity in the bench scale system (95 ± 5%) was 
comparable to the pilot BNR process and the degradation efficiencies were 
estimated to be 8± 0.8%, 38 ± 4% and 85 ± 22% in the anaerobic, anoxic and 
aerobic zones respectively. Both pilot and bench scale BNR processes showed 
that the aerobic zone was key to the biodegradation of EDCs. The biodegradation 
of EDCs in the bioreactors of the pilot and bench scale BNR processes followed 
the trend of aerobic >anoxic > anaerobic. The results from the pilot and bench 
scale BNR processes showed that BNR processes can effectively biotransform 
EDCs in wastewater. 
Batch experiments were conducted to estimate the biotransformation 
kinetics of E1 and E2 in BNR activated sludge under different redox conditions. 
The behavior of E1 and E2 in each of the batch tests was consistent with the 
observed biodegradation efficiencies in the BNR process that was the source of 
the sludge for the batch tests. The biotransformation rate constants for the 
transformation of E2 to E1 were estimated as 71 ± 1.5, 31 ± 3.3 and 1 ± 0.9 
L.gCOD-1d-1 for the aerobic, anoxic and anaerobic batch tests respectively while 
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the biotransformation rate constants for the degradation of E1 were estimated to 
be 7.3 ± 1.0, 3 ± 2.0, and 0.85 ± 0.6 L.gCOD-1d-1 for aerobic, anoxic and anaerobic 
batch tests respectively. The biotransformation of E1 was the slower step in the 
two step reaction occurring in the aerobic and anoxic batch tests while under 
anaerobic conditions there was a balance between the biotransformation of E2 to 
E1 and the biodegradation of E1. 
A comparison between the simulated E2 + yE1 values and measured E2-
Eq along the bioreactor of the bench scale BNR process revealed that the 
calibrated model parameters effectively predicted the steady state E2-Eq along 
the bioreactor of the BNR process, which was the source of the sludge for the 
batch tests. Hence, it was concluded that the calibrated model can be employed 
to predict the E2-Eq concentrations in BNR treatment processes.  
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Chapter 5 Biotransformation of Trimethoprim in Biological 
Nutrient Removal Treatment System – The Role of Active 
Microbial Groups 
An abridged version of this chapter was submitted to the journal of Environmental 
Science and Technology in manuscript form under the authorship of Ogunlaja O. O and 
Parker W. J. 
5.1 Introduction 
The removal of trace organic compounds (TrOCs) in wastewater 
treatment plants (WWTPs) has been an area of research for the past decade due 
to the potential risks associated with the undesirable effects of TrOCs on the 
ecosystem and human health (Heberer, 2002, Jones et al., 2004; Fent et al., 2006). 
Many of these compounds are either recalcitrant or partially removed during 
sewage treatment because the WWTPs were not designed to remove them 
(Ternes et al., 2003; Joss et al., 2004; Clara et al., 2005a). Thus, effluents from 
WWTPs have been identified as a primary source of TrOCs in the environment 
(Kolpin et al., 2002; Ternes et al., 2004; Lishman et al., 2006). Consequently, the 
optimization of WWTPs could play a critical role in attenuating the discharge of 
TrOCs into the environment (Onesios et al., 2009; Pomies et al., 2013).   
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WWTPs that are configured for biological nutrient removal (BNR) have 
been reported to have higher removal efficiencies of TrOCs along with 
macropollutants when compared to conventional activated sludge treatment 
systems (Clara et al., 2005a, Kimura et al., 2007, Ogunlaja et al., 2013). These 
previous studies have investigated the effects of WWTP design and operating 
conditions on the removal of TrOCs from wastewater. Some of the parameters 
that have been investigated included hydraulic retention time (HRT), solids 
retention time (SRT), biomass type, type and presence of growth substrate, 
temperature, pH, structure and physico-chemical properties of the TrOCs (Clara 
et al., 2005a; Cirja et al., 2007; Helbling et al., 2012). Despite all these studies, it is 
still unclear why BNR systems are more effective in removing TrOCs when 
compared to other conventional activated sludge systems.  
Biotransformation or biodegradation has been identified as a major 
removal mechanism for attenuating the discharge of TrOCs. One of the plausible 
biotransformation pathways for TrOCs in activated sludge systems is the 
degradation of TrOCs by specialized microbial groups within the mixed liquor. 
A few studies have attempted to identify these organisms in order to elucidate 
the roles they play in the biotransformation of TrOCs (Shi et al., 2004; Batt et al., 
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2006; Khunjar et al., 2011). However, there is no agreement in the literature on 
the type of active biomass (ammonia-oxidizing bacteria (AOB) and heterotrophic 
organisms) that is responsible for the biodegradation of TrOCs in activated 
sludge systems (Batt et al., 2006; Khunjar et al., 2011). Hence, further study is 
required to investigate the role of active biomass groups in the biotransformation 
of TrOCs. 
Trimethoprim, one of the prevalent TrOCs found in wastewater, is a 
hydrophilic synthetic antibiotic usually prescribed for treatment of chest or 
urinary tract infections (Nolan et al., 1989; Batt et al., 2006). TMP is prevalent in 
the effluent of wastewater treatment plants (Kolpin et al., 2002) due to its poor 
biodegradability (Kummerer et al., 2000) and hydrophilic nature (Aga, 2008). 
Trimethoprim concentrations as high as 0.53 µg/L has been reported in the 
effluents of wastewater treatment plant in the United (Batt et al., 2005; 
Glassmeyer et al., 2005). There are limited reports on the removal and 
biodegradation of TMP in BNR treatment processes, hence the investigation of 
the removal and biotransformation of TMP in a BNR activated sludge systems 
was the focus of this paper.  
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Models of TrOC fate can be usefully employed to analyze test data for the 
purpose of obtaining an improved understanding of the processes involved in 
TrOC removal. Biotransformation modeling of TrOCs in activated sludge 
systems  has usually been described by either first order (Byrns, 2001; Hashimoto 
and Murakami, 2009) or pseudo first order kinetics (Maurer et al., 2007; Wick et 
al., 2009). These kinetic expressions include one kinetic parameter, the dissolved 
TrOC concentration and the biomass concentration. In previous biodegradation 
studies, the biomass concentration has been approximated by the total or volatile 
suspended solid concentration (Joss et al., 2005; Gaulke et al., 2009). A weakness 
of this approach is that it does not consider the influence of growth substrates on 
the biotransformation kinetics of the TrOCs. TrOCs are present in minute 
concentrations in activated sludge systems and cannot sustain microbial growth. 
Usually, co-substrates like soluble organics or ammonia are necessary to serve as 
growth substrates (Pomies et al., 2013) for the active biomass that is presumably 
responsible for the biotransformation of TrOCs. Hence, the integration of active 
biomass fractions in biotransformation models may provide an improved 
description of the biotransformation of TrOCs in wastewater.  
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The objectives of this study were to  1) estimate the fractions of the active 
biomass- (polyphosphate accumulating organism (PAO), ordinary heterotrophic 
organism (OHO) and ammonia oxidizing bacteria (AOB)) in a BNR activated 
sludge process, 2) investigate the removal of trimethoprim (TMP) in the BNR 
process, 3) estimate the biotransformation rate constants of TMP with respect to 
PAO, OHO and AOB in aerobic BNR activated sludge and 4) assess the 
contributions of PAO, OHO and AOB towards the removal of TMP in aerobic 
BNR activated sludge. The results of this study will improve the understanding 
of the contributions of different biomass groups to TMP biotransformation, 
developing a comprehensive modeling tool that can facilitate the quantification 
of TMP removal in advanced wastewater treatment processes. 
5.2 Approach 
A BNR pilot plant was operated to investigate its performance with 
respect to the removal of conventional pollutants and TMP. The conventional 
pollutant data obtained from the BNR process operation were employed to 
estimate the active biomass fractions in the BNR activated sludge.  The mixed 
liquor in the BNR pilot plant was employed as the source of the inoculum for 
batch tests that investigated the biotransformation of TMP in aerobic batch tests. 
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The estimated active biomass fractions and the batch experiment data were then 
employed to calibrate developed pseudo first order model equations with 
respect to each of the active biomass fractions. The TMP removal rates obtained 
from the batch tests were then used to determine the contributions of each of the 
active biomass fractions towards the overall TMP removal in the aerobic batch 
test. Figure 5-1 summarizes the approach taken for the study. 
 
 
Figure 5-1. Overview of study approach. 
 
5.2.1 BNR Pilot Plant Description 
The pilot scale UCT-BNR process consisted of a 0.718 m3 primary clarifier 
tank, 0.025 m3 chemical dosing tank, 0.36 m3 bioreactor made of stainless steel, 
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0.286 m3 final clarifier for solid–liquid separation and associated pumps for fluid 
transfer. A schematic of the pilot BNR process is shown in Figure 5-2. A UCT-
BNR process was selected due to its ability to maintain a PAO population at low 
influent carbon loading. The pilot BNR was operated on authentic municipal 
wastewater that was augmented with sodium bicarbonate (22 g/L) to provide 
alkalinity, di-potassium phosphate (11 g/L) as phosphorus source and sodium 
acetate (34.36 g/L) to enhance the proliferation of PAOs. The bioreactor was 
partitioned into six 0.06 m3 cells to simulate pseudo plug flow. The first cell was 
operated as an anaerobic zone, the next two cells operated as anoxic zones and 
the last three cells operated as aerobic zones. The aerobic section of the bioreactor 
was mixed and aerated using coarse bubble aerators while the non-aerated 
sections were mixed using mechanical mixers. The solids residence time (SRT) 
was maintained by wasting mixed liquor from the last aerobic section of the 
bioreactor. The operating and design conditions of the pilot BNR process are 
summarized in Table 5-1. The temperature of the bioreactor was maintained at 18 
± 2oC using a temperature controlled insulated water jacket that was wrapped 
around the bioreactor while the pH was maintained within the range of 7.2-8.5. 
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Figure 5-2. Flow schematic of pilot UCT-BNR activated sludge treatment 
system. 
 
 
Table 5-1. Pilot BNR operating and design conditions 
 Size/description Unit 
Flow rate  1.3 m3/d 
Primary clarifier Area = 0.46 m2 
 Depth = 1.56 m 
Bioreactor Volume = 0.36 m3 
 Depth = 1.28 m 
 DO(aerobic) = 4 - 5 
DO(anoxic) = 1-2.5 
DO(anaerobic) = 0-0.2 
g/ m3 
g/ m3 
g/m3 
Final clarifier Area = 0.204 m2 
 Depth = 1.4 m 
Recycle rate Aerobic = 2.6 
Anoxic = 1.3 
m3/d 
m3/d 
SRT 
Aerobic SRT 
RAS flow rate 
Waste rate 
20 
10 
0.9 
0.018 
d 
d 
m3/d 
m3/d 
HRT 7 Hrs. 
   
  
174 
 
RAS-return activated sludge,SRT-solid residence time,HRT-hydraulic retension time 
 
5.2.2 Pilot Monitoring and Sampling  
The pilot plant was operated for over 12 months with regular monitoring 
of conventional and operational parameters for 6 months. Stable plant 
performance was ascertained by monitoring process operating conditions that 
included, chemical oxygen demand (COD), Total Kjeldahl Nitrogen (TKN), 
ammonia (NH3), nitrite (NO2), nitrate (NO3), phosphate (PO4), total suspended 
solid (TSS) and volatile suspended solid (VSS). Twenty four hour composite 
influent and effluent samples were collected thrice a week for three weeks ( 
except for the first week with 2 sampling campaigns) for TMP analysis. Eight 
hour composite samples were also collected for TMP analysis from the anaerobic, 
anoxic and aerobic zones of the bioreactor. For TMP analysis, the samples were 
filtered using 1.5 µm glass micro fibre filters (GF/F Whatman), and extracted 
using solid phase extraction.  
5.2.3 Estimation of Active Biomass Fractions 
The active biomass fractions in the BNR bioreactor were estimated by 
simulating the biomass growth in the bioreactor based on growth substrate 
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uptake as presented in detail elsewhere (Barker and Dold, 1997). The simulation 
exercise was conducted using the activated sludge model no. 2d (ASM2d) within 
the wastewater treatment modeling software BioWin 3.0 from Envirosim  
(Hamilton, Ontario). Average influent wastewater parameters (Table 5-2) and the 
pilot’s design and operating conditions in Table 5-1 were input into the simulator 
prior to simulating steady state performance of the pilot BNR process. The 
readily biodegradable fraction of the influent COD (fbs) was adjusted to reflect 
the sodium acetate that was added to the influent stream. The readily 
biodegradable fraction of the influent COD  has been reported to affect the 
biological phosphorus removal capability of BNR systems (Comeau et al., 1996; 
Barnard and Steichen, 2006). Simulated and observed soluble effluent COD and 
TKN were matched by adjusting the soluble unbiodegradable fractions of the 
influent COD (fsu) and influent TKN (fSNI). Simulated and observed effluent solid 
concentrations were matched by adjusting the final clarifier solids removal 
efficiency. The simulated and observed bioreactor mixed liquor volatile 
suspended solid concentrations were matched by adjusting the particulate 
unbiodegradable fraction of influent COD (fup). Aside from these calibrations, the 
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default values were used for the kinetic and stoichiometric parameters (Barker 
and Dold, 1997). 
 
Table 5-2. Average influent parameter values for BNR pilot plant simulation 
 
 
 
 
 
 
 
 
 
 
5.2.4 Batch Experiments  
A series of batch tests were performed to investigate the 
biotransformation of TMP in BNR activated sludge and to assess the 
contributions of active biomass, PAO, OHO and AOB to the biotransformation of 
TMP. The batch tests were designed using a combination of experimental 
conditions to facilitate the growth of different biomass groups in the different 
tests.  Duplicate aerobic batch tests were conducted to asssess the role of PAO, 
OHO and AOB on the biotransformation of TMP (Aerobic-1) while a third test 
Parameter Value Unit 
Flow rate 1.3 ± 0.4 m3/d 
COD 367 ± 48 gCOD/ m3 
TKN 25 ±11 gN/ m3 
TP 11 ± 6 gP/ m3 
NO3-N 0.54 ± 0.2 gN/ m
3 
NO2-N 0.06 ± 0.03 gN/ m
3 
ISS 16 ± 10 gISS/ m3 
pH 7.2 ± 0.2  
Ca 169 ± 9 g/ m3 
Mg 15 ± 4 g/ m3 
Alkalinity 268 ± 21 g/ m3 as CaCO3 
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(Aerobic-2) was conducted to assess the role of  only PAO and OHO in the 
biotransformation of TMP. A summary of the experimental conditions under 
which the batch tests were performed is shown in Table 5-3.  
The innocula for the batch tests were collected from the aerobic section of 
the pilot BNR process. The batch reactors (Figure 5-3) had a working volume of 
10 L that was filled with 6 L of activated diluted with 4 L of settled raw 
wastwater to achieve a mixed liquor volatile suspended solid (MLVSS) 
concentration of  approximately 2050 mg/L. An aqueous stock solution of 
ammonium chloride, di-potassium phosphate and sodium acetate was dosed 
into the reactors at the same time as  the TMP that was dissolved in methanol. 
The initial TMP concentration in the batch reactors ranged from 0.2 to 1 µg/L. 
The initial concentrations of the chemicals that were added to facilitate biomass 
growth in the batch tests are shown in Table 5-3. The mixed liquor in the reactors 
was mechanically stirred and aerated to maintain dissolved oxygen (DO) 
concentrations of approximately 2 – 5 g/m3. The temperature of the reactors were 
maintained at 18 ± 2oC and the pH was maintained in the ranged of  7.5 - 8.4. 
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Figure 5-3. Schematic diagram of batch test. 
 
Table 5-3. Initial concentrations of chemicals in batch reactors 
 
Chemical added 
Molecular  
formula 
  AO- 
1A 
AO- 
1B 
AO- 
2 
 
Unit 
Sodium acetate C2H3NaO2  COD 600 503 535 g COD/m3 
Di-potassium phosphate K2HPO4 PO4-P 162 193 188 g P/m3 
Ammonium Chloride NH4Cl NH3-N 114 98 n/a g N/m3 
Allylthiourea C4H8N2S ATU N/A N/A 13 g/m3 
Target Active Biomass   OHO,PAO,AOB 
 
OHO, 
PAO 
 
n/a-not added to reactor; AO-Aerobic, Allylthiourea - Nitrification inhibitor 
 
   
5.2.5 Batch Experiment Monitoring and Sampling 
The time dependent changes in the concentration of TMP and 
conventional parameters in the effluent samples were characterized to assess the 
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reactors’ performance. From each batch reactor, 500 mL mixed liquor samples 
were collected in prewashed amber bottles, just before and 15 minutes after the 
addition of TMP to the reactors and subsequently every four hours for three 
days. Each sample was centrifuged at 4000 rpm for 5 minutes and the centrate 
was filtered using 1.5 µm glass fiber filter paper (Whatman 934/AH). A volume 
of 60 ml of the filtrate was employed for analysis of COD, nitrogen species (NH4-
N, NO3-N, and NO2-N), soluble reactive phosphorus (PO4-P) and the unfiltered 
samples were analyzed for TSS and VSS concentrations according to Standard 
Methods (Eaton, 2005). A volume of 150 mL of the remaining filtered sample was 
placed in a prewashed amber bottle and pH adjusted to pH 8 using 0.1M sodium 
hydroxide. The samples were then spiked with 0.15 mL of a 0.5 ppm isotopically 
labelled trimethoprim, dissolved in methanol, before solid phase extraction 
(SPE). All parameters were analyzed in duplicate. The analysis of the 
conventional parameters and SPE extraction were performed immediately after 
filtering.  
5.2.6 Biotransformation Model 
A pseudo first order kinetic expression is commonly used to describe the 
biodegradation of TrOCs in activated sludge systems (Cowan et al., 1993; 
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Monteith et al., 1995; Schwarzenbach et al., 2003). Therefore, pseudo first order 
kinetic expressions were used to estimate the biotransformation rate constants of 
TMP in the batch experiments. Two different models were employed to 
investigate the use of MLVSS concentration and estimated active biomass 
concentration in determining the biotransformation rate constant of TMP in BNR 
activated sludge. Both models assumed that the MLVSS and the active biomass 
concentrations were constant throughout the duration of the batch tests. This 
assumption is typically valid for short duration batch tests. Model 1 did not 
differentiate between biomass species and hence the rate of biotransformation of 
TMP was assumed to be a function of the MLVSS concentration in the reactors 
(equation 5-1) 
𝑟𝑖 = −𝑘𝑖𝑋𝑚𝑙𝑣𝑠𝑠𝑆𝑖         5-1 
Where, 
𝑟𝑖 = rate of biotransformation of compound i [µg L-1hr-1] 
𝑘𝑖  = biotransformation rate constant for compound i [L gCOD-1hr-1] 
𝑋𝑚𝑙𝑣𝑠𝑠= mixed liquor volatile suspended solid concentration [gCOD L-1] 
𝑆𝑖=soluble concentration of compound i [µg.L-1] 
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By contrast, model 2 incorporated three biotransformation rates where the rate of 
biotransformation of TMP was assumed to be dependent on each of the active 
biomass concentrations (equation 5-2). 
 
𝑟𝑖 = −∑ 𝑘𝑖,𝑗𝑋𝑗𝑆𝑖
𝑛=3
𝑗=1         5-2 
Where, 
𝑘𝑖,𝑗  = biotransformation constant for compound i [L gCOD-1hr-1] with respect to 
biomass j 
𝑋𝑗 = active biomass concentration [gCOD L-1] 
𝑆𝑖=soluble concentration of compound i [µg.L-1] 
𝐽 = 𝑃𝐴𝑂,𝑂𝐻𝑂, 𝐴𝑂𝐵  
 
5.2.7 Chemical Analysis 
The filtered samples collected from the pilot BNR and the batch 
experiments  were extracted for TMP analysis by solid phase extraction (SPE) (Li 
et al., 2010) using Oasis HLB 60 mg cartridge from Waters. Prior to extraction, 0.1 
mL of a mixture of an internal standard (500 ng/mL) containing the stable isotope 
labeled surrogates of the analyte was added to the sample. The eluates were 
evaporated to dryness  under a gentle stream of nitrogen and reconstituted in 0.4 
ml of methanol. An internal standard (Trimethoprim- 13C6 ) that was prepared by 
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Prof. Chris Metcalfe’s lab in Trent Univerity, was added to the reconstituted 
samples prior to instrumental analysis to improve the quantitative analysis. The  
extracted samples were shipped on ice to be quantified at Trent University. The 
TMP concentrations were measured using high performance liquid 
chromatography interfaced to a tandem mass spectrometer with an electrospray 
ionization source using an API 3000 instrument procured from AB SCIEX 
(Concord Ontario Canada). A detailed description of the sample preparation and 
LC-MS/MS procedure that was employed to quantify the TMP was described 
elsewhere (Hoque et al., 2013). The limit of quantification and limit of detection 
were calculated to be between 0.1 to 2 ng/L. 
5.2.8 Statistical Analysis  
The conventional and chemical data were analyzed for outliers using the 
Grubb’s test. The significant outliers (p > 0.05) were removed before conducting 
descriptive statistics on the data. The averaged conventional data were 
introduced into BioWin for the simulation exercise. The fit between the 
simulated and measured TMP concentrations in the batch experiments was 
assessed on the basis of r 2 values and the Nash-Sutcliffe Efficiency (NSE) metric 
(Nash and Sutcliffe, 1970) (equation 5-3). NSE values ranges from–∞ to 1 but are 
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usually greater than 0. A negative value of NSE indicates that the mean of the 
measured value is a better predictor than the model. Typically, NSE values 
greater than 0.7 are considered to indicate a strong predictive characteristic of the 
model (Moriasi et al., 2007).   
𝑁𝑆𝐸 = (1 −
𝜎𝑒
2
𝜎𝑜
2)        5-3 
Where, 𝜎𝑒 = variance of residuals 
 𝜎𝑒 = variance of observed values 
5.3 Results and Discussions 
 
The pilot BNR process was monitored with respect to the removal of 
conventional wastewater pollutants. This data was used to ascertain the 
performance of the BNR treatment plant in terms of conventional contaminants 
removal and to provide an indication of the metabolisms of the different 
microbial groups that were active in the bioreactor. The ASM2d model was used 
to estimate the fractions of active biomass in the bioreactor on the basis of the 
conventional data. A series of batch experiments was conducted to investigate 
the biotransformation of TMP in BNR activated sludge. The biotransformation 
constants were estimated using pseudo first order kinetic expressions. The 
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estimated biotransformation constants were then used to calculate the 
contributions of the active biomass fractions towards the biotransformation of 
TMP. 
5.3.1 Conventional Contaminants Removal 
The measured responses of the conventional contaminants as presented in 
Table 5-4 shows that the effluent from the pilot plant was relatively consistent 
throughout the sampling campaign. This showed the efficient performance of the 
pilot plant irrespective of the variability in the influent contaminants. 
Carbonaceous (cBOD5) was consistently removed in the pilot with the effluent 
concentration ranging from 2 to 9 mg/L. This result suggests a good removal of 
biodegradable organic matter. In addition, the pilot was expected to have high 
removal efficiencies for TKN, TAN, NO2-N and TP. These patterns were 
consistently observed throughout the sampling period as shown in Table 5-4. 
This suggests that the pilot plant was effectively nitrifying, denitrifying and 
biologically removing phosphorus. Hence, it was concluded that the BNR pilot 
plant was achieving levels of treatment that are typical of operations at technical 
scale (Jeyanayagam, 2005; WEF, 2005).  
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5.3.2 Pilot Plant Calibration and Active Biomass Estimation 
The steady state effluent concentrations of the conventional pollutants and 
the MLVSS concentration in the bioreactor were simulated using the BioWin 
modeling software. To simulate the measured effluent and MLVSS 
concentrations of the pilot BNR, the influent wastewater fractions were adjusted 
to match the measured data. During the plant operation, the pilot plant influent 
was augmented with sodium acetate to ensure the proliferation of PAOs for 
biological phosphorus removal. Hence, the readily biodegradable fraction of the 
total influent COD (0.55 g COD/ g of total COD) was adjusted in the simulator to 
reflect the sodium acetate that was added to the influent stream. The simulated 
and observed soluble effluent COD and TKN were then matched by adjusting 
the soluble unbiodegradable fractions of the influent COD (0.04 gCOD/ g of total 
COD) and influent TKN (0.035 gN/g TKN) in the simulator. The solids capture 
rate in the final clarifier was adjusted to match the observed effluent suspended 
solid concentration. The simulated and observed mixed liquor volatile 
suspended solid (MLVSS) concentrations in the aerobic bioreactor were matched 
by adjusting the particulate unbiodegradable fraction of influent COD (0.043 g 
COD/ g of total COD). The measured and calibrated MLVSS concentrations in 
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the aerobic section of the bioreactor were 3600 ± 474 g COD/m3 and 3600 g 
COD/m3 respectively. The simulated concentrations for the active biomass 
groups- AOB, OHO and PAO in the aerobic section of the pilot BNR bioreactor 
were 40, 780 and 2710 g COD/m3. The relative error between the measured and 
steady state simulated values were below 20% which was deemed to signify 
good agreement between the measured and simulated data (Table 5-4). 
Table 5-4. Measured and predicted effluent concentrations (g/m3) from the 
pilot BNR process 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.3 TMP Removal in BNR Pilot Plant 
 The concentrations of TMP in the pilot were measured to investigate the 
performance of the pilot in terms of TMP removal. The influent TMP 
concentration (n=8) was 78 ± 39 ng/L while the effluent TMP concentration (n=8) 
Response Primary Effluent  
(Influent) 
Measured  
Effluent 
Calibrated 
Effluent  
Removal  
efficiency 
 Mean S.dev Mean S.dev  % 
COD 367 48 33 12 33 91 
TKN 25 12 2.3 0.2 2.3 91 
NH4-N 19 8 0.04 0.03 0.04 100 
NO3-N 0.54 0.2 3 2 3 n/a 
NO2-N 0.06 0.03 0.03 0.01 0.03 50 
TP 11 7 3 1.7 3 73 
TSS 32 2.5 9 1.6 10 72 
n/a-not applicable 
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was 28 ± 8 ng/L, hence the overall TMP removal efficiency was calculated as 59 ± 
14%. The TMP removal efficiency obtained in this study was similar to a prior 
study that investigated the removal of TMP in an MBR system (57 ±10 % ) 
(Radjenovic et al., 2009) but on average, 3-6 times higher than that reported for 
conventional activated sludge systems (11 ± 31%) (Gobel et al., 2007; Radjenovic 
et al., 2009; Ogunlaja et al., 2013). Thus, it was concluded that the performance of 
the pilot BNR process in terms of TMP removal was comparable to the 
performance of previously investigated advanced wastewater treatment 
processes. 
 The bioreactor of the BNR process was divided into three different zones 
operated at different redox conditions. Therefore, it was expected that the 
different zones would contribute at different proportions towards the 
biotransformation of TMP. This expectation was based on the fact that the 
amount of energy that is usually captured by the microorganisms in aerobic 
conditions is usually higher than the energy captured in anoxic and anaerobic 
conditions (Tchobanoglous et al., 2003). This bioenergy could be instrumental to 
the biotransformation of TMP in the BNR bioreactor. The TMP concentrations in 
the influent, effluent and the interstage of the BNR bioreactor are presented in 
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Figure 5-4. It is apparent from Figure 5-4 that the TMP concentration decreased 
along the interstage of the bioreactor, which suggested that each of the zones 
contributed to the overall TMP removal. 
 However, during the operation of the pilot BNR process, mixed liquors 
were recycled from the aerobic zone to the anoxic zone and from the anoxic zone 
to the anaerobic zone. The returned activated sludge was also recycled from the 
final clarifier to the anoxic zone of the bioreactor. These recycle flows can have 
dilution effects on the pilot plant influent at different points of the treatment 
system. Therefore, a set of mass balances were employed to characterize the fate 
of TMP in the pilot BNR process (Figure 5-5).    
 In the mass balances, the biotransformation efficiency of TMP in each zone 
was calculated as the difference between the mass flow entering and leaving the 
zone, divided by the mass flow entering the zone. The difference between the 
mass inflow and outflow in the aqueous phase across each zone of the bioreactor 
was assumed to be due to microbial biotransformation within the zone of the 
bioreactor. This assumption was based on the fact that previous studies had 
shown negligible TMP removal by sorption in activated sludge systems 
(Eichhorn et al., 2005; Perez et al., 2005; Batt et al., 2007; Aga, 2008). Therefore, the 
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TMP biotransformation efficiencies in the anaerobic, anoxic and aerobic sections 
of the BNR bioreactor were calculated to be 13 ± 12%, 17 ± 10 % and 24 ± 4% 
respectively. These results show that the biotransformation efficiency in the 
bioreactor of the BNR pilot increased from the anaerobic to the anoxic and 
aerobic zone.  Hence, it was concluded that TMP was biotransformed in all the 
redox zones of the BNR bioreactor, albeit at different percentages. 
 The TMP removals by each of the stages of the BNR process were 
estimated to compare the contributions of each stage towards the overall TMP 
removal in the BNR process. The contributions of the stages were calculated to be 
22 ± 28%, 29 ± 24% and 41 ±10% for anaerobic, anoxic, aerobic zones respectively. 
As expected, the results shows that the aerobic zone of the BNR process 
contributed the highest removal, followed by the anoxic zone and lastly the 
anaerobic zone. Hence it was concluded that the TMP removal in the BNR 
process was related to the oxidation-reduction condition in each of the zones. 
The energy that is captured by the microorganisms in aerobic conditions is 
usually higher than the energy captured in anoxic conditions and even higher 
than the energy captured in anaerobic conditions (Tchobanoglous et al, 2003). 
This difference in bioenergy could explain why the aerobic zone had the highest 
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biodegradation efficiency among the three stages for the pilot BNR process. In 
addition, aerobic heterotrophic organisms have the capability to produce 
oxygenase enzymes that catalyze the direct incorporation of molecular oxygen 
into organic compounds. This oxygenase reaction weakens the ring structure in 
the TMP compounds that can make it accessible for subsequent oxidation steps 
and more water soluble (Rittman and McCarty, 2001). Thus, the high 
biotransformation efficiency of TMP in the aerobic zone could have been due to 
the combination of the aerobic environment and the bacteria activity on the 
compound. Hence, the aerobic zones as compared to the anoxic and aerobic 
zones has the potential for significant biotransformation and removal of TMP in 
a BNR process. However, further study is recommended to investigate methods 
of improving the removal of TMP in anoxic and anaerobic environments.   
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Figure 5-4. Trimethoprim concentrations along BNR pilot plant. (deviation bar 
represents standard deviation of measurements (n=8)). 
  
 
Figure 5-5. Mass balances of Trimethoprim in BNR pilot plant (TMP mass 
flow rate in µg/d). 
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5.3.4 Performance of Batch Reactors with respect to Conventional 
Pollutants 
 
Batch tests were conducted to obtain an improved understanding of the 
kinetics associated with the removals that were observed in the BNR pilot plant. 
The performances of the batch tests were initially ascertained by investigating 
the behavior of the conventional pollutants through the duration of the 
experiments. Figures 5-6 and 5-7 show the profiles of the conventional pollutants 
in the batch tests conducted under aerobic conditions without nitrification 
inhibition (Aerobic-1) and with nitrification inhibition (Aerobic-2) respectively. It 
is apparent from Figure 5-6 that the AOB activity were active in Aerobic-1 batch 
test as evidenced by the decrease in ammonia that occurred simultaneously with 
an increase in nitrate. By contrast, there was no change in ammonia or nitrate 
concentration throughout the duration of the experiment in Aerobic-2 batch 
reactor, which indicated the inhibition of AOB activity by the added allylthiourea 
(Figure 5-7).  
Under aerobic conditions, PAOs oxidize intracellular poly-β-
hydroxybutyrates (PHBs) to obtain energy for growth and maintenance 
requirements. The intracellular PHBs support PAO growth and soluble 
phosphate (PO4) uptake from the bulk liquid in the reactor. The accumulated 
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polyphosphates provide the energy required for soluble VFA uptake in the 
anaerobic zone. Figures 5-6 and 5-7 show a decline in the PO4 concentrations that 
ceased after approximately 20-24 hours. The reduction in the PO4 concentration 
in the reactors signified that the PAOs were actively taking up PO4 to form 
intracellular polyphosphates. The cessation of PO4 uptake may have been due to 
the depletion of the intracellular PHBs of the PAO. In the absence of PHBs, the 
PAOs have no source of energy to carry out their metabolic activities under 
aerobic conditions. Hence, it was concluded that the PAOs in aerobic 1 and 2 
batch tests were active during the 20-24 hours of the tests and became inactive 
for the rest of the duration of the batch tests. 
Under aerobic conditions, ordinary heterotrophic organisms (OHO) 
oxidize COD for cellular growth and maintenance. Figures 5-6 and 5-7 showed a 
decline in the soluble COD concentrations, which effectively ceased after 
approximately 20-24 hours. After the soluble COD concentration in aerobic 1 and 
2 reached a minimum, the concentrations tended to gradually increase till the 
end of the reaction in both aerobic 1 and 2 batch tests. During biomass growth, 
decay and lysis also occur concurrently. The cell decay and lysis released soluble 
substrates and particulate substrates into the bulk liquid in the reactor. The 
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particulate substrates can undergo hydrolysis to produce more soluble substrate 
for cellular consumption (Grady et al., 1999). These results suggests that the rate 
at which OHOs oxidized the soluble COD for growth was initially faster than cell 
death and lysis at the beginning of the batch tests but after approximately 20-24 
hours of reaction, the rate of COD consumption became slower than the rate of 
release of soluble COD into the reactor by biomass death and lysis. This was 
demonstrated by the slightly increasing COD concentration in both batch tests. 
Hence, it was concluded that after 20-24 hours of reaction in the batch tests, the 
biomass in the reactors entered a stationary phase as depicted by the constant 
soluble COD concentrations. 
 
Figure 5-6. Profile of conventional pollutant concentrations in batch 
experiment without AOB inhibition (Aerobic-1). 
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Figure 5-7. Profile of conventional pollutant concentrations in batch 
experiment with AOB inhibition (Aerobic-2). 
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that the result of the duplicate aerobic-1 batch tests were consistent with each 
other, thereby implying good reproducibility of the results.  
The previous analysis of the conventional parameters had shown that 
PAO, OHO and AOB were active in aerobic-1 while PAO and OHO were active 
in aerobic-2 batch tests. The difference in trends between aerobic-1 and aerobic-2 
clearly suggests the impact of the AOB activity on the biotransformation of TMP. 
The  slower decline in TMP remaining in the aerobic reactor with nitrification 
inhibition as compared to the batch reactor without nitrification inhibition 
suggest that AOB plays a role in the biotransformation of TMP. Previous studies 
have suggested the capability of AMO that is produced by AOBs to oxidize a 
broad range of organic compounds along with the oxidation of ammonia (Batt et 
al., 2006; Khunjar et al., 2011).  The results obtained from the current batch tests 
suggest that AOBs play a role in the biotransformation of TMP in the BNR 
activated sludge. Hence, the incorporation of the concentrations of AOB in a 
biotransformation model could provide a better description of the behavior of 
micropollutants in activated sludge systems. 
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Figure 5-8. TMP Concentrations in the batch reactors: Aerobic 1A&B- without 
AOB inhibition, Aerobic 2- with AOB inhibition. 
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residuals between the predicted and measured TMP data was employed to 
simultaneously fit the models to the TMP responses from the batch tests with 
and without nitrification inhibition.  
Figures 5-9 and 5-10 show plots of the measured and predicted 
concentrations of TMP in the aerobic-1 and 2 batch tests respectively. The 
goodness of fit of the two models were estimated using r2 and NSE. The results 
(Table 5-5) show that the r2 and NSE values for both models 1 and 2 were larger 
than 0.98 for the tests, indicating that both models could represent the behavior 
of TMP in the batch tests. However, the higher residuals between the measured 
TMP concentrations and model 1 predicted TMP concentrations (Figure 5-10) as 
compared to model 2 predicted TMP concentrations indicated that model 2 was a 
better fit than model 1 for the aerobic-2 batch test. Hence, it was concluded that 
model 2 was able to better describe the behavior of TMP in the batch tests. An 
additional feature of this model is the ability to estimate the contribution of each 
active biomass group to the overall TMP removal in the BNR activated sludge.  
The estimated biotransformation rate constants for TMP in model 1 and 
model 2 are summarized in Table 5-5. From Table 5-5, it can be seen that the 
model 2 biotransformation rate constants were inversely proportional to the 
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active biomass fractions in the BNR mixed liquor employed for the batch test. For 
example, the AOB had the smallest proportion of the biomass concentration but 
the highest rate constant while PAO had the highest proportion of the biomass 
concentration but the lowest rate constant.  The ratio of the estimated 
biotransformation rate constants with respect to PAO, OHO and AOB was 1: 2: 
48. The estimated biotransformation rate constant from model 1 was consistent 
with a previous study that investigated the biotransformation of TMP under 
aerobic condition using sludge from A2O-MBR process, two-phase fate model 
and MLSS as the biomass concentration (Xue et al., 2010). However, the current 
study was the first to estimate the biotransformation rate constant for TMP with 
respect to active biomass groups in a BNR activated sludge, hence there was no 
previous study for comparison. 
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Figure 5-9. Simulated and measured Trimethoprim concentrations in aerobic 
batch reactors without AOB inhibition. 
  
 
Figure 5-10. Simulated and measured Trimethoprim concentrations in aerobic 
batch reactors with AOB inhibition. 
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Table 5-5. Estimated biotransformation rate constant for TMP with respect to 
PAO, OHO and AOB 
  Model-1             Model-2   
  Aerobic-1 Aerobic-2 Aerobic-1 Aerobic-2     
r2 0.986 0.924 0.986 0.987   
       
NSE 0.97 0.966 0.971 0.985   
    PAO OHO AOB  
kb 0.58 ± 0.06 0.32 ± 0.06 0.58 ± 0.06  13.7 ± 0.06 L/gCOD/d 
 
5.3.7 Contribution of Active Biomass Groups towards 
Trimethoprim Biotransformation 
 
To obtain an improved understanding of TMP removal rates by each 
active biomass, the estimated biotransformation rate constants were employed in 
model 2 to predict the species-specific rates. Figure 5-11 presents the 
contributions of PAO, OHO and AOB towards the overall TMP removal rate in 
the test reactors. It is apparent from Figure 5-11 that the observed TMP removal 
rates in aerobic-1 were greater than that of aerobic-2. In aerobic-1, the AOB and 
PAO contributed similarly while OHO contributed the least to the overall TMP 
removal rate for the first 40 hours of the batch test. A similar trend was also 
observed in the aerobic 2 batch test where PAO contributed a higher proportion 
than OHO for the first 40 hours of the biotransformation reaction. Therefore, it 
was concluded that each of the biomass groups in the BNR mixed liquor worked 
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collectively to achieve the observed TMP removal but contributed at different 
proportions in the order AOB = PAO > OHO for aerobic-1 and PAO > OHO for 
aerobic-2. 
In all, these results suggests that both AOB and PAO are instrumental to 
the significant removal of TMP in the BNR activated sludge. This means that 
both nitrification and biological phosphorus removal may be beneficial for the 
biotransformation of TMP in BNR activated sludge. This could explain why the 
BNR performs better than other conventional activated sludge (CAS) treatment 
systems for TMP removal. It is recommended that the approach employed in this 
study for TMP should be extended to other prevalent micropollutants in 
wastewater. 
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Figure 5-11. Contribution of PAO, OHO, and AOB to the overall TMP removal 
rate. 
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efficiencies in the anaerobic, anoxic and aerobic sections of the BNR bioreactor 
were calculated to be 13 ± 12%, 17 ± 10 % and 24 ± 4% respectively. This result 
indicated that TMP removal in the BNR process was related to the oxidation-
reduction condition in each of the zones. A comparison of TMP removal rates in 
aerobic batch reactors with and without AOB inhibition showed a faster removal 
rate in the reactor without AOB inhibition, suggesting that AOB plays a role in 
TMP removal in BNR activated sludge. PAO, OHO and AOB were ascertained to 
be actively undergoing metabolic activities in the batch tests as monitored by the 
disappearance of the conventional pollutants associated with their growth and 
cellular maintenance. 
The biotransformation of TMP in BNR activated sludge under aerobic 
condition obeyed a modified pseudo first order model that incorporated the 
fractions of the active biomass groups. Biotransformation rate constants for TMP 
with respect to PAO, OHO and AOB followed a pattern of kAOB > kOHO > kPAO. 
This model showed that PAOs, OHOs and AOBs contributed different 
proportions towards the biotransformation of TMP in BNR activated sludge with 
the trend AOBs = PAOs > OHOs. Hence, the developed modeling tool have been 
shown to provide enhanced quantification of TMP removal in BNR treatment 
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processes. The results of this study have improved the understanding of the 
contributions of the active biomass groups in BNR activated sludge towards 
TMP biotransformation in wastewater treatment. In all, the results of this study 
indicated one of the possible reasons why BNR treatment processes deliver better 
TMP removal as compared to CAS. 
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Chapter 6 Conclusions and Recommendations for Future Research 
6.1  Conclusions 
 
A comparison between the performances of three biological wastewater 
treatment processes (CAS, NAS and BNR) in terms of their capability to remove 
10 MPs that spanned a wide range of therapeutic classes indicated that the 
removal efficiency of TMP improved with the complexity of the three treatment 
processes configurations and SRTs. IBU, ADR, SMX, NP, E1 and BPA had 
moderate to high removals (> 65%) while CBZ and MEP remained recalcitrant in 
the three treatment process configurations. The removal of GEM was better in 
the NAS than in the BNR and CAS treatment configurations. In order to assess 
whether the observed chemical removal can be compared to the performance of 
the processes in terms of estrogenicity removal, a comparison between the 
performances of the three different process configurations in terms of their 
estrogenicity removal was investigated. The YES assay analyses showed an 
improvement in estrogenicity removal in the BNR and NAS treatment 
configurations as compared to the CAS treatment configuration. Generally, 
similar trend was observed between the treatment processes in terms of their 
chemical removal and biological response reduction. The unique contribution of 
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this study was the side-by-side comparison of the wastewater treatment 
configurations using both chemical and biological responses (YES assay).  
In the comparative study that investigated the performances of the CAS, 
NAS and BNR configurations in terms of their estrogenicity removal, the BNR 
had the highest removal efficiency as compared to the other two processes. 
However, the impact of the different stages of treatment on estrogenicity 
reduction in the BNR process was not examined in detail. Therefore, the removal 
of endocrine disrupting compounds in BNR wastewater treatment processes was 
investigated. The results from the detailed BNR study indicated that the pilot 
and bench scale BNR processes effectively removed EDCs in the authentic and 
synthetic wastewater, with removal efficiencies as high as 95% for both systems. 
The biodegradation of EDCs in the bioreactors of the two BNR processes 
followed the trend of aerobic >anoxic > anaerobic. In order to understand the fate 
of E1 and E2 under aerobic, anoxic and anaerobic conditions, a pseudo first order 
model was calibrated with data generated from batch tests under the target 
conditions. The biotransformation of E1 was estimated to be the slower step in 
the two step reaction in the aerobic and anoxic batch tests while under anaerobic 
conditions there was a balance between the biotransformation of E2 to E1 and the 
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biodegradation of E1.  In order to further understand the transformation 
dynamics between E1 and E2 under aerobic, anoxic and anaerobic conditions of 
the BNR process, a mass balance model was used to verify the estimated 
biotransformation rate constants using the operating conditions of the pilot 
which was the source of the inoculum for the batch tests. The model effectively 
predicted the fate of E1, E2, E2 + yE1 and E2-Eq in the different zones of the BNR 
bioreactor. This study was the first to investigate, model, calibrate and validate 
the biotransformation of E1 and E2 under different redox conditions in a BNR 
activated sludge using biological responses. 
The role of the active microbial groups on the biotransformation of 
Trimethoprim in BNR processes was investigated. The results indicated that 
AOB play a role in TMP removal in BNR activated sludge. TMP removal in the 
BNR system was related to the oxidation-reduction conditions in each of the 
zones. A combination of pilot scale BNR activated sludge system, batch tests and 
modeling exercise were employed to evaluate the contributions of PAO, OHO 
and AOB to the biotransformation of TMP in BNR activated sludge. Under 
aerobic conditions, the biotransformation of TMP in BNR activated sludge 
obeyed a modified pseudo first order model that incorporated the fractions of the 
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active biomass groups, where the biotransformation rate constants for TMP with 
respect to PAO, OHO and AOB followed a pattern of kAOB > kOHO >kPAO. The 
contributions of PAOs, OHOs and AOBs to the biotransformation of TMP in 
BNR activated sludge followed the trend of AOBs = PAOs > OHOs. This study 
have shown that both nitrification and biological phosphorus removal may be 
beneficial for the biotransformation of TMP in BNR activated sludge. These 
results could explain why the BNR performs better than other conventional 
activated sludge (CAS) treatment systems for TMP removal. This study was the 
first to investigate the role of PAO, OHO and AOB in the biotransformation of 
TMP in BNR activated sludge. 
6.2  Recommendations for Future Research 
It is recommended that the biodegradation models that incorporated the 
active biomass groups as applied to TMP in this study should be extended to 
other prevailing MPs in wastewater in order to investigate the role of the active 
biomass groups in their biotransformation. This approach will refine the current 
practice of using the lumped parameter of MLSS or MLVSS as the biomass 
concentration in biodegradation models and replace it with the specific active 
biomass group directly related to the operating conditions of the treatment 
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system. This model can be applied in the current structure of activated sludge 
models to effectively predict the concentrations of MPs in WWTP effluents in 
order to assist MPs environmental risk analysis for policy formulation. 
Additional research is also recommended to generate more data in order 
to further validate the estimated biotransformation rate constants of TMP with 
respect to the biomass groups and that of E1 and E2 under aerobic, anoxic and 
anaerobic conditions. The set of parameters that were calibrated and verified in 
this study are suitable for the operating conditions of the BNR process 
investigated in this study and might not be applicable to other treatment 
processes. Hence, further study is recommended to test the estimated 
biotransformation rate constants for a wide range of operating conditions and 
biological treatment processes in order to ascertain the robustness of the models. 
It is recommended for future studies to investigate the effect of 
temperature on the estimated biotransformation kinetics of the MPs in BNR 
activated sludge. Biologically mediated reactions are usually dependent on 
temperature because temperature affects microbial activities. Therefore, further 
research is needed to estimate the temperature correction factor for the estimated 
rate constants. 
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Studies should be performed to investigate the effects of varying 
concentration of dissolved oxygen on the removal of MPs in BNR activated 
sludge. The results of this study indicated that the degradation efficiencies of the 
MPs and EDCs improved in the aerobic tests as compared to the anoxic and 
anaerobic tests. Hence, further research is needed to quantify the effects of 
different concentrations of dissolved oxygen on the removal of MPs in BNR 
activated sludge.  
Finally, further study of the metabolites formed during the 
biotransformation of E1 in activated sludge systems is recommended. This 
research investigated the estrogenic potency of this metabolite. However, it 
would be beneficial to augment the biological analysis with a chemical 
identification and quantification of the formed metabolites. This will enable the 
formulation of a clearer biodegradation pathway for E2 and E1 in activated 
sludge systems. 
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Appendix A 
 
 
Figure A 1. Sources and distribution of pharmaceuticals in the environment. 
(Togunde, 2012). 
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Appendix B 
Pilot plant diagrams and operational performance 
 
Figure B 1. Pilot Plants (picture taken by Vince Pileggi). 
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Figure B 2. Daily pilot BNR influent and effluent COD. 
 
 
 
Figure B 3. Daily pilot BNR influent and effluent CBOD5. 
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Figure B 4. Daily pilot BNR influent and effluent DOC. 
 
 
 
Figure B 5. Daily pilot BNR influent and effluent TOC. 
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Figure B 6. Daily pilot BNR influent and effluent TAN. 
 
 
Figure B 7. Daily pilot BNR influent and effluent NO3-N. 
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Figure B 8. Daily pilot BNR influent and effluent NO2-N. 
 
 
Figure B 9. Daily pilot BNR influent and effluent TKN. 
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Figure B 10. Daily Pilot BNR influent and effluent PO4-P. 
 
Figure B 11. Daily Pilot BNR influent and effluent TP. 
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Figure B 12. Daily pilot BNR influent, effluent and BNR stages pH. 
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Figure B 13. Daily pilot BNR influent and effluent alkalinity. 
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Figure B 14. Daily pilot BNR influent and effluent TSS. 
 
 
 
Figure B 15. Daily pilot BNR influent and effluent VSS. 
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Table A1. QA/QC for Trimethoprim batch test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    O2-2 O2-8 O2-11 
Duplicate A (µg/L) 0.792 0.143 0.031 
  B (µg/L) 0.787 0.137 0.037 
Relative % difference  0.68 4.77 18.04 
       
in Milli Q Water      
Spike Actual  1 µg/L    
Spike Measured 1.53 µg/L    
% Recovery 153 %    
 Blank ND     
       
Background (Unspiked Mixed 
Liquor)  0.049 µg/L   
After Spiking      
Spike Actual  1 µg/L   
Measured 
Average 
(n=3) 0.80 µg/L   
  StDev 0.12    
% Recovery   75 %    
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Appendix C 
UCT-BNR Simulation Environment 
This section describes the modeling environment used to simulate the pilot BNR 
process. The operation of the pilot plant was simulated using BioWin 3.1® 
integrated model in the BioWin Platform. BioWin is a widely recognized 
commercially available wastewater treatment process model and simulation 
package that was developed by EnviroSim Associates Ltd, Canada. The 
simulation platform includes activated sludge-anaerobic digestion models which 
describes various biological processes in wastewater treatment, chemical 
precipitation reactions, and gas-liquid mass transfer models using fifty state 
variables and sixty process expressions. BioWin 3.1® modelling tool was chosen 
because it was suitable for the study objective which requires effective modelling 
of the different biological and physical processes that impact bacterial growth 
rate under varying redox and operating conditions. Therefore, the selected 
modeling environment was well equipped to effectively simulate the pilot UCT-
BNR process. Figure C1 shows the BioWin simulator configuration of the pilot 
UCT- BNR process.  
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Figure C 1. BioWin Simulator flow diagram of UCT-BNR process. 
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Appendix D 
YES Assay Preparatory Procedures and Solid Phase Extraction 
The preparatory procedures in this section were adapted from Routledge and 
Sumpter (1996) and the operating manual provided by Prof. C. Metcalfe as 
presented by Citulski (2012). 
Preparation of Stock solution 
A) Estradiol (E2) Standard 
  Weigh 55.6 mg of 98% pure 17-β-estradiol  
 
 Transfer E2 to a 100mL volumetric flask  
 Use Pasteur pipette to wash down any remaining E2 from the weighing 
boat into the volumetric flask using absolute ethanol  
 Add ethanol until the volumetric flask is filled; stopper the flask, seal with 
Teflon tape, and hand-shake for ~30 seconds until the E2 is dissolved 
  Charge a disposable 1mL glass pipette x3 with E2 stock solution; transfer 
1mL to a second 100mL volumetric flask; reseal the stock solution with 
stopper and Teflon tape, and place in freezer for storage  
 Fill second 100mL volumetric flask with absolute ethanol, stopper, seal 
with Teflon tape, and hand-shake for ~30 seconds  
 Charge a disposable 1mL glass pipette x3 with intermediate E2 solution; 
transfer 1mL to a third 100mL volumetric flask; dispose of the 
intermediate solution after use  
 Fill third 100mL volumetric flask with absolute ethanol, stopper, seal with 
Teflon tape, and hand-shake for ~30 seconds, store in the -20oC freezer, but 
return to room temperature before use (this is the working E2 standard for 
the assay, and has a concentration of 54.48μg/L (2 x 10-7M) E2).  
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B) Minimal Medium  
Add the following to 1000 mL of Milli-Q water and stir with magnetic stirrer on a 
hot plate set to 75oC until all constituents are dissolved:  
 13.61 g potassium phosphate monobasic (KH2PO4)  
 1.98 g ammonium sulphate ((NH4)2SO4)  
 4.2 g potassium hydroxide (KOH)  
 0.2 g magnesium sulphate (MgSO4,)  
 1mL of 40 mg/50 mL ferric sulphate (Fe2(SO4)3) 
 50 mg L-leucine  
 50 mg L-histidine  
 50 mg adenine  
 30 mg L-tyrosine  
 30 mg L-isoleucine   
 30 mg L-lysine hydrochloride  
 25 mg L-phenylalanine  
 20 mg L-arginine hydrochloride  
 20 mg L-methionine  
 100 mg L-glutamic acid  
 150 mg L-valine  
 375 mg L-serine   
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 Pipette 45mL aliquots into 100 mL Kimax bottles  
 Autoclave at 121oC for 10 minutes  
 Store sealed containers at room temperature  
Glucose Solution  
 Weigh out 20 g of (+)-D-Glucose, anhydrous, add to 250 mL Kimax bottle  
 Measure 100 mL of Milli-Q water into the Kimax bottle  
 Autoclave at 121oC for 10 minutes  
 Store sealed container at room temperature  
 
Vitamin Solution  
 Add the following to 180 mL of Milli-Q water in a sterile beaker:  
 8 mg of pyridoxine  
 8 mg of thiamine hydrochloride  
 8 mg (+)-pantothenic acid (D-calcium pantothenate)  
 40 mg inositol  
 20 mL of 2 mg/100 mL biotin in Milli-Q water  
 
 Sterilize the solution by syringe-filtering (using a 0.2μm filter tip) into a 
250 mL sterilized Kimax bottle  
 Store at 4oC  
 
L-Aspartic Acid Solution  
 Add 100 mg of L-aspartic acid to 25 mL of Milli-Q water  
 Sterilize the solution by autoclaving at 121oC for 10 minutes  
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 Store at room temperature  
 
L-Threonine Solution  
 Add 600 mg of L-threonine to 25 mL of Milli-Q water  
 Sterilize the solution by autoclaving at 121oC for 10 minutes  
 Store at 4oC  
 
Cupric Sulphate Solution  
 Add 320 mg of anhydrous cupric sulphate to 100 mL of Milli-Q water in a 
sterile beaker  
 Sterilize the solution by syringe-filtering (using a 0.2μm filter tip) into a 
100mL sterilized Kimax bottle  
 Store at room temperature  
 
Chlorophenol Red-β-Galactopyranoside (CPRG) Solution  
 Add 100 mg of chlorophenol red-β-D-galactopyranoside to 10mL of 
absolute ethanol in an amber glass vial  
 
 Store at 4oC  
 
Preparation of HER Yeast Culture 
Day One  
 Retrieve 10x concentrated yeast stock from the -20oC freezer and thaw in a 
beaker 
 Prepare growth medium in laminar flow hood by pipetting the listed 
solutions into a 45mL sterile aliquot of minimal medium:  
 
 5 mL glucose solution  
 1.25 mL aspartic acid solution  
 0.5 mL vitamin solution  
 0.4 mL threonine solution  
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 0.125 mL cupric sulphate solution  
 
 Vortex mix thawed 10x concentrated yeast stock to suspend cells  
 Add 250μL of 10x concentrated yeast stock to the growth medium, and 
place in incubator/shaker set to 28oC and 250 rpm  
 
 
Day Two (~ 24 hours after initiating incubation)  
 
 Mix a second batch of growth medium, as per Day 1 instructions  
 Using a sterile pipette, transfer 2 mL growth medium to a disposable 
cuvette, and use this as a blank to measure the optical density of the yeast 
solution; use a second sterile pipette to transfer 2 mL of the cultured yeast 
solution to a disposable cuvette  
 
 Measure the blank-corrected optical density of the yeast stock at 630nm 
(Genesys 10 UV-Vis Scanning Spectrophotometer or equivalent)  
 If OD630nm ~ 1.0, yeast stock is ready to be used (after a 24-hour incubation 
period, the OD630nm has typically been 0.90 – 1.25)  
 To the remaining growth solution, add cultured yeast in 0.5mL 
increments, and check the OD630nm after each addition until an absorbance 
of ~0.1 is achieved (about 2.5mL ± 0.5mL of yeast culture usually added)  
 Prepare enough bottles of growth solution to fill the amount of microtiter 
plates that will be used, and add sufficient yeast culture to each to achieve 
OD630nm of ~0.1, and then add 0.5mL of CPRG solution to each bottle; this 
mixture can now be used to fill the microtiter plates  
 
3.6.2 Preparation of the Microplates 
 
 Use 300 μL flat-bottomed microtiter plates (Whatman)  
 Prepare a ― ”dummy row” (sufficient to create a quadruplicate set of 
standard curves) as follows:  
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 Pipette 100μL of absolute ethanol into wells C2-C12 of a plate  
 Pipette 200μL of E2 working standard into well C1; then withdraw 
100μL from this well and add to well C2, fill and discharge the 
pipette x5 to mix the contents (this will yield a 2x dilution in well 
C2)  
 
 Withdraw 100μL of solution from well C2, and add to well C3, 
charging the pipette x5 to mix; repeat this process across the 
remaining wells, and discard the final excess 100μL from well C12  
 Cover the ― ”dummy row” with lab or autoclave tape, and then – 
working from the lowest concentration well, C12 – pipette four 
10μL aliquots of diluted E2 standard into wells E/F/G/H 12; repeat 
this process, successively uncovering wells C11 - C1 and adding the 
solution to the corresponding E/F/G/H wells  
 
 Pipette 100μL of absolute ethanol into each of wells A1 - A12 to create a 
negative blank  
 Allow ethanol/E2 solution to evaporate by placing the microplate in the 
laminar flow hood  
 When all solvent has evaporated from individual wells, add 200μL of the 
combined growth medium/CPRG/yeast mixture to each well in the 
sample assay microplate  
 After addition of yeast culture and incubation, the standard 
curve/negative control plate should resemble Figure D2.  
 
Environmental Sample Extracts  
 
 Add 80μL of cleaned solvent extract from an environmental sample to 
well 1 of the row; add another 80μL of extract to well 2, and as with the E2 
curve procedure, serially-dilute the contents of well 2 across the remaining 
wells; repeat as desired to obtain replicate curves  
 Allow solvent to evaporate by placing the microplate in the laminar flow 
hood  
  
256 
 
 
 When all solvent has evaporated from individual wells, add 200μL of the 
combined growth medium/CPRG/yeast mixture to each well in the 
sample assay microplate  
 Seal the plate(s) with autoclave tape  
 Place plates in the incubator/shaker and tape to the shaker plate; incubate 
at 32oC with the shaker tray set to 150 rpm, for 72 hours  
 
3.6.3 Reading the Microplates 
 A microplate reader (TECAN) was used to determine the absorbance of 
the samples at both 620nm (to evaluate sample turbidity) and 540nm (to 
evaluate colour development)  
 The corrected absorbance values were calculated as follows:  
 Corrected Absorbance = AB540 nm – (AB620nm – Control620nm, average)  
 
3.6.4 Preparation and storage of 10X concentrated yeast stock  
Day One  
 Make growth medium (minimal medium + vitamin solution/etc.) and add 
125μL of concentrated yeast stock (stored in the -80oC freezer) thawed in a 
beaker of ice in the laminar flow hood  
 
 Place in incubator at 28oC with the orbital shaker set to 250 rpm for 
approximately 24 hours  
 
Day Two  
 Make more growth medium and add 1mL of yeast from ― ” Day 1” 
culture per ~50mL (several can be made at one time)  
 Incubate at 28oC with the orbital shaker set to 250rpm for approximately 
24 hours  
 
Day Three  
 Transfer each culture made on Day Two to a sterile 50mL centrifuge tube 
(with closure)  
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 Centrifuge at 4oC for 10 minutes at 2000g  
 In laminar flow hood, decant supernatant and re-suspend centrifuged 
yeast pellet in 5mL of a minimal medium/glycerol mixture (45mL minimal 
medium + 5.5mL glycerol, previously autoclaved at 121 oC/10 minutes)  
 Transfer 0.5 mL aliquots to sterile GC vials (previously autoclaved at 121 
oC/10 minutes), cap and crimp, and store at -20 oC  
 The prepared yeast stocks are good for 4 months  
 
 
 
Figure D-1. Sample Extraction Process (Multi-Residue Extraction Technique). 
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Figure D-2. Example of Ethanol Negative Control Row (blank) and E2 
Standard Curve. 
 
 
Figure D-3. Example of YES-Assay Dose Response Curve for Blank and E2 
Standard Curve. 
 
 
  
259 
 
Appendix E 
Chemical Structure of Selected Chemical Compounds 
Ibuprofen (C13H18O2) 
 
Meprobamate (C9H18N2O4) 
 
Carbamazepine (C15H12N2O) 
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Gemfibrozil (C15H22O3) 
 
Trimethoprim (C14H18N4O3) 
 
Sulfamethoxazole (C10H11N3O3S) 
 
Androstenedione (C19H26O2) 
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Estrone (C18H22O2) 
 
17-β-Estradiol (C18H24O2) 
 
 
Nonyl-phenol (C15H24O) 
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Bisphenol-A (C15H16O2) 
 
Ethinylestradiol (C20H24O2) 
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Appendix F 
Micropollutant concentrations in treatment trains 
ng/L  July 
IBU MEP GEM CBZ TMP SMX ADR E1 
Sewage C1 7/7/2011 1427 16 24 242 134 82 72 40 
Influent C2 7/7/2011 1377 9 21 233 107 80 66 24 
CAS - N C3 7/7/2011 5 8 4 260 71 16 ND ND 
CAS C4 7/7/2011 141 9 31 280 86 32 7 3 
CAS - 
BNR C5 7/7/2011 ND 11 9 287 32 42 ND 2 
Sewage D1 7/19/2011 1247 8 22 209 118 107 50 24 
Influent D2 7/19/2011 1267 5 20 194 104 111 36 22 
CAS - N D3 7/19/2011 ND 5 ND 227 92 21 ND ND 
CAS D4 7/19/2011 440 5 37 223 97 42 8 6 
AN D5 7/19/2011 1327 5 21 198 44 50 24 18 
03AX D6 7/19/2011 657 2 10 146 26 14 ND 7 
C5O2 D7 7/19/2011 2 6 9 218 33 22 ND ND 
CAS BNR D8 7/19/2011 ND 5 9 234 30 16 ND ND 
           
   IBU MEP GEM CBZ TMP SMX ADR E1 
 Average Sewage 1337 12 23 226 126 94 61 32 
  Influent 1322 7 21 214 105 96 51 23 
  CAS - N 5 7 4 244 82 18 ND ND 
  CAS 291 7 34 251 92 37 7 4 
  CAS - BNR ND 8 9 260 31 29 ND 2 
           
 Stdev  IBU MEP GEM CBZ TMP SMX ADR E1 
  Sewage 127 5 2 23 11 18 16 11 
  Influent 78 3 1 28 2 22 21 1 
  CAS - N 0 1 0 12 7 2 ND ND 
  CAS 106 2 2 20 4 4 1 1 
  CAS - BNR ND 4 0 37 1 19 ND ND 
 
ng/L  August IBU MEP GEM CBZ TMP SMX ADR E1 
Sewage E1 8/3/2011 1257 9 23 175 112 148 59 2 
Influent E2 8/3/2011 1413 9 24 196 116 150 51 16 
CAS - N E3 8/3/2011 nd 14 nd 234 72 34 24 24 
CAS E4 8/3/2011 48 13 30 219 82 94 nd 2 
CAS - 
BNR E5 8/3/2011 nd 15 8 223 44 121 nd nd 
Sewage F8 8/24/2011 530 9 33 229 91 196 42 4 
Influent F1 8/24/2011 427 14 26 246 101 20 43 2 
CAS F2 8/24/2011 nd 22 nd 316 46 4 nd 2 
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CAS - N F3 8/24/2011 194 11 40 229 32 9 nd nd 
CAS - 
BNR F4 8/24/2011 nd 15 nd 274 68 2 54 42 
AN F5 8/24/2011 254 14 17 252 68 17 6 37 
AX F6 8/24/2011 224 11 20 232 116 47 nd 4 
O2 F7 8/24/2011 480 11 12 247 94 19 39 3 
Sewage G8 8/30/2011 25 19 9 195 105 36 10 8 
Influent G2 8/30/2011 27 21 11 219 101 34 10 9 
CAS G1 8/30/2011 nd 20 nd 293 97 nd nd 6 
CAS - N G3 8/30/2011 2 19 nd 258 96 41 nd 2 
CAS - 
BNR G4 8/30/2011 nd 10 nd 176 18 nd nd nd 
AN G5 8/30/2011 nd 22 nd 280 71 nd 3 8 
AX G6 8/30/2011 3 25 nd 308 75 5 nd 1 
O2 G7 8/30/2011 4 24 9 297 86 40 nd 2 
           
           
   IBU MEP GEM CBZ TMP SMX ADR E1 
 Average Sewage 604 12 22 200 103 127 37 5 
  Influent 622 14 20 221 106 68 34 9 
  CAS - N nd 15 40 240 67 28 24 13 
  CAS 81 18 30 276 75 49 nd 3 
  CAS - BNR nd 13 8 224 44 62 54 42 
           
           
 Stdev  IBU MEP GEM CBZ TMP SMX ADR E1 
  Sewage 619 6 12 27 11 82 25 3 
  Influent 661 6 8 25 9 71 22 7 
  CAS - N nd 4 ND 15 32 17 ND 16 
  CAS 100 5 ND 51 26 64 ND 3 
  CAS - BNR nd 3 ND 49 25 84 ND ND 
           
 RSD Sewage 103 47 56 14 11 65 67 71 
  Influent 106 41 39 11 8 105 64 75 
  CAS - N ND 29 ND 6 49 60 ND 120 
  CAS 123 27 ND 18 35 129 ND 81 
  CAS - BNR ND 22 ND 22 58 136 ND ND 
 
ng/mL  September IBU MEP GEM CBZ TMP SMX ADR E1 
Influent H1 Sept-14-2011 ND 0.017 ND 0.216 0.034 0.009 ND 0.004 
CAS H2 Sept-14-2011 ND 0.024 ND 0.226 0.033 0.004 ND 0.004 
CAS-N H3 Sept-14-2011 ND 0.027 ND 0.284 0.042 0.002 ND ND 
CAS-BNR H4 Sept-14-2011 ND 0.022 ND 0.254 0.025 ND ND 0.003 
AN H5 Sept-14-2011 ND 0.021 ND 0.262 0.030 ND ND 0.009 
AX H6 Sept-14-2011 ND 0.023 ND 0.270 0.025 ND ND 0.013 
O2 H7 Sept-14-2011 ND 0.021 ND 0.258 0.028 ND ND 0.009 
Sewage H8 Sept-14-2011 ND 0.017 ND 0.208 0.043 0.009 ND 0.005 
Influent I1 Sept-16-2011 1.607 0.008 0.035 0.168 0.031 0.130 ND ND 
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CAS I2 Sept-16-2011 0.034 0.008 0.043 0.193 0.037 0.077 ND ND 
CAS-N I3 Sept-16-2011 ND ND ND 0.002 0.001 ND ND ND 
CAS-BNR I4 Sept-16-2011 0.023 0.010 0.036 0.210 0.024 0.086 ND ND 
AN I5 Sept-16-2011 ND ND ND ND ND ND ND ND 
AX I6 Sept-16-2011 ND ND ND ND ND ND ND ND 
O2 I7 Sept-16-2011 ND ND ND ND ND ND ND ND 
Sewage I8 Sept-16-2011 1.529 0.011 0.049 0.225 0.041 0.185 ND ND 
Influent J1 Sept-20-2011 1.367 0.009 0.026 0.128 0.027 0.103 ND ND 
CAS J2 Sept-20-2011 0.035 0.008 0.031 0.209 0.031 0.119 ND ND 
CAS-N J3 Sept-20-2011 0.041 0.009 0.007 0.238 0.033 0.079 ND ND 
CAS-BNR J4 Sept-20-2011 0.019 0.009 0.031 0.218 0.026 0.116 ND ND 
AN J5 Sept-20-2011 0.022 ND ND 0.002 0.001 0.003 ND ND 
AX J6 Sept-20-2011 0.590 0.009 0.031 0.201 0.022 0.176 ND ND 
O2 J7 Sept-20-2011 0.022 0.009 0.029 0.187 0.022 0.162 ND ND 
Sewage J8 Sept-20-2011 1.437 0.008 0.024 0.146 0.035 0.164 ND ND 
           
           
           
 Average  IBU MEP GEM CBZ TMP SMX ADR E1 
  Sewage 1483 12 36 193 39 119 ND 4 
  Influent 1487 11 30 171 30 81 ND 4 
  CAS - N 41 12 7 175 26 41 ND ND 
  CAS 35 13 37 209 34 67 ND ND 
  CAS - BNR 21 14 33 227 25 101 ND ND 
           
 Stdev  IBU MEP GEM CBZ TMP SMX ADR E1 
  Sewage 65 5 17 42 4 96   
  Influent 170 5 6 44 3 64   
  CAS - N 0 12 0 151 22 55   
  CAS 1 9 8 17 3 58   
  CAS - BNR 3 8 4 23 1 21   
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Appendix G 
Trimethoprim batch test data 
 
Aerobic-1B ug/L mg/L mg/L mg/L mg/L mg/L
hr TRM-2 std-2 C/Co COD PO4-P NH3-N NO3-N NO2-N
0 0.529 0.124 1 503.00 193.76 98.27 4.03 0.42
0.25 0.643 0.012 0.940469 451.00 175.52 94.73 2.83 0.37
4.25 0.362 0.011 0.818182 231.00 148.04 69.54 26.67 0.93
16.07 0.161 0.004 0.174487 166.00 82.54 31.30 65.67 0.06
20.07 0.137 0.032 0.101026 154.00 79.62 18.59 78.33 0.17
24.65 0.103 0.021 0.083284 154.00 76.17 10.78 88.69 0.01
39.65 0.079 0.023 0.017889 168.33 80.44 5.56 91.67 0.02
43.73 0.073 0.022 0.01654 172.33 84.13 0.04 97.33 0.01
47.9 0.028 0.002 0.016129 186.00 85.03 0.01 98.67 0.01
64.07 0.022 0.002 0.016129 208.67 89.01 0.05 100.33 0.02
68.07 0.019 0.003 0.016129 216.00 92.19 0.02 101.00 0.01
73.07 0.018 0.002 0.016129 229.00 95.28 0.01 102.33 0.01
  
267 
 
 
 
 
Aerobic-1  (ug/L)
hr TRM-1-1 C/Co Std COD SD PO4-P SD NH3-N SD NO3-N SD NO2-N SD
0.00 0.656 0.179 600.33 28.22 162.40 3.81 114.67 0.99 0.40 0.00 0.02 0.00
0.25 0.549 1.000 0.022 599.67 22.14 152.00 4.35 113.40 2.09 0.20 0.00 0.01 0.00
4.25 0.489 0.892 0.018 286.67 51.64 118.00 3.35 81.23 1.24 1.70 0.00 0.73 0.00
16.07 0.160 0.292 0.001 171.30 18.88 40.46 0.65 39.60 1.18 30.00 1.00 0.76 0.01
20.07 0.122 0.222 0.021 144.67 4.04 32.39 0.21 25.40 11.88 47.00 1.00 0.01 0.01
24.65 0.094 0.171 0.013 128.33 4.62 22.30 0.59 19.10 0.50 52.00 1.00 0.69 0.01
39.65 0.058 0.106 0.030 135.33 2.08 22.20 0.21 7.73 0.21 76.00 1.00 0.05 0.02
43.73 0.054 0.098 0.027 138.67 4.51 22.30 0.20 0.40 0.20 86.33 0.58 0.21 0.01
47.90 0.024 0.043 0.006 142.67 1.53 23.20 0.05 0.33 0.06 88.33 0.58 0.10 0.01
64.07 0.020 0.036 0.004 146.30 0.00 23.20 0.00 0.17 0.03 89.00 1.00 0.04 0.00
68.07 0.018 0.032 0.002 152.33 0.58 23.10 0.05 0.06 0.01 93.00 1.00 0.03 0.00
73.07 0.017 0.031 0.002 166.33 1.53 30.20 0.10 0.07 0.01 95.00 1.00 0.02 0.00
Aerobic-2 ug/L
hr TRM-2 Std-1 C/Co COD SD NH3-N SD NO3-N SD PO4-P SD
0 0.218 0.18 535.00 19.47 15.20 0.99 3.50 0.00 187.52 1.73
0.25 0.214 0.02 1.000 462.67 22.03 15.20 2.09 3.40 0.00 170.32 3.49
4.25 0.165 0.02 0.771 231.33 19.35 16.00 1.24 3.50 0.00 36.68 0.62
16.07 0.095 0.00 0.446 172.33 2.52 15.80 1.18 3.60 1.00 16.68 0.19
20.07 0.086 0.02 0.400 164.67 3.79 16.70 1.80 3.80 1.00 12.42 0.04
24.65 0.072 0.01 0.337 169.67 6.03 15.90 0.50 3.90 1.00 12.44 0.46
39.65 0.039 0.03 0.182 174.33 1.53 16.80 0.21 3.60 1.00 13.61 0.10
43.73 0.038 0.03 0.178 188.33 2.52 15.20 0.20 4.20 0.58 14.35 0.05
47.9 0.026 0.01 0.121 194.00 13.00 15.30 0.06 3.50 0.58 13.58 0.03
64.07 0.021 0.00 0.098 202.00 12.00 14.50 0.03 3.50 1.00 12.87 0.03
68.07 0.014 0.00 0.065 217.50 6.36 15.70 0.01 3.50 1.00 14.39 0.11
73.07 0.009 0.00 0.041 219.00 11.00 15.20 0.01 3.40 1.00 20.07 0.05
